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PREFACE 
Since their description as infectious agents at the end of the 19
th
 century, staphylococci 
have been a continuous field of interest for clinicians and microbiologists. Most attention has 
ever gone to Staphylococcus aureus, being one of the major pathogens in humans and some 
animal species. Almost every aspect of this organism has been intensely studied, and it has 
been found to possess a remarkable versatility, being probably most pertinently illustrated in 
the development of resistance to all classes of antimicrobials that are used for treatment of its 
infections. Methicillin resistance, the historical name for general resistance to β-lactam 
antimicrobials, is of particular concern. Not only are β-lactams still one of the most frequently 
used groups of antimicrobials in human as well as veterinary medicine, methicillin resistance 
is also often being accompanied by additional antimicrobial resistances. 
Methicillin-resistant S. aureus (MRSA) has for the most part presented itself as merely a 
human problem, being a major hospital pathogen and having established a reservoir in healthy 
community members. However, since the early 2000s, MRSA is increasingly reported from 
domestic animals. A specific MRSA lineage, CC398, has emerged in pigs and has been found 
capable of affecting other species as well. Yet, for Belgium, the occurrence of MRSA has 
been poorly assessed for some important animal species, most notably dogs and bovines. 
In addition to MRSA, methicillin-resistant non-S. aureus staphylococci (MRNAS) have 
become acknowledged in the past decades as common pathogens in human hospitals. 
Moreover, MRNAS are suggested to function as a reservoir for the genetic determinant of 
methicillin resistance, the mecA gene. Until now, very little is known on the presence and 
diversity of MRNAS in animals and on their potential to serve as a reservoir for antimicrobial 
resistance determinants such as mecA. 
The aim of the research presented here was to gain more insight in the occurrence and 
diversity of methicillin-resistant staphylococci in animals, and to elucidate the potential of 
animal MRNAS to function as reservoir for methicillin and other antimicrobial resistances. 
The results of this research are presented in Chapters 4-7, and they are followed by a general 
discussion. This work is started with an introductory review of the literature on methicillin-
resistant staphylococci. In Chapter 1, the staphylococci are introduced and the most 
important techniques for identification and typing of staphylococci are briefly discussed. In 
Chapter 2, the genetics and some other relevant aspects of methicillin resistance are 
presented. Chapter 3 gives a short history of MRSA and summarises the current knowledge 
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on the ecology and epidemiology of methicillin-resistant staphylococci in those animal 
species that were investigated during this four-year study. 
  
  
I - Review of the Literature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Partly adapted from 
W. Vanderhaeghen, K. Hermans, F. Haesebrouck, P. Butaye. (2010)  
Methicillin-resistant Staphylococcus aureus (MRSA) in food production animals. 
Epidemiology and Infection 138, 606-625.
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CHAPTER 1 – THE STAPHYLOCOCCI 
1.1. Microbiology of staphylococci 
1.1.1 Taxonomy 
In Figure 1, the classification of the genus 
Staphylococcus is presented. The genus currently 
consists of 44 species and 21 subspecies (Euzéby, 
2012), which are listed in Table 1. Between the 
taxonomic levels of genus and species, 
subdivisions in Staphylococcus species groups can 
be made, based on DNA-DNA homology (Kloos, 
1980; Kloos and Schleifer, 1986; Schleifer and Bell, 2009).  
 
1.1.2 General characteristics of staphylococci 
1.1.2.1 Phenotypic characteristics 
Staphylococci are Gram-positive spherical 
bacteria that appear in single cells (size: 0.5 µm-
1.5 µm), pairs, short chains or irregular grape-like 
clusters, the latter being the etymological origin of 
their name (Gr. staphulê: bunch of grapes). Except for the strictly anaerobic Staphylococcus 
aureus subsp. anaerobius and Staphylococcus saccharolyticus, staphylococci are facultative 
anaerobic. Staphylococci are halophilic; most species can grow in NaCl concentrations of 
10% or more (Schleifer and Bell, 2009). 
Staphylococcal colonies are opaque and of variable colour, ranging from light grey to 
white to yellow-white and yellow-orange. The colour changes (becomes more pronounced) in 
course of time and depends on the incubation temperature. For a given isolate, the colony 
colour can vary depending on the kind of agar it is grown upon. On blood agar, a colony 
centre can often be distinguished with a different, often darker pigment. The colonies mostly 
have smooth edges and are slightly convex with a creamy appearance. After 24h of incubation 
at 35-37°C, colonies have diameters of 1-2 mm to 4-5 mm. 
 
  
 
 
Bacteria (domain) 
 
Firmicutes (phylum) 
 
Bacilli (class) 
 
Bacillales (order) 
 
Staphylococcaceae (family) 
 
Staphylococcus (genus) 
Figure 1. Classification of genus Staphylococcus 
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Table 1. List of the currently recognized Staphylococcus species (n = 44) and subspecies (n = 21), with 
indication of their (in)ability to clot plasma through production of coagulase (see below). The first column 
shows the species group to which some species have been assigned through investigations of their DNA 
homology (Kloos, 1980; Kloos and Schleifer, 1986; Schleifer and Bell, 2009). 
Species group Species (subspecies) Coagulase
a 
S. epidermidis 
S. capitis (subsp. capitis ; subsp. urealyticus) ; S. caprae ; S. epidermidis ; 
S. haemolyticus ; S. hominis (subsp. hominis ;  subsp. novobiospeticus) ;   
S. lugdunensis ; S. pasteuri ; S. saccharolyticus ; S. warneri 
 
S. hyicus 
S. chromogenes 
S. hyicus 
 
variable 
S. intermedius 
S. delphini ; S. intermedius ; S. pseudintermedius ; S. schleiferi (subsp. 
coagulans ; subsp. schleiferi) 
+ (except S. schleiferi 
subsp.schleiferi) 
S. saprophyticus 
S. cohnii (subsp. cohnii ; subsp. urealyticus) ; S. equorum (subsp. 
equorum ; subsp. linens) ; S. gallinarum ; S. kloosii ; S. saprophyticus 
(subsp. bovis ; subsp. saprophyticus ) ; S. xylosus 
 
S. sciuri 
S. sciuri (subsp. carnaticus ; subsp. rodentium ; subsp. sciuri) ;                 
S. vitulinus ; S. fleurettii ; S. lentus 
 
S. simulans S. simulans ; S. carnosus (subsp. carnosus ; subsp. utilis)  
Not assigned to a 
species group 
S. aureus (subsp. anaerobius ; subsp. aureus) 
S. agnetis 
S. arlettae ; S. auricularis ; S. condimenti ; S. devriesei ; S. felis ;             
S. lutrae ; S. massiliensis ; S. microti ; S. muscae ; S. nepalensis ;            
S. pettenkoferi ; S. piscifermentans ; S. rostri ; S. simiae ;                        
S. succinus (subsp. casei ; subsp. succinus) 
+ 
variable 
 
 
 
a
 + : the majority of strains is coagulase-positive // - : the majority of strains is coagulase-negative // variable: coagulase-production 
varies among strains 
 
The staphylococci are typically catalase-positive (except for S. aureus subsp. anaerobius 
and S. saccharolyticus), the latter distinguishing them from the catalase-negative streptococci 
and enterococci. Occasionally though, catalase-negative strains can be found (Piau et al., 2008; 
Kallstrom et al., 2011). Several staphylococcal species show (in)complete haemolysis (Schleifer and 
Bell, 2009). This trait can vary among different strains of a species (Hermans et al., 2010) and the 
level of haemolysis also depends on the source of red blood cells used as well as on length 
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and temperature of incubation. Staphylococci are susceptible to lysostaphin but resistant to 
lysozyme (Schleifer and Bell, 2009). 
A key phenotypic trait used to differentiate among staphylococci is the ability to clot blood 
plasma through conversion of fibrinogen into fibrin, by production of the enzyme coagulase 
(Table 1). Coagulase-positive staphylococci (CPS) are generally regarded as more pathogenic 
than coagulase-negative staphylococci (CNS) (Hermans et al., 2010). 
 
1.1.2.2 Genotypic characteristics 
Staphylococcal genomes consist of a single circular chromosome, with typically a low 
G+C content (27-41 mol%) and a size varying between 2.56 Mb and 3.04 Mb (EMBL Genomes 
Pages, 2011). 
The genome of S. aureus consists of two components, a core genome and an accessory 
genome, with the latter comprising the core-variable (CV) genes and mobile genetic elements 
(MGEs) (Lindsay, 2008). The core genome is relatively conserved between all lineages of S. 
aureus, of which ten major and several minor exist (Feil et al., 2003). Variation in the core 
genome occurs as single nucleotide polymorphisms and other minor changes in conserved 
core genes. Different combinations of CV genes shape the different lineages of S. aureus. 
Mobile genetic elements (MGEs) such as plasmids, bacteriophages, pathogenicity islands 
(PIs), transposons (Tn), staphylococcal chromosome cassettes (SCCs) and insertion sequences 
(IS) might carry virulence and/or resistance determinants and move around independently of 
lineages, granting S. aureus a large adaptability to changing environments (Firth and Skurray, 
2006; Lindsay, 2008). 
Less is known on the genomic structure and diversity of non-S. aureus staphylococci 
(NAS). It has been shown that the genomic backbones of Staphylococcus haemolyticus and 
Staphylococcus epidermidis are similar to S. aureus but that they evolve through different 
mechanisms (Takeuchi et al., 2005; Miragaia et al., 2007). Surprisingly, the uptake and loss of MGEs 
appears not to be a general mechanism in staphylococci for establishing diversity (Ben Zakour et 
al., 2009; Rosenstein et al., 2009; Heilbronner et al., 2011).  
 
1.1.3 Ecology and pathogenicity of staphylococci 
The staphylococci are commensals mainly associated with the skin and mucous 
membranes of humans, other mammals and birds (Kloos and Musselwhite, 1975; Kloos et al., 1976; 
Kloos, 1980; Devriese et al., 1985; Hauschild et al., 2010). They can also be found in amphibians, fish 
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and arthropods (Faghri et al., 1984; Kuzina et al., 2001; Slaughter et al., 2001; Newaj-Fyzul et al., 2008) and 
they have been detected in a variety of food products and on plants (Foster and Fogleman, 1993; 
García et al., 2002; Blaiotta et al., 2004; Olofsson et al., 2007; Resch et al., 2008; Coton et al., 2010; Herranen et 
al., 2010). Moreover, they are widespread in the environment, including air, water and solid 
surfaces (Strasters and Winkler, 1966; Kessie et al., 1998; Brooks et al., 2010; Coton et al., 2010), having 
even been found in some extreme environments such as the stratosphere, the deep sea and 
sugar thick juice (Wainwright et al., 2003; Sfanos et al., 2005; Justé et al., 2008). 
It is believed that staphylococci display some level of host- or niche-specificity (Kloos, 1980; 
Devriese, 1984a; Devriese et al., 1985; Devriese, 1990; Schleifer and Bell, 2009). However, most studies on 
the natural habitats of staphylococci date from several years ago, when the use of more 
reliable genotypic identification and typing methods was still limited and only part of the 
currently established species were known. Recently performed research based on genetic 
methods has further elucidated the population structure of some species, such as S. aureus 
(Smith et al., 2005; Rabello et al., 2007; Sung et al., 2008; Hata et al., 2010; Delgado et al., 2011; Sakwinska et 
al., 2011) and the Staphylococcus intermedius species group (Bannoehr et al., 2007). Yet, for most 
species, profound genetic population studies that include an adequate number of isolates from 
various habitats and geographical origins, from different host species and from infections as 
well as healthy carriers, are lacking. In addition, very little is known on factors that might 
explain host-specificity, rendering the interpretation of the concept of host- or niche-
specificity unclear for most staphylococcal species.  
Virtually all Staphylococcus species can cause infections upon favourable conditions. 
These include a lowered immunity of the host (e.g. through immuno-suppressive therapy) or 
damaged natural barriers that normally restrain the cells from entering hosts’ tissues (Kloos and 
Bannerman, 1994). The ability of the different species to cause infections also depends on the 
expression of virulence factors offering the capacity to adhere to the host’s tissues, to breach 
or avoid the host immune system, to multiply within the host and to generate products that 
damage the host (Kloos and Bannerman, 1994). It is widely acknowledged that S. aureus is the 
most virulent Staphylococcus species. Numerous toxins, surface proteins and exo-enzymes 
have been identified in this species, rendering it capable of causing aggressive and often lethal 
infections (Lowy, 2003). In contrast, the pathogenic potential of CNS generally relies on more 
subtle mechanisms such as adhesion to host surfaces and evasion of the immune system, 
rendering a more gentle and non-specific clinical picture with more subacute or chronic signs 
of infection (von Eiff et al., 2002; Queck and Otto, 2008). 
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In humans, staphylococci are among the most common causes of bacterial infections (Projan 
and Novick, 1997) and S. aureus is the most important pathogenic Staphylococcus species (Kloos 
and Bannerman, 1995). S. aureus infections can vary from mild to moderate skin and soft-tissue 
infections (SSTIs) to severe, live threatening invasive infections, such as pneumonia, 
osteomyelitis, endocarditis or bacteraemia (Kloos, 1980; Lowy, 1998). In addition, S. aureus can 
cause several toxinoses, such as toxic shock syndrome, scalded skin syndrome or food 
poisoning (Mead et al., 1999; Le Loir et al., 2003). S. aureus infections can affect all age-groups, 
sexes and races, and can occur in community members as well as hospitalised patients (Tenover 
and Gorwitz, 2006; Tracy et al., 2011). The vast majority of human infections caused by NAS are a 
consequence of hospitalisation (Kloos and Bannerman, 1994). NAS are among the five most 
commonly reported pathogens in hospital surveillances and are the most frequently reported 
pathogens in nosocomial bloodstream infections (Kloos and Bannerman, 1994; von Eiff et al., 2002). 
The most important NAS species causing infections is S. epidermidis, which can cause a 
variety of diseases such as bacteraemia, neonatal sepsis, native and prosthetic valve 
endocarditis, and infections of fluid shunts, prosthetic joints and orthopaedic devices (Galdbart 
et al., 1999; Heilmann and Peters, 2006; Muldrew et al., 2008; Hira et al., 2010). Other important NAS 
pathogens are S. haemolyticus, which has been described as the second most frequently 
isolated NAS species from blood cultures (Raimundo et al., 2002), Staphylococcus saprophyticus, 
which is the second most frequent cause of acute urinary tract infections among young female 
outpatients (Tristan et al., 2006), and Staphylococcus lugdunensis, which appears to be the 
relatively most virulent NAS species, resulting in more severe infections compared to other 
NAS infections (Queck and Otto, 2008). 
In veterinary medicine, three major pathogenic staphylococci are of importance, i.c. S. 
aureus, Staphylococcus pseudintermedius and Staphylococcus hyicus (Devriese, 1990; Kloos and 
Bannerman, 1995; Hermans et al., 2010). S. aureus causes disease in cattle, small ruminants, 
poultry, rabbits, pigs and horses (Devriese, 1990; Hermans et al., 2010). In cattle and small 
ruminants, it is one of the major causes of mastitis (Deinhofer and Pernthaner, 1993; Pitkälä et al., 
2004; Tenhagen et al., 2006). S. aureus can cause joint infections, osteomyelitis and septicemia in 
poultry (Fisher et al., 1998; McNamee and Smyth, 2000; Huff et al., 2000), and mastitis, exudative 
dermatitis, subcutaneous abscesses and pododermatitis in rabbits (Okerman et al., 1984; Hermans 
et al., 2010). Pigs may sporadically suffer from septicemia due to a S. aureus infection (Devriese, 
1990), while in horses, S. aureus can cause dermatitis and cellulitis (Devriese, 1984b). S. 
pseudintermedius is the most important Staphylococcus pathogen in dogs, causing 
predominantly skin infections and otitis (Philips and Kloos, 1981; Yamashita et al., 2005; Hermans et al., 
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2010). S. hyicus is particularly important in pigs as a cause of exudative epidermitis (greasy pig 
disease). It can also be involved in sporadic joint infections, flank biting and the ear-tip 
necrosis syndrome (Philips and Kloos, 1981; Devriese, 1990; Aarestrup and Jensen, 2002; Hermans et al., 
2010). Other NAS – and more specifically, the CNS – are acknowledged as the most important 
cause of subclinical mastitis of dairy cattle (Pitkälä et al., 2004; Tenhagen et al., 2006; Piepers et al., 
2007). In addition, CNS might cause (mild) clinical mastitis (Bradley et al., 2007; Piepers et al., 2007; 
Botrel et al., 2010). CNS can also cause mastitis in sheep and goats (Gutierrez et al., 1990; Deinhofer 
and Pernthaner, 1993; Las Heras et al., 1999) and can be implicated in various infections of other 
animal species (Devriese, 1990; Lilenbaum et al., 2000; Hermans et al., 2010). 
 
1.2 Identification and typing of staphylococci 
1.2.1 Phenotypical identification 
Within the family of the Staphylococcaceae, the genus Staphylococcus can be 
distinguished from the other three genera (Jeotgalicoccus, Macrococcus and Salinicoccus) by 
the oxidase-negativity of Staphylococcus (Schleifer and Bell, 2009). To differentiate the species 
within the genus Staphylococcus, various morphological and biochemical traits are used 
(Schleifer and Bell, 2009). As the first encounter with possible different species in a sample is on 
the primary isolation plate(s), successful isolation of different species should always start with 
a thorough study of colony morphology. However, to do so, it is essential that colonies are 
allowed to grow for a prolonged amount of time, as after 24h, most staphylococcal species 
basically appear the same. Ideal incubation conditions are 72h growth at 30-35°C followed by 
another 48h at room temperature (Kloos and Bannerman, 1994). 
For routine identification, a simplified phenotypical system has been described for human 
staphylococci by Kloos and Schleifer (1975) and for animal staphylococci by Devriese et al. (1985). 
Several commercial kits have been developed for rapid phenotypic identification of 
staphylococci. Examples are the BBL™ Crystal™ Gram-Positive ID Kit (Becton Dickinson), 
API Staph 32
®
 (BioMérieux) and Staph-zym
® 
(Rosco Diagnostica). Other methods include 
fully automated identification systems such as VITEK
®
 and VITEK
®
2 (BioMérieux) or BD 
Phoenix
TM
 Automated Microbiology System (Becton Dickinson). 
A drawback of commercial phenotypic identification systems is that they have mostly been 
validated for identification of human (clinical) staphylococci, resulting in a lower reliability 
for strains of animal origin. This has been well-demonstrated for staphylococci isolated from 
bovine mastitis (Santos et al., 2008; Capurro et al., 2009; Sampimon et al., 2009). Moreover, for 
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epidemiological and ecological studies, it is necessary that also less common staphylococcal 
species can accurately be identified. As there is often a lack of large collections of isolates 
from the less common species, phenotypical differences between these species are not always 
well-defined. In addition, considerable phenotypic variation can exist among isolates of the 
same Staphylococcus species, resulting in misidentification of isolates (Heikens et al., 2005; Layer 
et al., 2006; Kim et al., 2008). Hence, a variety of more reliable genotypic identification methods 
has been implemented for identification of staphylococci. 
 
1.2.2 Genotypical identification 
Genotypical identification methods can be grouped in two different approaches: 
sequencing of household genes that show a sufficient and reproducible level of variation 
between the different species, such as 16S rRNA (Johnson, 1994), rpoB (Drancourt and Raoult, 
2002), hsp60 (Goh et al., 1996; Goh et al., 1997; Kwok and Chow, 2003), sodA (Poyart et al., 2001; Sivadon et 
al., 2005), dnaJ (Shah et al., 2007), tuf (Heikens et al., 2005) or recA (Landeta et al., 2011), and 
fingerprinting-like techniques that link polymorphisms within genomic regions – ranging 
from a single gene to the whole genome – to different species. Examples of the latter 
techniques are internal transcribed spacer PCR of 16S and 23S rRNA (Barry et al. 1991; Mendoza 
et al., 1998), tRNA intergenic spacer PCR (Welsh and McClelland, 1991, 1992; Baele et al., 2000; Baele et 
al., 2001b; Supré et al., 2009), (GTG)5-PCR (Braem et al., 2011), amplified fragment length 
polymorphism (AFLP) (Piessens et al., 2010) and restriction fragment length polymorphism 
(RFLP)-PCR of genes such as gap, dnaJ and groEL (Yugueros et al., 2000, 2001; Layer et al., 2007; 
Hauschild and Stepanović, 2008; Santos et al., 2008). In general, a good agreement between 
genotypical identification methods is observed (Bergeron et al., 2011), being typically superior to 
phenotypical methods (Zadoks and Watts, 2009). 
An increasingly used method for identification of staphylococci and other bacteria is 
matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF), which is based on 
mass spectrometry analysis of the proteins contained in the surface of bacterial cells (Anhalt and 
Fenselau, 1975; Keys et al., 2004; Carbonnelle et al., 2007; Dupont et al., 2010). 
 
1.2.3 Phenotyping 
For certain CNS species, especially those that demonstrate a translucent colony type and/or 
pigment variation, e.g. S. epidermidis, S. warneri, S. lugdunensis, S. hominis, S. haemolyticus, 
S. simulans, S. saprophyticus and S. xylosus, thoroughly studying the colony morphology is a 
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good preliminary method for identifying prospective strains. As explained in section 1.2.1, 
this requires the application of adjusted incubation conditions. If doing so, colonies of the 
same strain exhibit similar features of size, consistency, edge, profile, lustre, and colour (Kloos 
and Bannerman, 1994). It must, however, be taken into account that certain strains may produce 
(a) variant morphotype(s) that could then be misclassified (Kloos and Bannerman, 1994). In that 
situation, additional studies are required to elucidate the relationship of each morphotype.  
Studying the morphology is in fact the first step of biotyping. Also other biological 
features can be tested for the means of typing, including the physiological and biochemical 
characteristics of isolates (Baird-Parker, 1963). Biotyping is still an initial typing method applied 
in many bacteriological laboratories (Casey et al., 2007). This can be combined with studying 
antibiograms (Kloos and Bannerman, 1994). Other phenotyping methods are serological typing 
(Live and Nichols, 1965) and phage typing (Wentworth, 1963). These techniques have been greatly 
abandoned, for the better of genotyping techniques. 
 
1.2.4 Genotyping 
A prerequisite for a good genotyping method is that it focuses on genomic regions that 
have an adequate degree of variability. Evidently, the latter is subjective; for different study 
intentions, different levels of discrimination are required (for example, infection control vs. 
evolutionary epidemiology). More below an overview is given of the most important 
techniques for genotyping of staphylococci. 
 
1.2.4.1 Restriction Fragment Length Polymorphism (RFLP) - Pulsed Field Gel 
Electrophoresis (PFGE) 
RFLP is based on the random distribution of restriction endonuclease cleavage sites on the 
bacterial genome. Upon digestion by an endonuclease, differences between strains are 
reflected in different fragment lengths and in different numbers of fragments. These 
differences can be generated by point mutations, insertions, deletions, inversions, or 
transpositions (Witte et al., 2006). According to the expected size and number of fragments, 
different methods are used to visualise the fragments. If working with an infrequently cutting 
enzyme (macrorestriction), the generated fragments are too large to be determined by ordinary 
gel electrophoresis. This can be resolved by using conditions of alternating current, called 
Pulsed-Field Gel Electrophoresis (PFGE). For typing of S. aureus and other staphylococci, 
PFGE using SmaI digestion is currently being considered as the gold standard method (Mulvey 
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et al., 2001; Murchan et al., 2003). Other enzymes can also be applied (Rasschaert et al., 2009; Argudin 
et al., 2010). 
The advantages of PFGE are its robustness and high discriminatory power, which make 
this method excellent for use in small scale epidemiological studies, where outbreak strains 
need to be distinguished from unrelated strains (Dominguez et al., 1994; Jones et al., 2002; Cookson et 
al., 2007). Disadvantages are its high cost and its laboriousness and the low comparability 
between laboratories. Attempts have been made to improve the latter problem, by 
harmonising the protocols (Mulvey et al., 2001; Murchan et al., 2003), with good result (Deplano et al., 
2006). However, intrinsic to the method, PFGE remains less suited for large-scale evolutionary 
studies (Blanc et al., 2002). 
 
1.2.4.2 Multiple-Locus Variable-number tandem-repeat Analysis (MLVA) 
MLVA has recently been developed for typing of S. aureus. In this technique the number 
of repeats in different tandem-repeat loci (called staphylococcal interspersed repeat units, 
SIRUs) yields an allelic profile, which can be used for comparing strains (Hardy et al., 2004, 
2006; Ikawaty et al., 2008, 2009). Although the technique appeared to have a high discriminatory 
power and good reliability (Hardy et al., 2006; Ikawaty et al., 2008), it is currently not widely used. 
Recently MLVA has been proven useful for typing of methicillin-resistant S. aureus (MRSA) 
strains of animal origin (Rasschaert et al., 2009) and for discriminating among bovine S. aureus 
strains (Gilbert et al., 2006). MLVA has also been described for typing of S. epidermidis strains 
(Johansson et al., 2006). 
 
1.2.4.3 Multilocus Sequence Typing (MLST) 
In multilocus sequence typing, internal fragments of a number of housekeeping genes are 
amplified and then sequenced (Maiden et al., 1998). The obtained sequences are compared to 
known alleles in a database (accessible on the internet) and an allele number is assigned. The 
allelic profile resulting from the combined allele numbers is called the sequence type (ST) 
(Maiden et al., 1998). Strains that differ in only one or two alleles are called Single Locus 
Variants (SLVs) and Double Locus Variants (DLVs), respectively. With ‘Based Upon Related 
Sequence Types’ (BURST) analysis, STs, SLVs and DLVs are grouped into Clonal 
Complexes (CCs). The ST that has the highest number of SLVs or DLVs is considered the 
ancestral ST, and a CC is numbered after its ancestral ST (Enright et al., 2000). 
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MLST protocols have been developed for S. aureus (Enright et al., 2000), S. epidermidis 
(Thomas et al., 2007) and S. pseudintermedius (Bannoehr et al., 2007). 
Considering the nature of the genes under investigation – slowly evolving genes that form 
part of the core genome – MLST is excellent for long-term evolutionary studies. Moreover, 
sequencing results are highly reproducible and easily exchanged through the internet, 
benefiting large-scale studies. On the other hand, the discriminatory power of MLST is rather 
low (Cookson et al., 2007), making MLST less suitable for microevolutionary studies. In 
addition, it is an expensive and time-consuming method. 
 
1.2.4.4 spa typing 
The staphylococcal protein A (spa) gene encodes the protein A, a cell wall-associated 
protein involved in highly diverse cell-host interactions. The gene contains a polymorphic X 
region, in which a variable number of different repeats of mostly 24-bp are present (Frenay et 
al., 1994). In spa typing, this repeat region is amplified and sequenced. The total number of 
repeats and the sequence of each repeat determine a repeat profile, the spa type. Different 
protocols have been proposed (Shopsin et al., 1999; Harmsen et al., 2003; Koreen et al., 2004). In 2003, 
a software package (Ridom StaphType) for rapid determination of the spa type was presented 
(Harmsen et al., 2003; www.ridom.de/staphtype). Since, the method and nomenclature of Harmsen et 
al. (2003) have been most widely used. While having long been available only for typing of S. 
aureus, recently, a spa typing method has been developed for S. pseudintermedius (Moodley et 
al., 2009). 
As it is also a sequencing method, spa typing shares some of its advantages with MLST, 
such as its high reproducibility and the possibility to exchange data via the internet. 
Moreover, as only one locus is being investigated, spa typing is less expensive and time 
consuming. Although the repeat region is less stable than the MLST housekeeping genes, 
conferring a higher diversity of spa types, there appears to be a good correlation between spa 
types and MLST, with related spa types being found in strains with the same genetic 
background (Mellmann et al., 2008). This provides usefulness of spa typing in evolutionary 
studies. However, its greater variability also provides a greater discriminatory power. 
Although slightly inferior to PFGE, spa typing can be of use in small-scale epidemiology 
research (Strommenger et al., 2006b; Cookson et al., 2007). Recently, the Panel on Biological 
Hazards of the European Food Safety Authority (EFSA) has recommended spa typing for 
discrimination between MRSA strains originating from food production animals (EFSA, 2009b).  
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CHAPTER 2   METHICILLIN RESISTANCE IN STAPHYLOCOCCI 
2.1 Cell wall synthesis, β-lactam antimicrobials and methicillin resistance 
The backbone of the Gram-positive cell wall is a multilayered net-like peptidoglycan 
sacculus that is essential for maintaining cell integrity and cell shape. It is made of glycan 
chains cross-linked by short peptides (Vollmer et al., 2008). Synthesis of the glycan chains is 
catalysed by transglycosylases, while cross-linking of the chains is catalysed by trans-
peptidases (Vollmer et al., 2008). Staphylococci have four native penicillin-binding proteins 
(PBPs) that possess transpeptidation activity (Giesbrecht et al., 1998); one of these, PBP2, also 
possesses transglycosylase activity (Murakami et al., 1994; Goffin and Ghuysen, 1998). 
The β-lactam antimicrobials are a group of natural and semi-synthetic compounds that are 
characterized by the presence of a functionally essential β-lactam ring (Figure 2). The 
bactericidal effect of β-lactam antimicrobials (in growing cells) arises through their binding 
with PBPs, leading to the acylation of the PBPs and to the inhibition of the transpeptidase 
reaction in peptidoglycan synthesis, eventually causing cell-burst mediated death followed by 
cell lysis (Giesbrecht et al., 1998). 
 
 
 
 
Shortly after the first clinical application of penicillin in the early 1940s, strains of S. 
aureus were identified that appeared resistant to its activity (Kirby, 1944). It was soon 
established that this was caused by the production of penicillinases or β-lactamases (Kirby, 1944, 
1945), enzymes that hydrolyse the β-lactam ring (Drawz and Bonomo, 2010). By the late 1960s, 
penicillin-resistant S. aureus strains had become a huge problem in hospitals all around the 
world and were also emerging in the community (Goldie et al., 1969). 
Figure 2. The essential chemical structure of different 
representatives of the class of β-lactam antimicrobials. http://textbookofbacteriology.net/antimicrobial_3.html 
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To counter the production of β-lactamases, β-lactamase-resistant β-lactam anti-microbials 
were developed. The first agent in this class, the semi-synthetic methicillin, was introduced in 
clinical practice in 1959. However, similar to what had occurred with penicillin, shortly upon 
introduction the first MRSA were detected (Barber, 1961; Jevons, 1961). A few years later, the 
first infections involving MRSA were reported (Stewart and Holt, 1963; Benner and Kayser, 1968). It 
was understood pretty quickly that in this case, resistance did not involve the degradation of 
the antibiotic by action of a β-lactamase (Seligman, 1966), but it still took two decades to 
identify that the actual cause was the expression of an acquired alternative PBP, called PBP2a 
or PBP2’ (Georgopapadakou, 1982; Hartman and Tomasz, 1984). 
In contrast to the native PBPs, PBP2a shows a very low affinity for β-lactam 
antimicrobials (Hartman and Tomasz, 1984). As a result, in the presence of β-lactams, the 
synthesis of peptidoglycan can be continued by the cooperative function of the transpeptidase 
activity of PBP2a and the transglycosylase activity of PBP2 (Pinho et al., 2001). 
The genetic determinant responsible for methicillin resistance, designated mec or mecA, 
was established to be located on the chromosome of S. aureus (Sjöström et al., 1975; Matsuhashi et 
al., 1986; Matthews et al., 1987). MecA appeared to be not native to S. aureus but to be inserted as 
a larger DNA fragment from another organism (Dubin et al., 1992; Hiramatsu, 1995). At the end of 
the 1990s, the nature of the genetic element that contained mecA was elucidated and it was 
called staphylococcal cassette chromosome mec, SCCmec (Katayama et al., 2000). 
 
2.2 Structure and characteristics of SCCmec 
2.2.1 SCCmec as mobile genetic element 
SCCmec elements integrate into and excise from the chromosome of S. aureus in a site-
specific manner. This site is called the integration site sequence (ISS) for SCC. It is located in 
an open reading frame (orfX) situated near the origin of replication that encodes a 23S rRNA 
methyltransferase (Katayama et al., 2000; IWG-SCC, 2009; Shore et al., 2011). Excision and integration 
are mediated by a group of serine recombinases, CcrAB or CcrC, that are encoded within the 
element (see below) (Katayama et al., 2000; Ito et al., 2001; Ito et al., 2004; IWG-SCC, 2009). 
Characteristic for the action of the Ccr enzymes is the establishment of direct repeats flanking 
the inserted SCCmec (Figure 3) (IWG-SCC, 2009; Wang et al., 2012a). 
It is unclear whether the integration of SCCmec in the chromosome of NAS species occurs 
at the same location and in the same manner as in S. aureus. 
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2.2.2 SCCmec essential regions: mec complex and ccr complex 
A SCCmec element is composed of two essential gene complexes: the mec complex and 
the ccr complex (Figure 3) (Katayama et al., 2000; IWG-SCC, 2009). 
 
 
 
 
The mec complex typically contains the mecA gene, complete or truncated copies of its 
direct regulatory genes, mecI and mecR1, and one or two copies of insertion sequence IS431 
(Hiramatsu et al., 1992; Katayama et al., 2001; Ito et al., 2004; IWG-SCC, 2009; García-Álvarez et al., 2011; 
Shore et al., 2011). Based on structural variations, five different classes of mec complex are 
currently distinguished (Figure 4). 
 
Class A: orfX - … -  IS431-mecA-mecR1-mecI                             - ... 
Class B: orfX - … -  IS431-mecA-ΔmecR1-ψIS1272                     - ... 
Class C: orfX - … -  IS431-mecA-ΔmecR1-IS431                          - ... 
Class D: orfX - … -  IS431-mecA-ΔmecR1                                    - ... 
Class E: orfX - … -  blaZ-mecALGA251-mecR1LGA251-mecILGA251    - ... 
 
Figure 4. Structure of the five different classes of mec complex that are currently being 
distinguished in staphylococci (www.sccmec.org). 
 
Figure 3. Basic schematic structure of a SCCmec element, with a type A mec gene complex (blue) and a ccr 
gene complex containing a ccrA and a ccrB gene (orange). Also the three Joining-regions (J1-J3), with an 
additional plasmid and transposon (Tn), are shown. The red arrowheads indicate the insertion site 
sequence (ISS) for staphylococcal cassette chromosome (SCC) that comprises direct repeat sequences. 
The ISS is located in an open reading frame designated orfX. 
Basic mec complex structures 
I – REVIEW OF THE LITERATURE  Chapter 2 – Methicillin resistance in staphylococci 
30 
Due to the presence of complete copies of mecI and mecR1, the class A mec complex is 
considered as the prototype mec complex (IWG-SCC, 2009). However, as appears from the class 
E mec complex, other basic structures might be present, possibly associated with the existence 
of mecA variants (see below). In addition, considerable variation can exist within the different 
mec complex classes. For example, in class C a differentiation is made between class C1.1, 
class C1.2 and class C2, based on the orientation and insertion location of IS431, the 
orientation of mecA and variations in the direct repeat units (dru) in the hypervariable region 
downstream of mecA (Ryffel et al., 1991). Also in other mec complexes variations have been 
described (IWG-SCC, 2009). New variations are likely to be found in the future, as there is an 
enormous number of SCCmec cassettes that have not been studied in detail, especially in 
methicillin-resistant NAS (MRNAS). 
The ccr complex contains one or two cassette chromosome recombinase (ccr) genes and 
additional orfs (Katayama et al., 2000; Ito et al., 2004; IWG-SCC, 2009). The classificication of ccr 
genes is quite complex and confusing. Currently, three phylogenetically distinct ccr genes, 
showing DNA sequence similarities ≤ 50%, have been identified: ccrA, ccrB and ccrC (IWG-
SCC, 2009). Within these three ccr genes, a distinction is made in allotypes, with ccr genes 
showing DNA similarities > 85% belonging to the same allotype and those showing DNA 
similarities between 50% and 85% belonging to different allotypes (IWG-SCC, 2009).  
For ccr genes A and B, to date six (A1, A2, A3, A4, A5, A7 and B1, B2, B3, B4, B5, B6, 
respectively) allotypes have been identified in staphylococci (Descloux et al., 2008; IWG-SCC, 2009; 
Pi et al., 2009; Zong and Lü, 2010; Li et al., 2011; Urushibara et al., 2011; www.sccmec.org). For ccrC, the 
large majority of alleles identified so far belonged to a single allotype, ccrC1; of this allotype, 
at least 10 variants have been identified in S. 
aureus and more can be found in NAS (Zong 
and Lü, 2010). These variants are allocated a 
number (e.g. ccrC1 allele 2). Recently, a 
second ccrC allotype, ccrC2, has been 
identified in Staphylococcus cohnii (Zong and 
Lü, 2010). 
According to the kind of ccr genes that are 
present, ccr complexes are categorised in 
types. At present, eight types have been 
recognized (www.sccmec.org) (Table 2), with 
type 6 having been described only in NAS, i.c. methicillin-resistant (MR) S. pseudintermedius 
ccr complex type Combination of ccr genes 
1 ccrA1 - B1 
2 ccrA2 - B2 
3 ccrA3 - B3 
4 ccrA4 - B4 
5 ccrC1 
6 ccrA5 - B3 
7 ccrA1 - B6 
8 ccrA1 - B3 
Table 2. Established types of ccr complex. 
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(Descloux et al., 2008), MR S. haemolyticus (Pi et al., 2009) and MR S. cohnii (Zong and Lü, 2010). 
Recently, a new ccr complex type has been identified in a MR Staphylococcus sciuri strain, 
combining a novel ccrA allotype (A7) and a ccrB3 allotype (Urushibara et al., 2011). 
 
2.2.3 SCCmec non-essential regions: joining regions J1, J2 and J3 
The other three parts of SCCmec are known as the J-regions, J1 to J3. These contain genes 
or pseudo-genes that are not essential and are designated ‘Joining regions’ (formerly 
‘Junkyard-regions’) (IWG-SCC, 2009). The J1-region is the part that lies between the ccr complex 
and the right extremity of SCCmec; J2 lies between the mec and ccr complex; J3 is the region 
between orfX and the mec complex (Figure 3). Some SCCmec elements have been found to 
harbour additional antimicrobial or metal resistance determinants in their J-regions (Ito et al., 
2001; Li et al., 2011). 
 
2.2.4 SCCmec types and subtypes 
SCCmec elements are categorized into different types based on the class of mec complex 
and the type of ccr complex that are 
present (Ito et al., 2001; IWG-SCC, 2009). 
Each SCCmec type is symbolized with 
a Roman numeral (Table 3). While 
initially it seemed that there were only 
a few different SCCmec types (Ito et al., 
2001), it has become clear that many 
more exist, and the nomenclature of 
SCCmec types is rapidly evolving. For 
the moment, eleven different SCCmec 
types (I - XI) are recognized in MRSA 
(Table 3). Yet, it can be expected that 
many more will be identified in the 
coming years, due to the accumulation of data, especially in MRNAS, on SCCmec elements 
that cannot be assigned to any of the current types. 
To overcome the uncontrolled publication of new SCCmec type designations, an 
international committee of experts, the International Working Group on the Classification of 
Staphylococcal Cassette Chromosome Elements (IWG-SCC), has issued guidelines to 
ccr complex type mec complex class SCCmec type 
1 B I (1B) 
2 A II (2A) 
3 A III (3A) 
2 B IV (2B) 
5 C2 V (5C2) 
4 B VI (4B) 
5 C1 VII (5C1) 
4 A VIII (A4) 
1 C2 IX (1C2) 
7 C1 X (7C1) 
8 E XI (8E) 
Table 3. SCCmec types identified in MRSA. 
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harmonize the classification of SCC elements (IWG-SCC, 2009). Among others, it was proposed 
to add the combination of ccr complex type and mec complex class in parentheses (Table 3). 
This rule also helps to counter the problem of composite SCCmec elements, which have 
increasingly been reported in recent years (IWG-SCC, 2009; Li et al., 2011). Such composite 
elements combine two or more ccr complexes with a mec complex (Ito et al., 2001; Oliveira et al., 
2001; Heusser et al., 2007; Ruppé et al., 2009; Li et al., 2011) (Table 4). 
 
SCCmec types are further divided into subtypes based on the structural variation within the 
J-regions (IWG-SCC, 2009). These have particularly been recognised in SCCmec types II and IV 
(IWG-SCC, 2009). The subtypes are appointed with a lower case letter (e.g. subtypes IVa, IVb, 
IVc, etc.). A huge amount of subtypes have already been identified and new are continously 
being described. Yet, recently, it has been shown that even within subtypes additional 
variation exists, especially in type IV cassettes (Liu et al., 2010; Damborg et al., 2011). 
 
2.2.5 SCCmec typing 
It has been found that the combination of the genetic background of MRSA strains with the 
type of SCCmec element that is present yields valuable epidemiological information (Enright et 
al., 2002; Robinson and Enright, 2003). Consequently, various SCCmec typing methods have been 
developed to aid in epidemiological studies of the origin and spread of MRSA strains. 
However, these typing methods have ever suffered from the high rate in which new SCCmec 
types and subtypes are described. At present, there is no SCCmec typing method that detects 
the five last recognised SCCmec types (VI-XI). In addition, the IWG-SCC guidelines 
encourage complete sequencing of SCCmec elements whenever previously unknown 
variations occur. 
Despite all this, SCCmec typing is still widely applied, inevitably resulting in the detection 
of many non-typeable SCCmec elements (i.e. non-typeable with the method applied). 
ccr complex types mec complex class SCCmec type Reference 
3 + SCCHg A III (3A&SCCHg) Ito et al., 2001; Oliveira et al., 2001 
2 + 5 B2 IV (2B&5) Heusser et al., 2007 
5 (allele 2) + 5 (allele 8) C2 V (5C2&5) Boyle-Vavra et al., 2005 ; Li et al., 2011 
Table 4. The most important composite SCCmec elements recognised so far (IWG-SCC, 2009). 
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Nonetheless, the existing SCCmec typing protocols still have their value, as they (can) yield 
information that allows a basic level of SCCmec classification. 
Currently, the most commonly used SCCmec typing methods are multiplex PCR methods. 
The first such multiplex PCR that was described was that of Oliveira and de Lencastre (2002), 
which can distinguish among type I to IV. However, this technique does not follow the actual 
definitions of SCCmec typing, i.e. SCCmec types I to IV are not defined based on the type of 
ccr complex and class of mec complex that are present but on the detection of one or more 
sequences that were believed to be specific for the respective SCCmec types (Oliveira and de 
Lencastre, 2002). This method appeared untenable and was greatly replaced by a protocol 
published in 2005 by Zhang et al. (2005). The advantage of the latter is a greater level of variety 
that can be detected (included subtypes IVa-d and type V SCCmec). However, this method 
similarly fails to use the ‘official’ method for designating a SCCmec type. In addition, it has 
been shown that this method can identify type V cassettes incorrectly as type III (Jansen et al., 
2009).  
A great improvement to the SCCmec typing methodology was added by Kondo et al. (2007), 
with their publication of protocols for six multiplex PCRs (M-PCRs). The first two of these 
M-PCRs are respectively aimed at detecting the type of ccr complex and the class of mec 
complex, allowing for differentiating between SCCmec types I-VI. The other four M-PCRs 
can be used for subtyping within type II, type III and type IV cassettes, by investigation of 
several orfs in the J-regions (Kondo et al., 2007). Until today, the method of Kondo is the most 
widely used SCCmec typing method. 
Another valuable multiplex method has been published in 2007, allowing for subtyping 
among eight known type IV subtypes (Milheiriço et al., 2007). In 2006 also a SCCmec typing 
method based on multilocus sequence typing (of four loci) was developed (Lina et al., 2006). As 
that method is relatively time-consuming and more expensive, it has not been widely used 
until now. 
 
2.2.6 SCC non-mec 
Various SCC elements have been identified that do not carry mecA but instead contain 
other functional genes, such as the production of capsular polysaccharide (Luong et al., 2002), 
heavy metal resistance (Mongkolrattanothai et al., 2004), the production of a histidine 
decarboxylase (Yokoi et al., 2011) and fusidic acid resistance (Holden et al., 2004). This suggests 
that SCC is in fact a ubiquitous mobile genetic element whose function in staphylococci is 
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inter- and intraspecies transfer of genetic information useful to the host cell living in various 
stressful environments (Katayama et al., 2003). The SCC non-mec elements are similar to 
SCCmec in the carriage of (a) ccr gene(s) in a ccr gene complex, the integration at ISS in the 
staphylococcal chromosome and in the presence of flanking direct repeat sequences at the 
SCC extremities (IWG-SCC, 2009). 
 
2.3 Variants of mecA 
Recently, quite some commotion occurred following the detection of a ‘new’ mecA gene in 
MRSA isolates from bovines and humans in the UK and other countries (Cuny et al., 2011; García-
Álvarez et al., 2011; Holmes and Zadoks, 2011; Shore et al., 2011). This gene, designated mecALGA251, 
shows only 70% DNA sequence homology to the classic mecA gene and 62-63% identity at 
the amino acid level (García-Álvarez et al., 2011; Shore et al., 2011) but grants nonetheless full 
methicillin resistance (García-Álvarez et al., 2011; Shore et al., 2011). As mentioned above, the gene 
also appeared in a previously unknown mec complex (class E) with a deviating composition 
(Figure 3). 
Noteworthy, mecA homologues have previously been reported in MRNAS. Even though 
the mecA gene sequence is generally very well conserved between different SCCmec types 
and different MRNAS species, more or less deviant mecA variants have been described in S. 
sciuri (Wu et al., 1996; Couto et al., 1996; Tsubakishita et al., 2010), Staphylococcus kloosii, 
Staphylococcus vitulinus and Staphylococcus capitis (Schnellmann et al., 2006) and 
Staphylococcus lentus and Staphylococcus fleurettii (Tsubakishita et al., 2010). However, it was 
not always clear whether these variants conferred phenotypical methicillin resistance. 
 
2.4. Origin of mecA and SCCmec in MRSA 
mecA and SCCmec are considered not to be native to S. aureus, as no homologous 
sequences are present in MSSA (Song et al., 1987). The origin of mecA has been a subject of 
many studies but remained long merely speculative (Song et al., 1987; Archer and Niemeyer, 1994). 
Starting from 1996, a series of studies proposed the origin of mecA to be located in a mecA 
homologue, named pbpD (Zhou et al., 2008), that is ubiquitously present in S. sciuri (Couto et al., 
1996; Wu et al., 1996; Wu et al., 1998; Couto et al., 2000; Wu et al., 2001; Couto et al., 2003; Severin et al., 
2005; Antignac and Tomasz, 2009). However, in 2010 new research revealed that three species of 
the S. sciuri species group, i.c. S. sciuri, S. vitulinus and S. fleurettii, all naturally possessed 
mecA homologues (Tsubakishita et al., 2010) but that the DNA sequence homology of the S. 
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fleurettii mecA was almost identical (99-100%) to the mecA gene found in MRSA strain 
N315, the first MRSA strain in which SCCmec was identified (Ito et al., 1999). In addition, the 
mecA gene of S. fleurettii provided phenotypical methicillin resistance and the region 
surrounding the mecA gene in S. fleurettii appeared to be highly homologous to the class A 
mec complex as found in MRSA strain N315 (Tsubakishita et al., 2010). Also the adjacent region 
upstream of this ‘class A mec complex’ was highly homologous to the corresponding part in 
the SCCmec type II element of MRSA N315. 
The mec sequences in S. fleurettii appeared not to be associated with ccr genes or other 
typical SCCmec sequences but with essential genes for cell metabolism. In S. sciuri and S. 
vitulinus, these regions were more divergent (Tsubakishita et al., 2010). Therefore, it was 
concluded that in S. fleurettii, the original chromosomal locus is present that has served as the 
template for the mec gene complex of SCCmec. Accordingly, SCCmec was suggested to have 
been created by a recombination event combining SCC non-mec with the S. fleurettii class A 
mec complex (Tsubakishita et al., 2010). 
 
2.5 Transfer of SCCmec among staphylococci 
It is generally acknowledged that SCCmec can be horizontally transferred among 
staphylococci (Hanssen and Sollid, 2006). Yet, despite accumulating data on the integration and 
excision mechanism of SCCmec (Wang et al., 2012a), the genetic transfer system mediating 
SCCmec movement remains to be elucidated (Katayama et al., 2000). 
Because of the comparatively greatest health impact of MRSA, much attention has always 
gone to possible SCCmec reservoirs for S. aureus. Several observations have been proposed 
as evidence that MRNAS might act as such SCCmec reservoirs: 
(i) the very high diversity of SCCmec in MRNAS (Miragaia et al., 2005; Miragaia et al. 
2007; Jamaluddin et al., 2008; Ruppé et al. 2009; Zong et al., 2011) 
(ii) the relatively higher frequency of methicillin resistance in NAS compared to S. 
aureus and the more uniform observation of methicillin resistance in NAS 
irrespective of geographical region (Diekema et al., 2001; Hanssen and Sollid, 2006; Garza-
Gonzalez et al., 2010) 
(iii) the observation that in certain geographic regions MRSA appears as pop-ups while 
there is a larger, constant population of MRNAS (Hanssen and Sollid, 2007) 
(iv) the observation that MSSA strains can act as the source for the MRSA strains that 
circulate in a given environment (Layer et al., 2006). 
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This indirect evidence has been substantiated with more direct indications that SCCmec 
transfer between MRNAS and S. aureus had taken place in vivo (Wielders et al., 2001; Berglund 
and Söderquist, 2008; Bloemendaal et al. 2010); so far, an actual transfer event has never been 
observed in vitro. Evidence of SCCmec transfer between MRNAS and S. aureus has only 
been derived from human studies. Among MRNAS species, especially MR S. epidermidis has 
often been proposed to act as a reservoir for type IV SCCmec elements for S. aureus (Barbier et 
al., 2010; Smyth et al., 2011). The SCCmec reservoir in animal MRNAS is poorly characterised 
and the correspondence in SCCmec types of MRNAS and MRSA in animals has not yet been 
assessed. 
 
2.6 Factors affecting methicillin resistance – Hetero-resistance  
A remarkable but as yet unexplained feature of methicillin resistance in staphylococci is 
that it is often heterogeneously expressed (Berger-Bächi and Rohrer, 2002). This means that the 
majority of cells within a population express low-level resistance and only a small proportion 
of the cells is highly resistant (Tomasz et al., 1991; Chambers 1997; Berger-Bächi and Rohrer, 2002). 
Expression of methicillin resistance is a complex matter, and cannot simply be explained 
by the action of the direct regulator genes, mecI and mecR1 (Weller 1999; Oliveira and de Lencastre, 
2011). In fact, several observations have shown that there is no correlation between the 
structural composition of the mec complex and the phenotype expressed by mecA-positive 
strains (Kobayashi et al., 1998; Weller 1999; Oliveira and de Lencastre, 2011). Many chromosomal 
factors, such as fem (factors essential for methicillin resistance) and aux (auxiliary) factors, 
modulate the expression of methicillin resistance (Chambers 1997; Berger-Bächi and Rohrer, 2002), 
resulting in different phenotypes. Moreover, PBP4 has been shown to be essential for 
expression of methicillin resistance in S. aureus (Memmi et al., 2008). 
Expression of resistance can also be altered at the phenotypic level, as a result of changes 
in environmental conditions (Chambers 1997). This is used in some routine susceptibility tests 
by incorporating NaCl into the growth medium and lowering the temperature, which increases 
the expression of resistance. 
 
2.7 Testing for methicillin resistance 
The gold standard for determining methicillin resistance in staphylococcal isolates is 
genotypic detection of mecA with PCR or detection of PBP2a, for example with agglutination 
tests (Brown, 2001; Louie et al., 2001; Sakoulas et al., 2001; Ferreira et al., 2003; Clinical and Laboratory 
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Standards Institute - CLSI, 2008). However, the existence of mecA variants may compromise the 
screening of isolates if this is done solely on the basis of mecA detection (García-Álvarez et al., 
2011; Shore et al., 2011; Cuny et al., 2011). 
If isolates are tested phenotypically for methicillin resistance, oxacillin and cefoxitin are 
the preferred agents to be used. CLSI recommends the use of the cefoxitin disk for testing 
both S. aureus and CNS, with different breakpoints for S. aureus and S. lugdunensis 
compared to CNS. However, the recommended breakpoints have been found to perform very 
poorly when used in S. pseudintermedius from dogs (Bemis et al., 2009; Schissler et al., 2009). In 
addition, the breakpoints have probably not or inadequately been tested for several CNS 
species, especially the most recently described species from animals. Species specific 
differences in performance of phenotypic tests have already been reported (John et al., 2009). 
Studies that aim to compare various testing methods do not show a clear picture as to 
which phenotypical method is the best one; these studies are often difficult to compare due to 
the use of different methods, different breakpoints and different study populations (York et al., 
1996; Stepanović et al., 2006; John et al., 2009; Zhang et al., 2011). 
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CHAPTER 3   METHICILLIN-RESISTANT STAPHYLOCOCCI IN ANIMALS 
3.1 MRSA 
3.1.1 A short history of MRSA: from human hospitals to livestock 
The detection of MRSA was initially limited to human healthcare centers. After the first 
reports from British hospitals at the beginning of the 1960s, MRSA started to appear 
worldwide (Benner and Kayser, 1968; Rountree and Beard, 1968; Smith et al., 1973). During the 1980s 
and particularly in the 1990s, MRSA became fully manifest as a nosocomial pathogen (Panlilio 
et al. 1992; Johnson et al., 2001; Diekema et al., 2004; Styers et al., 2006). In Europe, a northsouth 
gradient in MRSA hospital prevalence developed during the 1990s, and this gradient has 
maintained until now, as shown in the most recent European Antimicrobial Resistance 
Surveillance System (EARSS) annual report (http://www.ecdc.europa.eu/en/activities/surveillance/ 
EARSNet/Pages/index.aspx.). Countries from southern Europe show invasive MRSA prevalences 
up to 50%, while the percentage of invasive MRSA in Scandinavia and The Netherlands has 
remained low (< 5%). 
At the time, it was noticed that certain MRSA clones had spread over several countries and 
even continents (Cookson and Philips, 1988; Witte et al., 1997; Aires de Sousa et al., 2000). By using 
MLST combined with SCCmec typing, Enright et al. (2002) showed that the majority of 
international epidemic hospital MRSA strains at that time belonged to five lineages: CC5, 
CC8, CC22, CC30 and CC45. Initially, these so-called hospital-associated MRSA strains 
(HA-MRSA) were characterised by the carriage of the larger SCCmec types I–III (Oliveira et al., 
2002; Robinson and Enright, 2003) and by their multi-resistant phenotype (Speller et al., 1997; Lowy 
1998; Tenover et al., 2001). However, in Belgium and other European countries, nosocomial 
MRSA strains harbouring SCCmec cassettes of type IV and being susceptible to more 
antimicrobials have been emerging since the 90’s (Deplano et al., 2000; Galdbart et al., 2000; Denis et 
al., 2004; Dauwalder et al., 2008; Campanile et al., 2009; Vindel et al., 2009). 
A second phase in the history of MRSA started halfway the 1990s, when MRSA infections 
involving strains different from HA-MRSA were increasingly documented in non-hospitalised 
patients (Udo et al., 1993; Herold et al., 1998; CDC report, 1999; Bukharie et al., 2001; Chambers 2001). Such 
cases, called community-associated or community-acquired MRSA (CA-MRSA), were soon 
reported worldwide. CA-MRSA strains were found to be belong predominantly to ST1, ST8, 
ST30, ST59, ST80 and ST93 (Vandenesch et al., 2003). In addition, CA-MRSA appeared to carry 
the SCCmec types IV and, to a lesser degree, type V or new variants (Okuma et al., 2002; Ito et al., 
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2004; Tristan et al., 2007; Skov and Jensen, 2009). CA-MRSA have also been found to frequently 
produce potent toxins or other virulence factors, as for example Panton–Valentine leukocidin 
(PVL) (Dufour et al., 2002; Vandenesch et al., 2003) and arginine catabolic mobile element (ACME) 
(Barbier et al., 2011). 
At present, the epidemiology of MRSA in humans is rapidly evolving. The difference 
between HA- and CA-MRSA has complicated (Song et al., 2011; Stefani et al., 2012): strains with a 
genetic background typical for community MRSA are becoming established in the hospital 
environment (Campanile et al., 2011; Song et al., 2011) and reversely, hospital MRSA strains are 
appearing in the community (Song et al., 2011). 
In contrast to the dramatic evolution of MRSA in human medicine, animals did not play a 
major role during most of the history of MRSA. Even though MRSA was first isolated in 
animals in 1972, from Belgian cows with mastitis (Devriese et al., 1972), this first detection was 
not the beginning of a steady increase of MRSA prevalence in bovine or other animal 
infections. Based on the results of biotyping methods available at the time, it was concluded 
that those first isolates were of human origin (Devriese and Hommez, 1975). Thereafter, reports on 
MRSA in animals appeared only occasionally from companion animals (Werckenthin et al., 
2001). The strains found in these studies were also mostly suspected or proven to be human 
genotypes (Scott et al., 1988; Cefai et al., 1994; Seguin et al., 1999; Manian et al., 2003). Hence, for a long 
time, the largest concern on MRSA in (companion) animals was the potential role as vectors 
for (re-)infection of human contact persons (Scott et al., 1988; Cefai et al., 1994; Manian et al., 2003).  
The perspectives on MRSA in animals changed quite drastically at the beginning of the 
2000s, when MRSA was unexpectedly isolated from a family of pig farmers and one of their 
pigs (Voss et al., 2005). Results of subsequent investigations showed that pig farmers from the 
same geographical region were carrying MRSA in a >760-fold higher carriage rate than the 
general Dutch population. Markedly, PFGE analysis of the MRSA strains showed that they 
were all resistant to digestion with restriction endonuclease SmaI, but spa typing and RAPD 
analysis proved that all strains were closely related to each other. When a few months later a 
pig farmer from another region, an unrelated veterinarian working mostly with pigs, that 
veterinarian’s son and a nurse treating the boy were all found to be colonized with a related 
MRSA strain, it was concluded that pig farming might pose a significant risk for MRSA 
carriage in humans (Voss et al., 2005). However, the type of MRSA involved was identified as 
belonging to the ST398 genetic background (Armand-Lefevre et al., 2005; Huijsdens et al., 2006), 
which was a highly obscure clone in the normal healthy human population (Armand-Lefevre et 
al., 2005). This indicated that the pigs were not acting as vectors for human MRSA but were 
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functioning as true MRSA reservoir. A third phase in the history of MRSA began, with 
MRSA no longer being an exclusive human issue and the ‘new’ lineage CC398 playing a 
major role. 
 
3.1.2 Occurrence and characteristics of MRSA in dogs, pigs and bovines 
3.1.2.1 Characteristics of MRSA CC398 
 CC398 is the clonal complex of which ST398 is the evolutionary founder. In total 30 
STs have been identified so far in CC398, including 20 SLV, five DLV and four triple locus 
variants of ST398 (http://saureus.mlst.net - eBURST; accessed 17.02.2012). ST398 is by far the most 
frequently identified type. 
 Virtually all strains are resistant to digestion with the standard endonuclease SmaI. This 
is due to the presence of a restriction/methylation system, new for the genus Staphylococcus 
(Bens et al., 2006; Uhleman et al., 2012). Various other restriction enzymes, such as XmaI and Cfr9I, 
have been proven to be suitable alternatives for SmaI (Rasschaert et al., 2009; Argudín et al., 2010). 
 A large number (> 50) of related spa types can be found in MRSA CC398 strains. The 
majority of these types are combinations of repeat sequences r02, r08, r16, r24, r25 and r34 
(http://spaserver.ridom.de). Some other repeat sequences, such as r106, r07, r12 and r31, are less 
frequent but are closely related to certain common repeats. 
 A great variety of SCCmec types has been described in MRSA CC398. Type IVa and V 
are most frequently detected, with V appearing more widespread (de Neeling et al., 2007; Pomba et 
al., 2010; Alt et al., 2011; Argudín et al., 2011; Arriola et al., 2011; Crombé et al., 2011). In some studies no 
subtyping of SCCmec type IV was performed (van Loo et al., 2007; van Duijkeren et al., 2007; van 
Duijkeren et al., 2008; Yu et al., 2008; Feβler et al., 2010a); yet, to date, no other subtype than IVa has 
been found in MRSA CC398. 
Recent studies have shown that type V cassettes from CC398 strains frequently differ from 
classic type V elements, in that they are much larger ( 50 kb), are combined cassettes 
containing two ccrC complexes (5C2&5 – see Table 4) and possess the czrC gene, conferring 
cadmium and zinc resistance (Aarestrup et al., 2010; Cavaco et al., 2010; Schijffelen et al., 2010; Cavaco et 
al., 2011; Li et al., 2011). In addition, SCCmec types IX and X have been newly described from 
MRSA CC398 strains. Some studies have also reported the presence of SCCmec type III 
(Huijsdens et al., 2006; Nemati et al., 2008; Van Rijen et al., 2008); however, this needs to be regarded 
with caution, as the multiplex method used in these studies (Zhang et al., 2005) has been shown 
to falsely report cassettes of type V as type III (Jansen et al., 2009; Argudín et al., 2010). MRSA 
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CC398 strains also frequently possess cassettes that cannot be typed with the current typing 
methods (Alt et al., 2011; Argudín et al., 2011; Crombé et al., 2011). 
 MRSA CC398 strains usually lack most of the common S. aureus virulence factors 
(Walther et al., 2009; Feβler et al., 2010a; Schijffelen et al., 2010; Argudín et al., 2011; Hallin et al., 2011). 
Some strains have been identified that carried the genes for PVL (Welinder-Olsson et al., 2008; Yu 
et al., 2008; Salmenlinna et al., 2010; Stegger et al., 2010). Yet, in these cases, a lack of animal contact 
was reported.  
 MRSA CC398 strains have a distinctive antimicrobial resistance profile. Resistance to 
tetracycline is present in all or nearly all strains; resistance to macrolide-lincosamide-
streptogramin antimicrobials, aminoglycosides and trimethoprim is frequently detected; 
resistance to phenicols and fluoroquinolones is occassionally detected (Guardabassi et al., 2007; 
Witte et al., 2007; Lewis et al., 2008; Nemati et al., 2008; Feβler et al., 2010a; Argudín et al., 2011; Crombé et 
al., 2011). 
The multiresistance phenotype of MRSA CC398 has been associated with plasmids 
carrying various resistance genes (Kadlec and Schwarz, 2009b; Kadlec and Schwarz, 2010) and with 
specific genes encoding resistance to several antimicrobial classes. Examples are the cfr gene, 
encoding resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and 
streptogramin A antimicrobials – the so-called PHLOPSA phenotype (Long et al., 2006; 
Kehrenberg et al., 2009), and vga, encoding resistance to lincosamides, pleuromutilins and 
streptogramin A. Two new representatives, vga(C) and vga(E), have been originally identified 
in MRSA CC398 (Kadlec and Schwarz, 2009b; Schwendener and Perreten, 2011). Also genes 
conferring trimethoprim resistance (dfrK) and apramycin resistance (apmA) have been newly 
described in MRSA CC398 (Kadlec and Schwarz, 2009a; Feβler et al., 2011). 
 
3.1.2.2 MRSA in dogs 
The ecological importance of S. aureus for dogs appears to be low (Devriese, 1990; Rubin and 
Chirino-Trejo, 2010). It can be isolated from different body sites of dogs but its colonisation 
capacity, principal body reservoirs and carriage rates are not clear (Yamashita et al., 2005; 
Hanselman et al., 2009; Rubin and Chirino-Trejo, 2010). 
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3.1.2.2.1 MRSA CC398 
MRSA CC398 has occasionally been detected in dogs in different countries, both from 
healthy carriage (Nienhoff et al., 2009; Floras et al. 2010) and infections (Witte et al., 2007; Floras et al. 
2010; Haenni et al., 2012) but the prevalence of MRSA CC398 in dogs is unclear.  
All MRSA CC398 strains reported so far from dogs carried a type V SCCmec element 
(Witte et al., 2007; Nienhoff et al., 2009; Floras et al. 2010; Haenni et al., 2012). 
 
3.1.2.2.2 Non-CC398 MRSA 
The MRSA strains predominantly found in dogs are non-CC398 strains that belong to 
human lineages. Carriage of MRSA is rare in populations of healthy dogs in the community. 
No MRSA was detected in healthy dogs in Slovenia (Vengust et al., 2006), Denmark (Bagcigil et al., 
2007), the UK (Baptiste et al., 2005), Canada (Murphy et al., 2009) and the USA (Griffeth et al., 2008), 
while a carriage rate of 0.7% was found in Hong Kong (Boost et al., 2007) and Portugal (Couto et 
al., 2011) and of 0.5%-1.5% in Canada (Hanselman et al., 2008, 2009). An often used method for 
assessing carriage of MRS(A) in community dogs is investigating the animals upon admission 
to veterinary hospitals (Hanselman et al., 2008; Murphy et al., 2009; Couto et al., 2011). 
Also as a pathogen, MRSA is uncommon in dogs (Loeffler and Lloyd, 2010). The rate at which 
MRSA can be isolated from infections of dogs has been assessed as 1.1% in Ireland (Abbott et 
al., 2010) and as 1.5% in Germany (Ruscher et al., 2009). MRSA can be isolated from various 
infections, mostly from the skin (wound infections, surgical site infections, pyoderma) and the 
ear (otitis) (Tomlin et al., 1999; Baptiste et al., 2005; Weese and van Duijkeren, 2010; Haenni et al., 2012). 
Both human hospital clones and community clones have been described in dogs and in 
general, the lineage(s) that dominate(s) in a certain country or area are involved (Loeffler and 
Lloyd, 2010). One of the most frequently reported MRSA strains in dogs is ST22-MRSA-IV, 
corresponding to the well-known hospital clone EMRSA-15; it has been found in Germany 
(Strommenger et al., 2006a), New Zealand (Grinberg et al., 2008), Portugal (Couto et al., 2011), the UK 
(Baptiste et al., 2005; Loeffler et al., 2005) and Ireland (O’Mahony et al., 2005). In Australia, one of the 
oldest pandemic strains of hospital MRSA, ST239-MRSA-III, was identified (Malik et al., 2006). 
Typical for their genetic background, the hospital-associated MRSA strains in dogs show a 
multidrug-resistant phenotype, to antimicrobials such as chloramphenicol, macrolides-
lincosamides and fluoroquinolones (Strommenger et al., 2006a; Boost et al., 2007). Yet, most canine 
MRSA infections can be treated successfully (Loeffler and Lloyd, 2010). 
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CA-MRSA strains that have been identified in dogs include ST80 in the Netherlands (van 
Duijkeren et al., 2005), CC5-MRSA-II in Canada (Weese et al., 2006) and Germany (Nienhoff et al., 
2009), and CC8-MRSA-IV (the Lyon clone), ST8-MRSA-IV (USA300) and ST5-MRSA-I 
(the Geraldine clone) in France (Haenni et al., 2012). 
Though direct observational evidence is lacking, transmission of MRSA from humans to 
dogs has been suggested in several studies (Cefai et al., 1994; Manian et al., 2003; van Duijkeren et al., 
2004b; Baptiste et al., 2005; Strommenger et al., 2006a; Weese et al., 2006; Rutland et al., 2009). Reversely, 
carriage of human MRSA strains in dogs and other pets has repeatedly been implicated in 
cases of re-infection of human contacts (Scott et al., 1988; Cefai et al., 1994; Weese et al., 2005). 
 
3.1.2.3 MRSA in pigs 
3.1.2.3.1 MRSA CC398 
The natural reservoir of MRSA CC398 appears to be in pigs and MRSA CC398 is the 
predominant MRSA type that is present in pigs, especially in Europe. So far, carriage of 
MRSA CC398 has been identified in pigs or pig farms in 18 European countries: The 
Netherlands (Voss et al., 2005; de Neeling et al., 2007; van Duijkeren et al., 2008), Belgium (Crombé et al., 
2011; Dewaele et al., 2011), Germany (Witte et al., 2007; Köck et al., 2009; Tenhagen et al., 2009; Alt et al., 
2011), Denmark (Guardabassi et al., 2007; Espinosa-Gongora et al. 2011; Agersø et al., 2012), Switzerland 
(Huber et al., 2010; Overesch et al., 2011), Spain and Tenerife (Gómez-Sanz et al., 2010; Morcillo et al., 
2012; Porrero et al., 2012), Portugal (Pomba et al., 2009), Croatia (Habrun et al., 2011), Italy (Battisti et 
al., 2010) and Austria, Czech Republic, France, Poland, Slovakia, Slovenia, Finland, Hungary 
and Luxembourg (EFSA, 2009a). MRSA CC398 has also been described in pigs outside Europe. 
On the American continent it has been detected in Canada (Khanna et al. 2008), the USA (Smith et 
al., 2009) and Peru (Arriola et al., 2012), and in Asia it has been found in China (Wagenaar et al., 
2009), Singapore (Sergio et al., 2007) and Korea (Lim et al., 2012). 
The reported carriage rates at pig level vary considerably between countries, from 1% in 
Denmark (Guardabassi et al., 2007), 18.6% in Canada (Khanna et al., 2008), 40% in Belgium and The 
Netherlands (De Neeling et al., 2007; Crombé et al., 2011) to 52% in Germany (Alt et al., 2011). Farm-
level rates are generally higher: 45% in Canada (Khanna et al., 2008), 66% in Denmark 
(Guardabassi et al., 2007) and 68% in Belgium (Crombé et al., 2011). However, figures on 
prevalence or carriage rates have to be interpreted carefully, as in most studies, different 
isolation methods have been used and different sample populations (finishers vs. breeders, 
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piglets vs. older pigs, open vs. closed farms, pigs at the abattoir vs. pigs at the farm etc.) have 
been investigated. 
MRSA CC398 has also been isolated from various infections of pigs. The first such report 
was published in 2007, when MRSA ST398 was found implicated in exudative epidermitis 
from Dutch pigs (van Duijkeren et al., 2007). Meanwhile, its implication in other skin infections 
has been described (Sergio et al., 2007; Schwarz et al., 2008; Pomba et al., 2010) and MRSA CC398 has 
also been isolated from infections of the urogenital tract, the uterus and the mammary gland 
(Schwarz et al., 2008; Kadlec et al., 2009) and from deep-seated tissues and septicaemia (Meemken et 
al., 2010; Kadlec et al., 2009). 
The fact that MRSA CC398 appears to have its main reservoir in pigs raises the question 
whether S. aureus (ST398) is a normal commensal of pigs. From previous ecological studies, 
it is known that S. aureus, together with Staphylococcus hyicus, is the most important 
Staphylococcus species in pigs, prevailing on both the healthy skin and in the nostrils (Kloos et 
al., 1976; Kloos, 1980; Devriese et al., 1985; Shimizu et al., 1987; Devriese, 1990; Baele et al., 2001a) and 
being occasionally detected in infections (Devriese et al., 1990; Hasman et al., 2009). However, for a 
long time, very little was known on the genetic background of the S. aureus strains residing in 
pigs. Some recent studies have confirmed that ST398 is indeed one of the main S. aureus 
types carried by pigs (Armand-Lefevre et al., 2005; Guardabassi et al., 2007; Hasman et al., 2009).  
 
3.1.2.3.2 Non-CC398 MRSA 
Besides MRSA CC398, a variety of other MRSA types have been identified in pigs (Table 
5).  
In Asia, MRSA of CC9 appears to be the predominant clone. In general, ST9 is, together 
with ST398 and ST433 (CC30), a common genetic background of S. aureus strains carried by 
pigs (Armand-Lefevre et al., 2005; Hasman et al., 2009). Other genetic backgrounds, such as CC5, 
ST8, ST22 and ST45, are considered to be typically associated with humans. 
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Table 5. Isolation rates, farm-level prevalence and SCCmec types of non-CC398 MRSA isolated from pigs in 
different countries. 
MRSA type Country 
Isolation 
rate
a 
Farm-level 
prevalence
a SCCmec type
a,b 
Reference 
ST1 Italy, Spain, Cyprus NA NA V Franco et al., 2011 
ST1 Italy ND
 
5.9%
c 
V, IVb, IV (2B&5)
d 
Battisti et al., 2010 
ST1 Switzerland 0.2%
e 
NA IVc Overesch et al., 2011 
ST1 Denmark 0.1%
c 
0.1% ND Agersø et al., 2012 
ST5 USA 3.8%
c,f 
NA III Gordoncillo et al., 2011 
CC5 Canada 14.1%
g 
55.6% ND Khanna et al., 2008 
CC5 Japan 0.9%
c 
4.3% NT Baba et al., 2010 
ST8 Norway NA NA IV Sunde et al., 2011 
ST8 Peru 5%
c 
NA IVc Arriola et al., 2012 
CC9 China 11.4%
c 
41.9% III Cui et al., 2009 
ST9 Hong Kong 16%
c 
NA IVb, V Guardabassi et al., 2009 
CC9 China NA 55.6%
h 
ND Wagenaar et al., 2009 
ST9 Malaysia 1.4%
c 
30% V Neela et al., 2009 
ST9 Thailand 10%
c 
25% NT (1C2) Anukool et al., 2011 
ST9 Italy ND
 
0.8%
c 
V Battisti et al., 2010 
ST22 Singapore NA NA IV Sergio et al., 2007 
ST30 Portugal NA NA V Pomba et al., 2009 
CC30 Denmark 0.5%
c 
0.6% ND Agersø et al., 2012 
ST45 Serbia 7.1%
c 
NA IVa Velebit et al., 2010 
ST49 Switzerland 0.5% - 1.3%
e 
NA V Overesch et al., 2011 
ST72 Korea 0.6%
c 
4.5% IVa Lim et al., 2012 
CC97 Spain 3.8%
c 
ND V Gómez-Sanz et al., 2010 
CC97 Italy ND 11%
c 
V Battisti et al., 2010 
a NA: not applicable; ND: not determined  //  b NT: SCCmec types that could not be assigned to any of the established SCCmec types; 
for these types and for combined cassettes being variants of a certain type, the ccr-mec combination is given.  //  c nasal swabs //  
d No detailed information was provided on which of the given SCCmec types was present in ST1 strains. // e type of samples unclear  //  f 
non-commercial pig-breeding  //  
g
 nasal-rectal swabs  // 
 h
  dust samples 
 
Non-CC398 MRSA strains show variable antimicrobial resistance profiles, depending on 
their genetic background. Strains of CC9 typically are resistant to multiple non-β-lactam 
antimicrobials, such as fluoroquinolones, macrolide-streptogramin antimicrobials, tetracycline 
I – REVIEW OF THE LITERATURE  Chapter 3 – Methicillin-resistant staphylococci in animals 
47 
and gentamicin; occasionally, resistance to chloramphenicol, fusidic acid, cotrimoxazole, 
amikacin, tigecycline and quinupristin/dalfopristin has been reported (Cui et al., 2009; Guardabassi 
et al., 2009; Neela et al., 2009; Wagenaar et al., 2009; Anukool et al., 2011). Among the other non-CC398 
MRSA strains in pigs, resistance to tetracycline and macrolide-streptogramin antimicrobials 
are commonly observed (Sergio et al., 2007; Pomba et al., 2009; Gómez-Sanz et al., 2010; Franco et al. 
2011; Overesch et al. 2011). 
 
3.1.2.4 MRSA in bovines 
It is not clear whether S. aureus is a normally important Staphylococcus species carried by 
bovines as so far, the healthy carriage of staphylococci on various body sites of dairy cows 
has been inadequately assessed. S. aureus has been found in the nares of dairy cows (Kloos, 
1980; Devriese et al., 1985) and younger animals might carry more readily S. aureus in the nares 
(Matos et al., 1991). On the healthy skin, S. aureus might be uncommon (Devriese, 1990), though in 
Japan, S. aureus was the third most frequently isolated Staphylococcus species on the back 
skin of dairy cows (Nagase et al., 2002). S. aureus readily colonizes the teat skin, and might there 
form the reservoir for mastitis. A difference between strains from cases of bovine mastitis and 
strains from the nares of cattle appears to exist (Devriese, 1990).  
As mentioned in section 1.1.3, it is well-known that S. aureus is one of the major 
pathogens in bovine mastitis (Pitkälä et al., 2004; Tenhagen et al., 2006). 
Studies on host-specificty of S. aureus have shown that some S. aureus genetic 
backgrounds are specific for cows, and more specifically, for bovine mastitis. Especially 
CC97 and CC151 appear to be important clones specific for dairy cows (Smith et al., 2005; 
Rabello et al., 2007; Sung et al., 2008; Hasman et al., 2009; Hata et al., 2010; Delgado et al., 2011; Sakwinska et 
al., 2011). 
 
3.1.2.4.1 MRSA CC398 
Healthy carriage of MRSA CC398 has occasionally been reported in bovines. In veal 
calves, carriage rates of 1% in Switzerland (Huber et al., 2010), 6.5% in France (Haenni et al., 
2011a) and 28% - 50% in the Netherlands have been reported (Mooij et al., 2007; Graveland et al. 
2009, 2010). In Germany, MRSA CC398 was detected in nasal samples of dairy cows and 
calves on a farm where also pigs were raised and where MRSA was also found in mastitis 
milk samples (Spohr et al., 2011). 
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Also in mastitis, MRSA CC398 has only occasionally been reported, in Switzerland (Huber 
et al., 2010; Sakwinska et al., 2011) and especially in Germany (Monecke et al., 2007; Argudín et al., 2010; 
Feβler et al., 2010a). Little is known on the exact burden of MRSA CC398 in mastitis. In 
Switzerland, MRSA CC398 accounted for 1.4% of S. aureus strains from mastitis milk 
samples (Huber et al., 2010). In Germany, within-herd prevalences of MRSA CC398-positive 
cows were found to vary between 1.4% and 16.7% in three dairy farms (Spohr et al., 2011). In 
that study, all MRSA was detected in milk samples from cows with mastitis. Recent data on 
the occurrence of MRSA (CC398) in mastitis of Belgian bovines are lacking (Devriese et al., 
1997). 
 
3.1.2.4.2 Non-CC398 MRSA 
By our knowledge, only one report has mentioned the nasal carriage of non-CC398 MRSA 
in bovines. In Switzerland, 1 of 400 beef cows (0.3%) carried MRSA ST1 (Huber et al., 2010). 
This strain harboured a type IV SCCmec cassette and was additionally resistant to 
erythromycin and tetracycline. 
Several reports have mentioned the presence of non-CC398 MRSA in clinical as well as 
subclinical cases of bovine mastitis (Holmes and Zadoks, 2011). However, a major problem for 
interpretation of the results of many reports is that, especially in older studies, there is often a 
lack of control on the presence of the mecA gene, which can result in unreliable data (De 
Oliveira et al., 1999). Therefore, several studies having not or only partially verified the presence 
of mecA should be interpreted with care (Devriese et al., 1997; Cuteri et al., 2002; Erskine et al., 2002; 
Farzana et al., 2004; Turutoglu et al., 2006). Another problem is that the genetic background of 
MRSA from mastitis is sometimes not determined (Lee, 2003, 2006; Moon et al., 2007). A third 
problem is that almost all studies do not provide sufficient information to assess the 
occurrence rate of (non-CC398) MRSA in mastitis. Table 6 gives a summary of those reports 
in which the genetic background of the strain was identified, with, where possible, addition of 
the occurrence rate of the MRSA strains and the type of SCCmec that was present. 
As appears from Table 6, most non-CC398 MRSA strains belong to well-known human 
lineages and not to the lineages considered typical for bovine mastitis, CC97 and ST151 (Smith 
et al., 2005; Rabello et al., 2007; Sung et al., 2008; Hasman et al., 2009; Hata et al., 2010; Delgado et al., 2011; 
Sakwinska et al., 2011). Yet, importantly, the MRSA strains harbouring the new mecA variant 
mecALGA251 in type XI SCCmec cassettes do appear to have emerged from typical bovine or 
animal-related S. aureus (García-Álvarez et al., 2011). Being originally described from the UK, 
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meanwhile, such MRSA strains have also been found in dairy cows in Portugal, France, The 
Netherlands and Denmark (Holmes and Zadoks, 2011). 
 
Table 6. Quarter- and farm-level prevalence and SCCmec types of non-CC398 MRSA isolated from bovine 
mastitis in different countries. 
MRSA type Country 
Quarter-level 
prevalence
a 
Farm-level 
prevalence
a 
SCCmec 
type
a Reference 
ST1 Hungary ND NA IVa Juhász-Kaszanyitzky et al., 2007 
ST1 South Korea ND ND IVa Nam et al., 2011 
ST5 South Korea 0.01% ND IVg Kwon et al., 2005 
ST5 Japan ND 1.5% II Hata et al., 2010 
ST5 France ND ND I Haenni et al., 2011b 
ST8 Turkey ND ND IV Türkyilmaz et al., 2010 
CC8 Switzerland ND ND ND Monecke et al., 2007 
ST72 South Korea ND ND IV, IVa Nam et al., 2011 
CC130 (ST130) UK ND ND XI
b 
García-Álvarez et al., 2011 
CC130 (ST1245) UK ND ND XI
b 
García-Álvarez et al., 2011 
ST151 UK ND ND XI
b 
García-Álvarez et al., 2011 
ST239 Turkey ND ND III Türkyilmaz et al., 2010 
ST329 Turkey ND ND III Türkyilmaz et al., 2010 
ST425 UK ND ND XI
b 
García-Álvarez et al., 2011 
ST580 South Korea ND ND IVg Kwon et al., 2005 
a ND: not determined; NA: not applicable  // b MRSA strains harbouring the new mecALGA251 gene 
 
Antimicrobial resistance in non-ST398 MRSA strains from bovine mastitis depends on the 
specific genetic background. In strains with a CA-MRSA background (ST5 and ST580) only 
resistance to aminoglycosides was detected (Kwon et al., 2005; Haenni et al., 2011b), while ST1 
strains from Hungary were resistant to tetracycline and erythromycin (Juhász-Kaszanyitzky et al., 
2007). In CC8-SCCmec III MRSA from Turkey, typical HA-MRSA strains, resistance to 
tetracycline, macrolide-lincosamide antimicrobials, fluoroquinolones and aminoglycosides 
was common (Türkyilmaz et al., 2010). Strains harbouring mecALGA251 have been found to express 
very few additional antimicrobial resistances (Cuny et al., 2011). 
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3.2 MRNAS 
3.2.1 Occurrence, species diversity and characteristics of MRNAS in dogs 
The most important Staphylococcus species in dogs is S. pseudintermedius, being 
commonly carried in the nose and at the anal region (Devriese, 1990; Allaker et al., 1992; Devriese et 
al., 2005; Hanselman et al., 2009) and frequently causing infections associated with superficial 
layers of the body (such as pyoderma, deep pyoderma, pododermatitis) and the ear (otitis) 
(Philips and Kloos, 1981; Hermans et al., 2010; Yamashita et al., 2005; Loeffler et al., 2007). Accordingly, the 
most important MR Staphylococcus species in dogs is MR S. pseudintermedius (MRSP) (van 
Duijkeren et al., 2011a). Healthy carriage rates of MRSP range from 0%-2.1% in Canada 
(Hanselman et al., 2008; Murphy et al., 2009), 1.5% in Slovenia (Vengust et al., 2006), 3% in the USA 
(Griffeth et al., 2008) to 4.5% in Canada (Hanselman et al., 2009) and 6.2% in Portugal (Couto et al., 
2011). The MRSP carriage rate among diseased dogs has been reported to be 6.7% (Griffeth et 
al., 2008). Isolation rates of MRSP from infections of dogs vary from 2% (De Lucia et al., 
2011) to 6.8% (Rusher et al., 2009) and 13% (Nienhoff et al., 2011). The prevalence of methicillin 
resistance among S. pseudintermedius isolated from dog infections was reported to vary 
between 66.5% (Kawakami et al., 2010) and 77% (Kania et al., 2004). 
Much research has recently been done into the population dynamics of MRSP. It appears 
that, similar as MRSA in humans, MRSP spreads clonally in dogs (van Duijkeren et al., 2011a). 
Two major lineages seem to exist: MLST ST71-spa t02-SCCmec II-III, dominating in Europe 
but also having been detected in Hong Kong, Canada and the USA, and MLST ST68-spa t06-
SCCmec V, dominating in North America (Perreten et al., 2010). Other STs, with a more local 
spread, have been identified (Perreten et al., 2010). 
Interestingly, the type II-III cassettes are actually – according to the official mode of 
defining SCCmec elements – type III (3A) elements. The designation II-III arises from their 
composition of two parts of high similarity to a type II cassette of S. epidermidis and a type III 
cassette of S. aureus (Descloux et al., 2008). Another special SCCmec element in MRSP is the 
type VII-241 (Perreten et al., 2010), which is composed of a type 6 ccr complex and a class A 
mec and, hence, is different from the type VII (5C1) cassettes identified in MRSA (Descloux et 
al., 2008; Zong and Lü, 2010). Besides these types various other SCCmec types have been 
described in MRSP, such as III, IV, V and several non-typeable elements (Sasaki et al., 2007; 
Ruscher et al., 2009; Perreten et al., 2010). 
MRSP strains typically show a multidrug resistant phenotype, in both carriage and 
infections. Resistance to aminoglycosides, fluoroquinolones and macrolides-lincosamides is 
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generally high, while resistance to chloramphenicol, trimethoprim and tetracycline is less 
frequently detected (Ruscher et al., 2009; Kawakami et al., 2010; Perreten et al., 2010; Couto et al., 2011; De 
Lucia et al., 2011; Nienhoff et al., 2011). These resistance phenotypes are mostly generated by 
similar genes as found in S. aureus (Perreten et al., 2010). 
Besides S. pseudintermedius, another coagulase-positive NAS species, Staphylococcus 
schleiferi subsp. coagulans, and various coagulase-negative NAS species can be isolated from 
healthy dogs. Yet, it is not always clear whether these are true residents (Devriese, 1990; 
Stepanović et al., 2001; Nagase et al., 2002; Yamashita et al., 2005; Hanselman et al., 2009; Rubin and Chirino-
Trejo, 2010). Similarly, the presence of MRNAS other than MRSP in dogs has poorly been 
assessed so far. A carriage rate of 11.5% methicillin-resistant CNS has been reported in 
healthy dogs in Slovenia, without further species determined (Vengust et al., 2006). In Denmark, 
13% of healthy dogs carried methicillin-resistant CNS (Bagcigil et al., 2007). There, MR S. 
epidermidis and MR S. haemolyticus predominated with also MR S. sciuri and MR 
Staphylococcus warneri having been identified. MR S. haemolyticus, MR S. warneri and MR 
Staphylococcus hominis were also isolated from healthy dogs in Australia (Malik et al., 2006). 
The prevalence of methicillin resistance among S. schleiferi subsp. coagulans from dog 
infections was found to be 20% in one study (Kawakami et al., 2010) and 75% in another (Kania et 
al., 2004); an even higher prevalence of 92% was reported for S. schleiferi subsp. schleiferi 
(Kania et al., 2004). 
So far, the genetic background of MRNAS other than MRSP has not yet been studied in 
dogs. Very little is also known on SCCmec elements carried by MRNAS from dogs. In one 
study from Australia, type I SCCmec was identified in MR S. hominis, type IV in MR S. 
warneri and MR S. epidermidis and type IV and V in MR S. haemolytcius (Malik et al., 2006). 
 
3.2.2 Occurrence, species diversity and characteristics of MRNAS in pigs 
The most important Staphylococcus species in pigs is S. hyicus, being present on both the 
healthy skin and in the nostrils (Kloos et al., 1976; Kloos, 1980; Devriese et al., 1985; Shimizu et al., 1987; 
Devriese, 1990; Baele et al., 2001a). S. hyicus is particularly well-known for its role as causative 
agent of exudative epidermitis (greasy pig disease) in piglets, an often acute generalised skin 
infection which can lead to death or retarded growth (Werckentin et al., 2001; Hermans et al., 2010). 
Other NAS species frequently found in pigs are S. sciuri, S. lentus, S. hominis, 
Staphylococcus chromogenes, Staphylococcus xylosus and Staphylococcus simulans (Devriese 
et al., 1985; Shimizu et al., 1987; Devriese, 1990; Baele et al., 2001a). A recent study on the composition 
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of whole microbial communities in porcine nostrils found that staphylococci were the 
dominant group when the composition was investigated using culturing techniques, while 
they were nearly absent when culture-independent methods were used. Interestingly, besides 
S. aureus, S. epidermidis was the only Staphylococcus species that was present in >50% of the 
investigated samples, while S. hyicus was completely absent (Lowe et al., 2011). Recently, a new 
Staphylococcus species has been identified as a major component of the staphylococcal nasal 
population in Swiss pigs, designated Staphylococcus rostri (Riessen and Perreten, 2010). 
Despite the common presence and importance of NAS in pigs, so far, the presence of 
MRNAS in pigs has only sparsely been studied. By the best of our knowledge, MR S. hyicus 
has not yet been reported to occur in pigs (Werckenthin et al., 2001). In a Danish study, no 
MRNAS were found in 100 nasal samples from pigs originating from three pig farms (Bagcigil 
et al., 2007). In contrast, MRNAS were present in 260 of 716 (36.3%) nasal samples collected 
from pigs on 241 Swiss farms. Among the 52 representative isolates selected for further 
investigation, only S. sciuri (n = 29) and S. fleurettii (n = 23) were identified (Huber et al., 2011). 
In a recent study from the Netherlands, MRNAS were detected in nasal samples from pigs on 
five out of ten investigated farms. The most commonly identified species were MR 
Staphylococcus cohnii (n = 6), MRSH (n = 4) and MRSE (n = 3), with single isolates being 
found of MR Staphylococcus equorum, MR S. fleurettii, MR S. lentus, MR Staphylococcus 
pasteuri, MR S. sciuri and MR Staphylococcus saprophyticus (Tulinski et al., 2012). In that same 
study, also dust samples from the farms were investigated, and in the positive samples from 
four farms, two MR S. epidermidis and single isolates of MR S. cohnii, MR S. equorum, MR 
S. haemolyticus, MR S. saprophyticus and MR S. sciuri were isolated. In the USA, nasal and 
rectal samples were collected from an unspecified number of pigs at a livestock auction; 
among the seven NAS that were found, six proved to possess mecA, and these were identified 
as MR S. lentus (n = 3), MR S. sciuri (n = 2) and MR S. xylosus (n = 1) (Zhang et al., 2009).  
The clinical relevance of MRNAS for pigs is unclear. Only a single study, from the 
Netherlands, assessed the presence of MRNAS in clinical pig samples and no MRNAS were 
detected (van Duijkeren et al., 2004a). 
Very little is known on the SCCmec elements present in MRNAS from pigs. In the 
MRNAS from Dutch pigs and dust samples, types III, IV, IVc, IVvar (a IV variant from which 
the subtype could not be determined), V, VI and various non-typeable SCCmec elements were 
found (Tulinski et al., 2012). All MRNAS from pigs at the livestock auction in the USA 
harboured type III cassettes (Zhang et al., 2009). 
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The single study, from Switzerland, that phenotypically investigated additional 
antimicrobial resistances in MRNAS from pigs found resistance rates ≥ 25% and ≤ 50% for 
tetracycline, erythromycin and clindamycin, ≥ 10% and ≤ 20% for cotrimoxazole and 
gentamicin and ≤ 5% for ciprofloxacin and vancomycin (Huber et al., 2011). 
In Belgium, MRNAS carriage has never been assessed in pigs. 
 
3.2.3 Occurrence, species diversity and characteristics of MRNAS in bovines 
Very little literature exists on the ecology of staphylococci in veal calves or beef cows. It 
appears that all attention on staphylococci in bovines has been drawn to dairy cows. Yet, as 
for S. aureus, the healthy carriage of NAS on various body sites of dairy cows, and especially 
in the nostrils, has been poorly assessed (White et al., 1989; Devriese, 1990; Nagase et al., 2002). In 
contrast, NAS and more specifically the CNS play a very important role as causative agents of 
mastitis and they have been the subject of increased attention in recent years. Over the last 
decades, the better control of mastitis caused by major contagious pathogens has been 
accompanied by an increase in the incidence of mastitis caused by minor pathogens. As 
mentioned in section 1.1.3, the CNS are currently acknowledged as the most important cause 
of subclinical mastitis (Pitkälä et al., 2004; Tenhagen et al., 2006; Piepers et al., 2007) and might also 
cause (mild) clinical mastitis (Bradley et al., 2007; Piepers et al., 2007; Botrel et al., 2010). 
Very little is known on species diversity and characteristics of MRNAS carried in veal 
calves, dairy or beef cows but species belonging to the S. sciuri species group are often 
detected (Table 7). 
High additional antimicrobial resistance to tetracycline and macrolide-lincosamide 
antimicrobials has been described for MRNAS from veal calves, with resistance to 
fluoroquinolones, aminoglycosides, chloramphenicol and fusidic acid being less frequently 
detected (Haenni et al., 2011a; Huber et al., 2011). Similar antimicrobial resistance profiles as in 
veal calves were described in MRNAS carried by cows but resistance rates were lower (Huber 
et al., 2011). 
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Table 7. Carriage rates, species diversity and SCCmec types of MRNAS carriage isolates from bovines in 
different countries. 
Country Bovine type 
MRNAS 
carriage rate 
Species 
SCCmec 
types
a Reference 
Switzerland Veal calves
b 
72% S. sciuri (98%)
c 
S. haemolyticus (2%)
c 
ND Huber et al., 2011 
Cows
b 
52.1% S. sciuri (72%)
c 
S. fleurettii (22%)
d 
S. haemolyticus (4%)
d 
S. warneri (2%)
d 
ND 
France Veal calves
b 
36.6% S. sciuri (97.8%) 
S. haemolyticus (2.2%) 
III, NT 
ND 
Haenni et al., 2011a 
USA Cattle
e 
ND S. sciuri (46.7%) 
S. xylosus (33.3%) 
S. lentus (13.3%) 
S. cohnii (6.7%) 
I, III, V
f
 
 
Zhang et al., 2009 
a ND: not determined // b nasal swabs // c from a selection of 51 isolates // d from a selection of 50 isolates // e nasal/rectal swabs // f no 
details were provided concerning the SCCmec distribution among the different MRNAS species 
 
Despite the major importance of CNS as mastitis pathogens, MRNAS are seldom detected 
in mastitis. Though reports on MRNAS in mastitis appear to be increasing in recent years, it is 
not clear whether this is caused by an actual trend or by increased and improved (by detection 
of mecA) research efforts. Among S. epidermidis isolates from individual cow milk samples, 
approximately 30% were mecA positive in studies from Belgium (Piessens et al., 2011), Portugal 
(Nunes et al., 2007), the Netherlands (Sampimon et al., 2011) and the USA (Sawant et al., 2009). In 
Germany, MR S. epidermidis, MR S. haemolyticus, MR S. capitis, MR S. saprophyticus and 
MR S. sciuri were detected in mastitis milk samples (Feβler et al., 2010b; Spohr et al., 2011); in 
Korea, MR S. epidermidis, MR S. hominis, MR S. intermedius, MR S. sciuri, MR S. 
saprophyticus and MR S. simulans were isolated (Moon et al., 2007); in the Netherlands MR S. 
epidermidis, MR S. chromogenes, MR S. equorum, MR S. fleuretii, MR S. sciuri, MR 
Staphylococcus succinus and MR S. warneri were found (Sampimon et al., 2011); and finally, in 
Switzerland, MR S. haemolyticus, methicillin-resistant S. cohnii, S. fleurettii and S. sciuri 
were isolated from bulk tank milk (Huber et al., 2011). 
Only a single study, from Germany, reported the SCCmec types from MRNAS from 
mastitis. Type III SCCmec was found in MR S. saprophyticus, type IV in MR S. capitis and 
MR S. epidermidis, and type V in MR S. haemolyticus. In MR S. epidermidis, also a variant 
of type IV (2B&4) and a non-typeable element were found (Feβler et al., 2010b). 
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Some studies have reported high resistance to tetracycline, kanamycin and erythromycin in 
MR S. epidermidis from mastitis (Moon et al., 2007; Sampimon et al., 2011). In other MRNAS, very 
low additional resistance levels were detected (Huber et al., 2011; Sampimon et al., 2011). 
The presence of mecALGA251 in MRNAS from bovine sources is yet to be investigated. 
 
3.3 Methicillin-resistant staphylococci in animals – Conclusions 
In dogs, MRSP and MRSA are most frequently detected. MRSP appears to spread clonally, 
and two major lineages exist. In contrast, MRSA strains in dogs are predominantly human 
clones; MRSA CC398 has occasionally been reported and appears to be of little importance. 
The presence of MRNAS other than MRSP has been poorly studied in dogs.  
In pigs, MRSA appears to be the dominant methicillin-resistant staphylococcal species, 
though the presence of MRNAS has been very poorly assessed. MRSA CC398 is largely 
dominating, especially in Europe. Some other MRSA lineages, CC9 in the first place, are 
more or less frequently detected.  
In bovines, the healthy carriage of MRS has been poorly assessed, with occasional reports 
of MRSA CC398, mainly from veal calves. In mastitis, presence of MRS has received more 
attention and their occurrence appears low, for MRSA as well as MRNAS. Occasionally, 
human MRSA strains are isolated from mastitis. However, recently, MRSA CC398 seems to 
emerge in bovine mastitis but its prevalence is poorly studied. In Belgium, recent data on 
MRSA in mastitis are lacking. 
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The molecular epidemiology of MR staphylococci in animals has received increased 
attention in the past years. MRSA is currently considered an important problem in domestic 
animals. Yet, its presence in Belgian animals has been sparsely assessed. Furthermore, there is 
a general lack of data on the presence of MRNAS in animals, their species diversity and their 
possible role as reservoir for SCCmec and other antimicrobial resistance determinants. 
Therefore, the main objectives of this research were: 
 To estimate the relative importance of MRSA in S. aureus mastitis in dairy cows and 
to assess the within-herd prevalence of MRSA in MRSA-positive farms (Chapter 4). 
 To investigate the presence and diversity of MRSA and MRNAS in Belgian dogs on 
admission to a veterinary teaching hospital (Chapter 5). 
 To assess the presence and species diversity of MRNAS in pigs and to investigate the 
diversity of SCCmec elements and the occurrence of additional antimicrobial resistances in 
MRNAS from pigs (Chapter 6). 
 To assess the presence and species diversity of MRNAS in different bovine groups 
(veal calves, dairy cows, beef cows) and to investigate the diversity of SCCmec elements and 
the occurrence of additional antimicrobial resistances in MRNAS from bovines (Chapter 7). 
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4.1 Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA) is infrequently reported in mastitis. 
Yet, as in many other countries, the prevalence of methicillin resistance among S. aureus from 
mastitis is currently unknown in Belgium. To elucidate this, the presence of mecA was 
investigated in 118 S. aureus strains originating from diagnostic mastitis milk samples from 
118 different farms experiencing S. aureus mastitis. MRSA strains were characterized by disk 
diffusion susceptibility testing, spa typing, MLST and SCCmec typing. In an additional study, 
four MRSA-positive farms were selected to assess the within-herd prevalence of MRSA, by 
sampling all cows in lactation. Isolated MRSA strains were similarly characterized. 
The mecA gene was detected in 11 (9.3%) of the 118 S. aureus isolates, indicating that 
nearly 10% of the Belgian farms suffering from S. aureus mastitis have a MRSA problem. 
The within-herd prevalence varied between 0% and 7.4%. Characterization of the MRSA 
strains showed that they were all resistant to tetracycline. Additional resistances to 
macrolides, lincosamides and aminoglycosides were frequently detected. The strains were 
ST398, spa types t011 or t567 and had SCCmec type IVa or V, proving that they belong to the 
emerging livestock-associated MRSA (LA-MRSA) strains of CC398. 
Our study shows that after detection in Belgian pigs, horses and poultry, LA-MRSA has 
also attained Belgian cattle. It is the first report on frequent isolation of LA-MRSA from 
bovine infections. As the within-herd isolation rate resembles that of regular S. aureus in 
farms experiencing S. aureus mastitis, the multi-resistance of LA-MRSA strains may cause 
future treatment problems. 
 
4.2 Introduction 
Staphylococcus aureus is a major pathogen in dairy cattle mastitis (Waage et al., 1998; 
Tenhagen et al., 2006; Piepers et al., 2007). Resistance of S. aureus to antimicrobial agents can 
complicate treatment of its infections (Lowy, 2003). For treatment of mastitis, methicillin 
resistance, which is caused by the expression of the mecA gene, is of particular interest. 
Indeed, this mechanism confers resistance to almost all types of β-lactam antibiotics active 
against S. aureus, and these antibiotics are still frequently used in mastitis treatment (Sawant et 
al., 2005). However, methicillin-resistant Staphylococcus aureus (MRSA) has never been 
important in mastitis. After the very first report of MRSA in mastitis in 1972 (Devriese et al., 
1972), MRSA has been described in mastitis only occasionally (Lee, 2003, 2006; Kwon et al., 2005; 
Juhász-Kaszanyitzky et al., 2007; Moon et al., 2007; Hendriksen et al., 2008). From such studies, it seems 
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that the prevalence of MRSA in mastitis is generally low. Yet, data on MRSA in mastitis need 
to be assessed carefully, as there are often ambiguities in the presence of mecA, level of 
investigation and origin of the detected MRSA strains. 
Recently, a specific MRSA clone, CC398, has been found to be associated with pigs, veal 
calves, broiler chickens, companion animals and people in close contact with livestock. 
MRSA of this type, called livestock-associated MRSA (LA-MRSA), typically has closely 
related spa types (de Neeling et al., 2007; Denis et al., 2009), carries mostly staphylococcal cassette 
chromosome mec (SCCmec) types IVa and V (Witte et al., 2007; Van Den Eede et al., 2009) and 
cannot be typed with PFGE using SmaI digestion (Bens et al., 2006). In addition, LA-MRSA 
shows resistance against tetracycline and, to a lesser extent, macrolides, lincosamides, 
aminoglycosides and fluoroquinolones (Witte et al., 2007). Generally LA-MRSA lacks common 
virulence factors found in other MRSA (Monecke et al., 2007; Walther et al., 2009). This is 
remarkable because, although infrequently compared to colonization, LA-MRSA has been 
isolated from infections, of both animals and humans (e.g. Hermans et al., 2008; Krziwanek et al., 
2009). To our knowledge, so far only one study has reported on the isolation of MRSA ST398 
from a case of mastitis (Monecke et al., 2007). 
We performed two studies to assess the role of MRSA in Belgian S. aureus mastitis. In the 
first study we investigated how many S. aureus isolated from mastitis were resistant to 
methicillin. Second, we investigated the within-herd prevalence of MRSA in Belgian herds 
where cows were previously shown to suffer from MRSA mastitis.  
 
4.3 Materials and methods 
4.3.1 Methicillin resistance in S. aureus isolated from mastitis 
4.3.1.1. Strains 
From November 2006 through April 2007, the regional veterinary laboratories were asked 
to send us a representative isolate from all farms on which an S. aureus-mastitis problem was 
detected. Care was taken to include only one strain per visited farm. As such, a collection of 
118 non-duplicate isolates of S. aureus, originating from cases of subclinical or clinical 
mastitis from different farms were obtained. 
 
4.3.1.2. DNA extraction 
An Eppendorf cup (Eppendorf, Germany) containing a 500 ml Brain Heart Infusion (BHI) 
broth (BioRad, France) overnight pure culture was centrifuged for 3 min at approx. 
III – EXPERIMENTAL STUDIES  Chapter 4 – MRSA ST398 associated with mastitis 
67 
20,000 x g, at room temperature. After the removal of the supernatant, 45 ml of sterile, 
distilled water and 5 ml of a 1 mg/ml lysostaphin (Sigma–Aldrich, USA) solution at 4°C were 
thoroughly mixed with the pellet of cells. After incubation for 10 min at 37°C, 45 ml of 
sterile, distilled water, 5 ml of a 2 mg/ml proteïnase K (Merck, Germany) solution at 4°C and 
150 ml of Tris–HCl of 0.1M at pH 8.0 were added. The resulting solution was incubated for 
10 min at 60°C, followed by 5 min at 100°C and then centrifuged for 5 min at approx. 
20,000 x g, at room temperature. DNA was stored at -20°C until use. 
 
4.3.1.3. Identification of methicillin-resistant S. aureus 
A triplex PCR, targeting a Staphylococcus-specific 16S rRNA sequence, the mecA gene 
and the S. aureus-specific region of the thermonuclease gene (nuc), was performed as 
previously described (Maes et al., 2002). The amplified DNA fragments were separated by 
electrophoresis on a 2% agarose (Sigma–Aldrich, USA) gel stained with SYBR Safe DNA gel 
stain (Invitrogen, USA), for 2 h at 80 V, using an O’RangeRuler 100 bp DNA ladder 
(Fermentas, Germany). 
 
4.3.1.4. Characterization of methicillin-resistant S. aureus 
4.3.1.4.1. Susceptibility testing 
Strains proven to be MRSA were tested for susceptibility to non-β-lactam antimicrobial 
agents, by using the disk diffusion method. A panel of 16 antimicrobial agents was used: 
chloramphenicol, gentamicin, kanamycin, tobramycin, fusidic acid, erythromycin, tylosin, 
lincomycin, quinupristin/dalfopristin, linezolid, mupirocin, ciprofloxacin, tetracycline, 
rifampicin, sulfonamides and trimethoprim (NeoSensitabs, Rosco, Denmark). Results were 
recorded after 24 h incubation at 37°C and interpreted according to the directions for use of 
Rosco with the method described by the Clinical and Laboratory Standard Institute (CLSI) 
guidelines (CLSI, 2008).  
 
4.3.1.4.2. spa typing  
Of all MRSA strains, the polymorphic X-region of the Staphylococcus protein A (spa) 
gene was amplified according to the Ridom StaphType standard protocol (www.ridom.de/ 
staphtype). Amplicons were purified with a Nucleospin Extract II kit (Macherey-Nagel, 
Germany) and then sequenced using the same primers. The sequenced DNA was then run on 
a CEQ 8000 Genetic Analysis System (Beckman Coulter, United Kingdom) according to the 
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manufacturer’s instructions. The resulting spa types were assigned by using the Ridom 
StaphType software package (Ridom GmbH, Germany). 
 
4.3.1.4.3. Multilocus sequence typing 
Multilocus sequence typing (MLST) was performed on all MRSA strains. In short, seven 
household genes of S. aureus were amplified using primers previously described (Enright et al., 
2000). Amplicons were purified with a Nucleospin Extract II kit (Macherey-Nagel, Germany) 
and then sequenced using the same primers. The sequenced DNA was then run on a CEQ 
8000 Genetic Analysis System (Beckman Coulter, United Kingdom) according to the 
manufacturer’s instructions. Allele numbers and sequence type (ST) were assigned by using 
the S. aureus MLST website (http://saureus.mlst.net). 
 
4.3.1.4.4. Staphylococcal cassette chromosome mec typing. 
The SCCmec type was determined using three different sets of primers (Oliveira and de 
Lencastre, 2002; Zhang et al., 2005; Milheiriço et al., 2007). For differentiation among SCCmec types 
I–IV we used all the primers described by Oliveira and de Lencastre (2002). The PCR mix 
consisted of 25 ml of Taq PCR Master Mix (Qiagen GmbH, Germany), 4 ml of H2O and 
16 ml of the primers, in the reported concentration. To this mix 5 ml DNA was added. For 
subtyping SCCmec of type IV, we used the primers described by Milheiriço et al. (2007). The 
PCR mix consisted of 25 ml of Taq PCR Master Mix (Qiagen GmbH, Germany), 6.4 ml of 
H2O, 0.2 mM of primers J IVa forward (F) and reverse (R), 0.2 mM of J IVb F and R, 0.4 mM 
of ccr B2 F and J IVc F and R, 0.8 mM of ccrB2 R, J IVd F and R, 0.9 mM of J IVg F and R, 
and 0.9 mMof J IVh F and R. To the mix 5 ml DNA was added. A third set, meant to detect 
SCCmec type V and to have a control for SCCmec types IVb, IVc, IVe and IVf, was based on 
the method described by Zhang et al. (2005). The PCR mix consisted of 25 ml of Taq PCR 
Master Mix (Qiagen GmbH, Germany), 10.4 ml of H2O, 0.6 mM of primers Type V F and R, 
0.8 mM of Type IVc F and R, and 1.0 mM of Type IVb F and R. To the mix 5 ml DNA was 
added. We used the same PCR program for all the three sets: an initial denaturation of 4 min 
at 94°C, 35 cycles of denaturation at 94°C for 30 s, annealing at 53°C for 30 s and extension 
at 72°C for 1 min, followed by a final extension for 4 min at 72°C.  
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4.3.2 Methicillin-resistant S. aureus within-herd prevalence 
From the results of the first study, four MRSA-positive farms were selected for 
investigation of the within-herd prevalence of MRSA, defined as the number of MRSA-
positive cows relative to the total number of lactating cows present in the specific farm. A 
randomly chosen fifth farm volunteered to serve as control (Table 9). Milk samples were 
taken from each quarter. All samplings were done by the same person, from February 2008 
through April 2008. 
Samples were immediately transported to the Veterinary and Agrochemical Research 
Centre (VAR), where each sample was plated on Columbia Colistine Aztreonam Plates (CAP) 
supplemented with 5% sheep blood (Oxoid, Germany) and on chromID MRSA plates 
(Biomérieux, France). Suspected S. aureus or MRSA colonies were purified. Pure colonies 
were then subjected to the MRSA triplex PCR, as described above. Strains identified as 
MRSA were characterized by susceptibility testing, spa typing, MLST and SCCmec typing, as 
described above. 
 
4.4 Results 
4.4.1. Methicillin resistance in S. aureus isolated from mastitis 
4.4.1.1. Detection of methicillin-resistant S. aureus 
All 118 isolates phenotypically identified as S. aureus were confirmed to be S. aureus by 
the triplex PCR. A total of 11 isolates (9.3%) contained mecA (Table 8). Two MRSA 
originated from clinical mastitis, the other nine from subclinical mastitis (Table 8). 
 
4.4.1.2. Antimicrobial susceptibility testing 
Antibiotic resistance patterns of the 11 MRSA strains are shown in Table 8. Nine of them 
showed additional resistance to at least two different antibiotics. All strains were resistant to 
tetracycline; nine were resistant to trimethoprim, seven to aminoglycosides and lincomycin, 
five to macrolides and two to ciprofloxacin (Table 8). No resistance was detected to the other 
antimicrobial agents tested. 
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4.4.1.3. Multilocus sequence typing, spa typing and staphylococcal cassette 
chromosome mec typing 
Ten strains were spa type t011. One strain had a different yet related spa type, t567 (Table 
8). All MRSA strains were ST398 (Table 8). Five strains had SCCmec type IVa, and five had 
SCCmec type V. The SCCmec type of one strain could not be determined with the different 
sets of primers we used (Table 8). 
 
Table 8. Resistance profile, multilocus sequence type (MLST), spa and staphylococcal cassette 
chromosome (SCC)mec type of each methicillin-resistant S. aureus (MRSA) strain in study 1. 
Strain Type of mastitis Resistance profile
a 
spa  MLST SCCmec
b 
1 Subclinical AG, TET, TMP t011 398 IVa 
2 Clinical AG, TET, TMP t011 398 IVa 
3 Subclinical AG, ML, LM, TET, TMP t011 398 IVa 
4 Subclinical LM, CIP, TET, TMP t011 398 V 
5 Subclinical TET t567 398 NT 
6 Subclinical AG, ML, LM, TET, TMP t011 398 IVa 
7 Subclinical LM, CIP, TET, TMP t011 398 V 
8 Clinical AG, ML, LM, TET, TMP t011 398 IVa 
9 Subclinical KAN, TOB, ML, LM, TET, TMP t011 398 V 
10 Subclinical AG, ML, LM, TET, TMP t011 398 V 
11 Subclinical TET t011 398 V 
a AG: all aminoglycosides tested; KAN: kanamycin; TOB: tobramycin; ML: all macrolides tested; LM: lincomycin; 
CIP: ciprofloxacin; TET: tetracycline; TMP: trimethoprim 
b NT: not typeable with the primers used 
 
4.4.2. Methicillin-resistant S. aureus within-herd prevalence 
4.4.2.1. Identification of methicillin-resistant S. aureus 
The percentage of cows carrying MRSA in their milk varied between 0% and 7.4% (Table 
9). Quarter level prevalence ranged from 0% to 1.98%. Three of the four selected farms were 
positive. MRSA could not be detected in one farm previously found positive nor in the control 
farm (Table 9). 
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Table 9. Within-herd prevalence of methicillin-resistant S. aureus in study 2. 
Farm
a Herd size 
(n cows) 
Herd size 
(n quarters) 
Positive cows Positive quarters 
n % n % 
1 63 252 4 6.3 6 1.98 
2 68 272 5 7.4 5 1.83 
3 77 308 3 3.9 3 0.97 
4 51 204 0 0 0 0 
5 69 276 0 0 0 0 
 
 
One cow from the first farm carried MRSA in three of her quarters. In all other positive 
cows, MRSA was found in only one quarter, resulting in 14 isolates in total (Table 10). Most 
isolates were found in the right-hind (six isolates) and right-front (four isolates) quarter (Table 
10). Of the 11 cows that had MRSA in only one quarter, nine of the MRSA isolates were 
found in one of the hindquarters. 
 
4.4.2.2. Antimicrobial susceptibility testing 
All six strains isolated from the first farm had the same susceptibility profile (Table 10). 
They were all resistant to tetracycline, macrolides and lincomycin, and were susceptible to all 
other antimicrobial agents tested. 
In the second farm, two out of five strains were resistant to trimethoprim, tetracycline and 
aminoglycosides, and susceptible to all other antimicrobial agents tested. The three other 
strains had additional resistances to macrolides and lincomycin (Table 10). 
The three strains from the third farm were resistant to aminoglycosides, macrolides, 
lincomycin, tetracycline and trimethoprim (Table 10). They were susceptible to the other 
antimicrobial agents tested. 
 
4.4.2.3. Multilocus sequence typing, spa typing and staphylococcal cassette 
chromosome mec typing 
All MRSA strains showed spa type t011 (Table 10). The strains originating from the first 
farm had SCCmec type V, while all strains isolated from the cows of the other two farms had 
SCCmec type IVa (Table 10). MLST was performed on one representative MRSA strain per 
a no. 5: control farm 
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farm. As strains from farm 2 showed two different resistance profiles, one representative 
strain from each profile was tested. All the four strains tested were ST398 (Table 10). 
 
Table 10. Resistance profile, multilocus sequence type (MLST), spa and staphylococcal cassette 
chromosome (SCC)mec type per methicillin-resistant S. aureus strain in study 2. 
Farm Cow (quarter
a
)  Strain Resistance profile
b 
Spa MLST
c 
SCCmec 
1 
1 (LH) 1 ML, LM, TET t011 ND V 
2 (RH) 2 ML, LM, TET t011 ND V 
3 (RF) 3 ML, LM, TET t011 ND V 
4 (LF) 4 ML, LM, TET t011 398 V 
4 (RH) 5 ML, LM, TET t011 ND V 
4 (RF) 6 ML, LM, TET t011 ND V 
       
2 
5 (LH) 7 AG, TET, TMP t011 398 IVa 
6 (LF) 8 AG, ML, LM, TET, TMP t011 ND IVa 
7 (RH) 9 AG, TET, TMP t011 ND IVa 
8 (RH) 10 AG, ML, LM, TET, TMP t011 398 IVa 
9 (RH) 11 AG, ML, LM, TET, TMP t011 ND IVa 
       
3 
10 (RH) 12 AG, ML, LM, TET, TMP t011 ND IVa 
11 (RH) 13 AG, ML, LM, TET, TMP t011 ND IVa 
12 (RF) 14 AG, ML, LM, TET, TMP t011 398 IVa 
a LF: left-front; LH: left-hind; RH: right-hind; RF: right-front 
b AG: all aminoglycosides tested; LM: lincomycin; ML: all macrolides tested; TET: tetracycline; TMP: trimethoprim 
c ND: not determined 
 
4.5 Discussion 
The prevalence of methicillin resistance in S. aureus isolated from mastitis in our first 
study is unexpectedly high. In the abundance of studies investigating the antibiotic resistance 
of mastitis pathogens, few reports have noted a substantial occurrence of methicillin 
resistance, meaning MRSA is usually negligible as a mastitis pathogen (Hendriksen et al., 2008). 
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However, we found nearly 10% of our 118 S. aureus strains to be MRSA. This means that 
nearly 10% of the Belgian farms experiencing S. aureus mastitis are affected by MRSA. 
Reports can be found in which a higher prevalence of MRSA among S. aureus isolated 
from mastitis cases is described. In Turkey, Turutoglu et al. (2006) found 18 out of 103 (17.5%) 
S. aureus isolates from mastitis milk samples to be MRSA. However, they did not mention 
whether all strains were collected from different farms experiencing S. aureus mastitis. In 
addition, their detection method was limited to phenotypic disk diffusion testing. Performing 
only phenotypic tests has previously been shown to lead to false positive or false negative 
results (Murakami et al., 1991; De Oliveira et al., 1999). Generally it is now accepted that checking for 
the presence of mecA is the most reliable method for the detection of methicillin resistance, 
and staphylococci carrying mecA should be regarded as resistant to almost all types of β-
lactam antibiotics (CLSI, 2008). Consequently, to accurately assess our results, only other reports 
in which mecA was proven to be present should be considered. Still, even then, it remains 
difficult to make viable comparisons, due to differences in sampling methodology or a lack of 
information on the source of the strains. For example, two South Korean studies did not 
mention exactly how many of their samples originated from mastitis (Lee, 2003, 2006). A 
Hungarian study sampled only a single farm (Juhász-Kaszanyitzky et al., 2007). In two other studies 
from South Korea, the data involved quarter level results (Kwon et al., 2005; Moon et al., 2007).  
Despite these difficulties to fully assess our results, it must be acknowledged that the 
MRSA prevalence we found is quite high. However, some other remarks should be made. 
First, the burden of MRSA for Belgian milk production cannot be assessed, because we have 
no data on the total number of farms that were visited during the sampling period. Also, while 
our study allows us to estimate the importance of methicillin resistance in Belgian S. aureus 
mastitis, we cannot judge the importance of MRSA for mastitis as a whole. A hint to address 
the latter can be found in a recent study that investigated the importance of S. aureus in 
Belgian mastitis. It was found that S. aureus was the most prevalent species in Belgian quarter 
milk samples from subclinical mastitis, with 25% of culture-positive quarter samples with a 
geometric mean composite somatic cell count of ≥ 250,000 cells/mL harboring S. aureus 
(Piepers et al., 2007). Regarding this, our result is certainly quite worrying. 
Another important fact is presented by our typing data. All our strains had characteristics 
typical for the emerging livestock-associated MRSA CC398 strains. Consequently, it seems 
that our findings should rather be regarded as a further expansion of the host range of the 
CC398 MRSA clone than as an indication of a generally increasing incidence of methicillin 
resistance in mastitis-associated S. aureus. This should however not be less worrying. In 
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addition to its resistance against all β-lactam antibiotics, which are still the most used 
antimicrobial agents in the treatment of mastitis, the typical antibiotic resistances of LA-
MRSA also include some other antibiotics used to treat or prevent mastitis, such as 
aminoglycosides and macrolides (Sawant et al., 2005). This could lead to serious treatment 
problems. Moreover, in our second study we found that the within-herd prevalence of LA-
MRSA ranged between 0% and 7.4%. In the farms where MRSA was found, it varied from 
3.9% to 7.4%, with a corresponding quarter level prevalence of 0.97–1.98%. This resembles 
the within-herd quarter level prevalence of S. aureus described earlier in a cross-sectional 
collection of Belgian milk samples (Piepers et al., 2007), suggesting that, considering its spread 
in farms, LA-MRSA behaves similar to regular mastitis-causing S. aureus. The possibility 
that LA-MRSA could become equally important in mastitis as normal S. aureus should thus 
be thoroughly investigated. Unfortunately, we have no data on the individual health status of 
the cows from which MRSA was isolated in our second study, so we cannot state that the LA-
MRSA strains we found were actually involved in mastitis. As it was shown that within-cow 
transmission between quarters likely occurs in S. aureus mastitis (Barkema et al., 1997), the fact 
that 11 of the 12 cows carried LA-MRSA in only one quarter could mean that the isolates 
concerned only contaminants. However, S. aureus infection of only one quarter also certainly 
exists (Barkema et al., 1997). Moreover, S. aureus was shown to more frequently infect the right 
and hind quarters (Barkema et al., 1997, 2006). Of the 11 single-quarter LA-MRSA isolates we 
found, 10 originated from right quarters and nine from hind quarters. Considering also our 
first study, which clearly showed the capacity of LA-MRSA to cause mastitis, the actual 
presence of LA-MRSA in Belgian mastitis should urgently be studied in more depth, in order 
to profoundly assess its possible burden. 
LA-MRSA has been reported only once before in mastitis in cows, one LA-MRSA strain 
that was found among 128 S. aureus isolated from German mastitis cases (Monecke et al., 2007). 
While this strain was spa type t034, our strains were spa types t011 and t567. It thus seems 
unlikely that a specific subclone of LA-MRSA is associated with mastitis, but more research 
is required to confirm this. Until now, it is also unclear whether LA-MRSA has an actual 
reservoir in dairy cattle. Whereas veal calves have been found carrying LA-MRSA in the 
Netherlands (Mooij et al., 2007) and Belgium (unpublished data), the colonization capacity of 
LA-MRSA in milking cows has not yet been investigated. 
The presence of LA-MRSA in infections has been reported substantially less frequent than 
carriage, and has only been described occasionally in pigs (van Duijkeren et al., 2007), horses 
(Hermans et al., 2008; Loeffler et al., 2009), humans (e.g. Krziwanek et al., 2009) and a dog (Witte et al., 
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2007). Our findings thus seem to add new proof of a certain pathogenic potential of LA-
MRSA. Remarkably, many common virulence factors, including those considered to be 
involved inmastitis, such as toxic shock syndrome toxin- 1 (TSST-1), haemolysins and 
enterotoxins (Matsunaga et al., 1993), have been shown to be largely absent in LA-MRSA 
(Monecke et al., 2007; Walther et al., 2009). However, as we did not check for the presence of 
virulence factors in our strains, the significance of our data regarding the pathogenic potential 
of LA-MRSA is hard to assess. Yet, in addition to the other reports on LA-MRSA associated 
with infections, our findings urge for further research into the virulence capacities of LA-
MRSA. 
 
4.6 Conclusions 
We found an unusual high prevalence of MRSA in Belgian cases of subclinical and clinical 
S. aureus mastitis in cows. All strains belonged to the CC398 clone, which, seen its multi-
resistance, may lead to treatment problems. Future research is warranted to assess the actual 
spread and corresponding burden that LA-MRSA may pose for dairy cattle farming and to 
elucidate which virulence factors are involved. 
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5.1 Abstract 
This study investigated the nasal carriage of methicillin-resistant staphylococci (MRS) in 
dogs (n = 177) prior to medical examination or surgery in a veterinary teaching hospital. 
Nasal swab samples were collected after induction of anaesthesia and incubated overnight in 
salt enriched trypticase-soy broth. Cultures were analysed on two different agar media 
containing cefoxitin. Suspected MRS isolates were genotypically identified and characterised 
by antimicrobial susceptibility testing and staphylococcal cassette chromosome mec 
(SCCmec)-typing. Methicillin-resistant Staphylococcus aureus (MRSA) isolates were 
additionally characterised by spa typing and multilocus sequence typing. The presence of 
Panton- Valentine leukocidin (pvl) genes was determined by PCR. MRS carriage was 
compared between animals with or without an infectious process. 
Two MRSA were isolated, both belonging to typical Belgian human hospital clones and 
lacking pvl. Additionally a methicillin-resistant Staphylococcus haemolyticus carrying a type 
V SCCmec was detected. No relationship was observed between MRS carriage and presence 
of infections. 
The results suggest that MRS are present in dogs originating from the community, albeit at 
a low prevalence. This could pose risks for cross contamination of dogs and their owners. 
 
5.2 Introduction 
Research on methicillin-resistant staphylococci (MRS) in animals is increasing. In 
Belgium, methicillin-resistant Staphylococcus aureus (MRSA) of multilocus sequence type 
(ST) 398 appears to dominate in livestock and horses (Nemati et al., 2008; Denis et al., 2009; 
Persoons et al., 2009; Van den Eede et al., 2009; Vanderhaeghen et al., 2010a). However, little is known 
on the presence of MRSA and other MRS in the Belgian dog population. In other countries, 
MRSA strains found in pets generally have a genetic background suggestive of a human 
hospital origin (van Duijkeren et al., 2004b; Baptiste et al., 2005), indicating that they may function as 
reservoirs or vectors for human MRSA (Guardabassi et al., 2004; Loeffler and Lloyd, 2010). Still, 
MRSA ST398 has recently been found colonising and infecting dogs (Witte et al., 2007; Floras et 
al., 2010). As yet, the true importance of MRSA ST398 for pets remains unknown (Loeffler and 
Lloyd, 2010; Smith and Pearson, 2010). 
Until now, methicillin resistance in non-S. aureus staphylococci (NAS) from dogs has 
mainly been investigated in other coagulase-positive species, especially Staphylococcus 
pseudintermedius, as this is the most important staphylococcal pathogen in dogs (Bemis et al., 
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2006; Hanselman et al., 2008; Devriese et al., 2009). However, an increasing number of reports point 
to the importance of coagulase-negative staphylococci as infectious agents in both human and 
veterinary medicine (Piette and Verschraegen, 2009; Moodley and Guardabassi, 2009; Taponen and 
Pyörälä, 2009). In some species, such as Staphylococcus epidermidis and Staphylococcus 
haemolyticus, methicillin resistance is known to be widely disseminated (Piette and 
Verschraegen, 2009). Similar as with MRSA, pets could function as reservoirs or vectors for 
transfer of methicillin-resistant NAS (MRNAS) to humans. 
This study aimed at assessing the carriage of both MRSA and MRNAS in dogs originating 
from a country where MRSA ST398 is ubiquitously present in livestock (EFSA, 2009a). 
Therefore, the presence of MRS was investigated in nasal swab samples from dogs admitted 
to a veterinary teaching hospital. 
 
5.3 Materials and methods 
5.3.1 Sample collection 
Samples were collected from a convenience population of 177 dogs that were presented for 
diagnostic examination or surgery at the Department of Medicine and Clinical Biology of 
small animals at the Faculty of Veterinary Medicine of Ghent University, Belgium, between 
March 2008 and April 2009. This institution is primarily a referral hospital, treating 
predominantly pets that are referred by other veterinarians (further referred to as second- and 
third-line patients). The investigated animals had not been hospitalised prior to the moment of 
sampling. No selection criteria were wielded except that the dogs needed to be anaesthetised 
for medical purposes. Samples were collected just after induction of anaesthesia, by inserting 
and rubbing a dry cotton swab in both nostrils. Samples were kept in Stuart transporter 
medium (Meus s.r.l., Italy) and stored at -80°C until further analysis.  
 
5.3.2 Sample analysis 
Each sample was grown overnight at 37°C in Trypticase Soy Broth (TSB) (BioMérieux, 
France) supplemented with 2% NaCl and 3.5 mg/l cefoxitin. Then, 1 ml of each enrichment 
culture was inoculated onto a ChromID™ MRSA plate (BioMérieux, France) and Columbia 
agar (Oxoid, Germany) supplemented with 5% sheep blood and 3.5 mg/l cefoxitin. After 24 h 
incubation at 37°C, suspected staphylococcal colonies were selected from each plate for 
purification on Columbia agar with 5% sheep blood (Bio-Rad, Belgium). 
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Pure colonies were Gram stained and tested for catalase and oxidase production, and 
presumptively identified by the BBL Crystal Gram positive identification kit (Becton 
Dickinson, USA).  
 
5.3.3 Identification and characterisation of methicillin-resistant staphylococci 
Confirmation of MRSA and methicillin resistance was done by a PCR amplifying 
sequences specific for Staphylococcus 16S rRNA, mecA and a S. aureus specific part of the 
thermonuclease gene nuc, as described previously (Maes et al., 2002; Vanderhaeghen et al., 2010a). 
NAS possessing the mecA gene were identified to the species level by rpoB gene sequencing 
using the primers and conditions reported by Drancourt and Raoult (2002). 
MRS were tested for additional resistances to a panel of sixteen antimicrobials 
(chloramphenicol 60 µg, gentamicin 40 µg, kanamycin 100 µg, tobramycin 40 µg, fucidic 
acid 100 µg, erythromycin 78 µg, tylosin 150 µg, lincomycin 19 µg, linezolid 30 µg, 
quinupristin + dalfopristin 15 µg, mupirocin 10 µg, ciprofloxacin 10 µg, tetracyclines 80 µg, 
rifampicin 30 µg, sulfonamides 240 µg and trimethoprim 5.2 µg) with the disk diffusion test 
using Rosco Neo-Sensitabs (Rosco Diagnostics, Denmark) and following recommendations 
from Clinical and Laboratory Standards Institute (CLSI) for inoculum preparation, inoculation 
and incubation (CLSI, 2008). Interpretation was done according to the information provided by 
Rosco Diagnostics for using the CLSI method (http://rosco.dk). S. aureus ATCC 25923 was 
included as quality control strain. The staphylococcal cassette chromosome mec (SCCmec) 
was typed by PCR, as described by Vanderhaeghen et al. (2010a). MRSA strains were additionally 
characterised by spa typing (Harmsen et al., 2003) and multilocus sequence typing (MLST) 
(Enright et al., 2000). The presence of pvl genes, lukP-V and lukP-L, was determined using 
primers and conditions described by Lina et al. (1999). 
 
5.3.4 Patient’s characteristics and statistical analysis 
Retrospective analysis of the standard patient files was performed to categorise all 
investigated animals according to their reason for hospital admission. Essentially, a 
differentiation was made between dogs suffering from an infectious process and others. The 
χ²-test (with significance level of 5%) was used to compare carriage of MRS between both 
groups of animals. 
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5.4 Results 
5.4.1 Identification and characterisation of methicillin-resistant staphylococci 
The mecA gene was found in three isolates: two MRSA and one methicillin-resistant S. 
haemolyticus (MRSH) (Table 11). The MRS were found in samples originating from different 
dogs, corresponding with an MRS prevalence of 1.7% (Wald’s 95% CI: 0–3.59%). 
Further typing of the two MRSA strains revealed one strain to be ST45 and spa type t740. 
This strain showed additional resistance to ciprofloxacin and erythromycin. The other strain 
was ST5 and spa type t447, and it showed no additional resistance. Both MRSA carried a 
SCCmec cassette of type IVd and were negative for pvl genes. The MRSH strain was resistant 
to fusidic acid and sensitive to all other antibiotics tested. It carried a type V SCCmec. 
 
Table 11. Identification and characterisation of methicillin-resistant staphylococci present in 
nasal samples from 177 dogs.  
Sample
 
Identification 
a 
Resistance profile 
b 
spa 
c 
MLST 
c,d 
SCCmec 
e 
PVL genes 
f 
55 MRSA CIP – ERY t740 ST45 IVd / 
62 MRSA - t447 ST5 IVd / 
101 MRSH FUS NA
 
NA
 
V NT
 
a MRSA: methicillin-resistant Staphylococcus aureus; MRSH: methicillin-resistant Staphylococcus haemolyticus 
b CIP: ciprofloxacin; ERY: erythromycin; FUS: fusicid acid; - : no additional resistances detected 
c NA: not applicable  //  d MLST: multilocus sequence typing  //  e SCCmec: staphylococcal cassette chromosome mec 
f / : absence of both lukP-V and lukP-L genes; NT: not tested 
 
5.4.2 Patient’s characteristics and statistical analysis 
Of the 177 investigated animals, 27 were suffering from an infectious process. This 
included the dog carrying MRSA strain ST45-t740, which was suffering from otitis media 
with associated vestibular syndrome. In the patient files of this dog, it was found that the dog 
had been treated with enrofloxacin in the month before the sampling. However, more detailed 
information (route of admission, dose, treatment duration...) was lacking. Also for five of the 
other 26 dogs suffering from an infectious process the patient files noted the use of 
antimicrobials in the month proceeding the moment of sampling, but except for the kind of 
agent, also in these cases more detailed information was absent.  
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Dogs not affected by an infectious process, including the animal carrying MRSA strain 
t447-ST5 and the one carrying MRSH, were admitted for various problems, such as 
locomotive problems, tumours, neurologic disease or elective surgery. The presence of an 
infection was not found to have a significant effect on the carriage of MRS (p > 0.05). 
 
5.5 Discussion 
In the population of 177 animals that were investigated, only two (1.1%; Wald’s 95% CI: 
0–2.69%) were carrying MRSA. This indicates that MRSA has a very low prevalence in the 
total population of dogs admitted to our clinic. Moreover, since the investigated animals had 
not been hospitalised prior to the moment of sampling, they can be considered as dogs 
originating from the community, suggesting that MRSA also has a low prevalence in the 
general dog population. Similar low prevalences have been found in other studies (Baptiste et 
al., 2005; Hanselman et al., 2008; Nienhoff et al., 2010). However, our results should be interpreted 
with care. The study population consisted predominantly of second- and third- line patients, 
suffering from serious or chronic disease. Such sub-population is likely not to be 
representative for the general dog population. This is especially true since the patient files 
showed that several animals had been treated with antimicrobials before arriving at our 
institution. For example, the dog carrying MRSA strain ST45-t740 had previously been 
treated with enrofloxacin. However, as the information on previous antimicrobial use that was 
recorded in the patient files was very indistinct, the influence of antimicrobial use was hard to 
account for. In addition, the dogs likely originated not from throughout Belgium but from a 
rather limited region around our clinic. A study investigating a more randomised and 
geographically diverse population is therefore required to confirm our results. 
According to recent studies, the predominant coagulase-positive methicillin-resistant 
Staphylococcus sp. carried by dogs entering veterinary hospitals is methicillin-resistant S. 
pseudintermedius (MRSP) (Hanselman et al., 2008; Nienhoff et al., 2010, 2011). MRSP was also 
found to be present on the skin of healthy dogs (Griffeth et al., 2008). Moreover, a clonal 
expansion of MRSP throughout different European countries has recently been demonstrated 
(Ruscher et al., 2010). Therefore, it was rather surprising that no MRSP was found in our 
samples. Possibly, MRSP resides in Belgian dogs originating from the community in a 
prevalence lower than the detection threshold associated with the size of our study population. 
A larger study should elucidate this. 
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The presence of 2% NaCl in our enrichment broth might have been too restrictive to allow 
for growth of MRSP in some samples. However, S. pseudintermedius has already been 
successfully detected using a medium containing 7.5% NaCl (Hanselman et al., 2008). It is also 
unlikely that our sampling location can explain the absence of MRSP in our samples. Indeed, 
carriage of S. pseudintermedius was reported to be highest in the nasal cavity (Harvey and Noble, 
1998) and MRSP has previously been shown to be present in the nose of dogs (Nienhoff et al., 
2010, 2011). Notably, one study even found MRSP being present only in nasal swabs compared 
to rectal or axillary swabs (Hanselman et al., 2008). 
The most decisive methodological element to explain the absence of MRSP in this study 
might be the use of cefoxitin, which was used in both the enrichment broth and in the agars 
for subculturing the enrichment broth. Recent studies have demonstrated that, when the 
presence of mecA is set as a gold standard, the use of cefoxitin disk diffusion susceptibility 
testing following the current CLSI breakpoints produces high amounts of false negative 
results when testing for methicillin resistance in veterinary isolates of S. pseudintermedius 
(Bemis et al., 2009; Schissler et al., 2009). However, if the current cefoxitin disk diffusion 
interpretive criteria are unsuited for in vitro testing of methicillin resistance in S. 
pseudintermedius, this does not mean that this antimicrobial cannot be used for selective 
isolation. At least for MRSA, cefoxitin was shown to allow for more readily growth compared 
to oxacillin, possibly due to a an enhanced induction of PBP2a by cefoxitin (Rohrer et al., 2001; 
Perry et al., 2004). So far, similar effects have not been investigated for MRSP. This highlights 
the need for more research to be performed into optimal isolation methods for MRS other than 
S. aureus. 
We were not able to detect MRSA ST398 in this study, suggesting that this type has not 
(yet) found its way into the broader Belgian dog population. It seems plausible that the 
environment of the dogs plays a main role in determining the presence or absence of MRSA 
ST398. Similar as for humans, particularly dogs frequently in contact with MRSA positive 
livestock may be at risk. Yet, in Canada, MRSA ST398 has been found in a dog breeding 
kennel (Floras et al., 2010). One of the employees living on a pig farm possibly functioned as 
source of contamination. This demonstrates that further research on MRSA ST398 in dogs 
originating from the community is warranted. Meanwhile also the prevalence of MRSA 
ST398 in companion animals specifically associated with farms should be investigated. 
The MRSA strains detected in this study are well known Belgian hospital clones, 
accounting for nearly 50% of MRSA cases in Belgian acute-care hospitals according to the 
most recent Belgian surveillance study, conducted in 2008 (Vandendriessche et al., 2012). Our 
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findings thus agree with the general observation that MRSA strains in dogs are similar to the 
local hospital clones (Loeffler and Lloyd, 2010). Their presence has been shown to pose risks for 
cross-contamination of people in contact with the animals (Cefai et al., 1994). Therefore, if 
control of human MRSA infection or carriage appears to be difficult, Belgian clinicians might 
need to consider whether the patient has pets acting as MRSA vectors (Scott et al., 1988). 
We found only one MRNAS isolate, a MRSH carrying SCCmec type V. MRSH have 
sporadically been found in companion animals in other studies (van Duijkeren et al., 2004a; Malik et 
al., 2006; Bagcigil et al., 2007). There is however a lack of knowledge on the existence of species-
specific lineages of (MR)SH, and the occurrence of transmission events between different 
hosts has not been studied. Together with other NAS species such as S. epidermidis, S. 
haemolyticus is becoming an increasingly important human hospital pathogen (Piette and 
Verschraegen, 2009). Clearly, the population biology of important (nosocomial) NAS species in 
various animal hosts is an open field awaiting further research, and a possible link between 
NAS in animals and humans should be investigated. 
The clinical condition (infected vs. non-infected) of our dogs did not play a determinative 
role on the carriage of MRS. However, due to the low prevalence of MRS in our population, 
the relevance of these findings is probably negligible. Still, in general, little is known on the 
pathogenic potential of MRS for pets and a study attributing this would therefore be useful. 
 
5.6 Conclusions 
MRS appear to be present in a low prevalence in Belgian community dogs admitted to a 
veterinary clinic. No MRSA ST398 or MRSP were detected with the method used. The 
carriage of MRSA strains belonging to predominant hospital clones could pose risks for both 
the animals and the owners. More research should elucidate the epidemiology of MRS in pets. 
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6.1 Abstract 
While methicillin-resistant Staphylococcus aureus (MRSA) ST398 is known to be 
widespread in pig farms, few studies have investigated the species diversity and SCCmec 
types of methicillin-resistant non-S. aureus staphylococci (MRNAS) residing in the nose of 
pigs. We examined nasal swab samples of 200 pigs originating from 10 Belgian pig farms 
previously found positive for MRSA ST398. Suspected staphylococcal isolates were 
subjected to a 16S rRNA-mecA-nuc PCR. Confirmed MRNAS were genotypically identified 
to the species level and investigated with a SCCmec typing PCR.  
MRNAS (n = 72) were detected on all 10 farms and were carried by 29.5% of the pigs. 
Seven MRNAS species were found: Staphylococcus epidermidis (38.9%), Staphylococcus 
sciuri (18.1%), Staphylococcus pasteuri (18.1%), Staphylococcus rostri (12.5%), 
Staphylococcus warneri (8.3%), Staphylococcus haemolyticus (2.7%) and Staphylococcus 
hominis (1.4%). SCCmec cassettes were of type IV (62.5%), type III (22.2%), type V (5.6%) 
or could not be assigned to any of the known types (NT) (9.7%). Four NT variants (NT 1-4) 
were found.  
The predominance of methicillin-resistant S. epidermidis (MRSE) in our samples is 
remarkable, as MRSE is mainly associated with humans. The finding of different SCCmec 
elements in MRNAS that also prevail or predominate in MRSA ST398 shows that MRNAS 
might be an important SCCmec reservoir for MRSA in pigs. Yet, the occurrence of multiple 
other SCCmec types illustrates that further studies are required to understand the presence and 
spread of SCCmec in MRS from animals. 
 
6.2 Introduction 
Methicillin-resistant Staphylococcus aureus (MRSA) originates from methicillin-
susceptible S. aureus (MSSA) by acquisition of mecA, a gene carried within a mobile genetic 
element called staphylococcal cassette chromosome mec (SCCmec). Based on structural 
composition eleven different types (I-XI) and numerous subtypes of SCCmec have been 
recognized in MRSA so far (website of the International Working Group on the Classification of 
Staphylococcal Cassette Chromosome Elements, IWG-SCC; www.sccmec.org). In non-S. aureus 
staphylococci (NAS), mecA/SCCmec has been demonstrated to prevail as well (Ibrahem et al., 
2009). In human clinical samples, the presence of methicillin-resistant NAS (MRNAS) has 
been well-studied, and the MRNAS species most frequently encountered are methicillin-
resistant Staphylococcus epidermidis (MRSE) and methicillin-resistant Staphylococcus 
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haemolyticus (Petinaki et al., 2001; Ibrahem et al., 2009). In veterinary medicine, MRNAS have 
mostly been studied as pathogens in ruminant mastitis (Rajala-Schultz et al., 2009). Only a few 
studies also investigated carriage of MRNAS in livestock (Bagcigil et al., 2007; Zhang et al., 2009; 
Huber et al., 2011) and companion animals (van Duijkeren et al., 2004a; Bagcigil et al., 2007). However, 
little is yet known on the carriage of MRNAS in pigs nor on the MRNAS species involved. 
It has been suggested that MRNAS function as a mecA/SCCmec reservoir associated with 
the formation of MRSA from MSSA (Barbier et al., 2010; Bloemendaal et al., 2010). Although this 
has mainly been studied in human medicine, it could also be relevant for animals. Indeed, in 
the past years, the emergence of a specific MRSA lineage, sequence type (ST) 398, was 
reported in domestic animals (Voss et al., 2005; Van den Eede et al., 2009; Vanderhaeghen et al., 2010b). 
While MRSA ST398 strains have been shown to carry predominantly SCCmec cassettes of 
type IV(a) and V (Vanderhaeghen et al., 2010b), little is known on the types of SCCmec elements 
that are present in MRNAS from animals.  
The objectives of this study were to assess the carriage and species distribution of MRNAS 
on pig farms previously found positive for MRSA ST398 and to investigate the SCCmec 
elements that they possess. 
 
6.3 Materials and methods 
6.3.1 Sampling 
Ten Belgian pig farms were visited between August and December 2009. Farms were 
selected based on the presence of MRSA ST398 positive pigs as determined in a 2007 survey 
(Crombé et al., 2011). Four farms harboured only fattening pigs, two farms were breeding 
farms, with sows and piglets, and four farms were farrow-to-finish farms, with sows, piglets 
and fattening pigs. On each farm, a convenience sample of ten pigs of each represented age 
group was sampled, resulting in a total of 200 pigs (60 sows, 60 piglets and 80 fattening pigs). 
All pigs were healthy at the moment of sampling. 
A dry cotton swab was used to collect a sample from both nostrils of each animal. Samples 
were stored in Stuart transporter medium (Meus s.r.l., Italy) for transport to the laboratory, 
and laboratory processing of the samples was commenced three to six hours after sampling. 
 
6.3.2 Bacterial isolates 
Each sample was grown overnight at 37°C in 7.5% NaCl Brain Heart Infusion (BHI) broth 
(Becton Dickinson, US) and then subcultured on four different agars: ChromID MRSA agar 
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(BioMérieux, France), Columbia Agar (Oxoid, Germany) supplemented with 5% sheep blood 
(BioMérieux, France) and 3.5 mg/l cefoxitin (Sigma-Aldrich, US), ChromID S. aureus agar 
(BioMérieux, France), and Columbia colistin-aztreonam agar with 5% sheep blood (Oxoid, 
France). Plates were incubated at 37°C. After 24-36h, each of the four plates was examined 
for colonies showing a staphylococcal morphology; per plate, one representative colony of 
each different suspected morphology was selected and purified on Columbia agar with 5% 
sheep blood (Bio-Rad, Belgium). Isolates were grown for 48-72h at 37°C followed by another 
24-48h at room temperature, to be able to fully judge their morphotype (Kloos and Bannerman, 
1994). Afterwards, for each sample, the purified isolates from the four different agar plates 
were compared. Isolates showing identical morphotypes were judged as being identical to 
each other (Kloos and Bannerman, 1994) and only one such isolate was further included in the 
study. If identical morphotypes were found on (one of) the agar plates with cefoxitin 
(ChromID MRSA, blood agar + cefoxitin) and (one of) the plates without cefoxitin (ChromID 
S. aureus, colistin-aztreonam agar), an isolate originating from (one of) the cefoxitin-
containing agar plates was selected. 
Hereafter, an ‘isolate’ refers to a pure culture showing a colony morphotype unique for a 
given sample. Isolates were stored at -80°C in 50% glycerol until further use. 
 
6.3.3 Detection of mecA and identification of MRNAS 
From all isolates, DNA was extracted as previously described (Vanderhaeghen et al., 2010a). 
Then, all isolates were examined with a 16S rRNA-mecA-nuc triplex PCR (Maes et al., 2002). 
MRNAS isolates, recognized as showing amplification of 16S rRNA and mecA, were further 
identified to the species level using tRNA intergenic spacer PCR combined with capillary gel 
electrophoresis (Baele et al., 2000). It was taken into consideration that certain staphylococcal 
species, such as Staphylococcus simulans and Staphylococcus sciuri, give poor or no 
amplification of 16S rRNA in the triplex PCR (Maes et al., 2002); therefore, also isolates that 
were only mecA positive in the triplex PCR but had a clear staphylococcal morphology were 
included in a tRNA identification assay.  
In case tRNA intergenic spacer PCR was not sufficient to identify an isolate, rpoB 
sequencing was performed, with the primers and conditions reported by Drancourt and Raoult 
(2002). An isolate was identified when there was 98% or more sequence similarity with 
GenBank sequences of one species. 
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6.3.4 Cefoxitin disk diffusion testing 
The correspondence between presence of mecA and phenotypic cefoxitin resistance was 
investigated for all MRNAS isolates with the disk diffusion test, using 30 µg cefoxitin disks 
(Rosco Diagnostics, Denmark) and following Clinical and laboratory Standards Institute 
recommendations M31-A3 (CLSI, 2008). S. aureus strains ATCC 25923 and ATCC 43300 were 
used as internal quality controls. The strength of the correlation was assessed by estimating 
the occurrence of resistance to cefoxitin in the mecA-positive population, using logistic 
regression analysis with significance level of 5%. 
 
6.3.5 Determination of oxacillin and cefoxitin minimum inhibitory concentration 
For those MRNAS isolates that had discordant results for mecA PCR and cefoxitin 
resistance in the disk diffusion test, oxacillin and cefoxitin minimum inhibitory concentrations 
(MICs) were determined using E-test according to the manufacturer’s instructions 
(BioMérieux, France). S. aureus strains ATCC 25923 and ATCC 43300 were used as quality 
control strains. 
 
6.3.6 Testing for penicillin-binding protein 2a production 
In addition to MIC determination, MRNAS isolates that had discordant results for mecA 
PCR and cefoxitin resistance in the disk diffusion test were tested for the production of 
penicillin-binding protein 2a (PBP2a), the protein encoded by mecA, using the Clearview 
Exact PBP2a test assay (Alere, Belgium). S. aureus ATCC 25923 and ATCC 43300 were 
used as quality control strains. 
 
6.3.7 Antimicrobial susceptibility testing 
For all mecA-positive NAS isolates, MICs of 17 non-β-lactam antimicrobials 
(erythromycin, clindamycin, quinupristin/dalfopristin, linezolid, tiamulin, kanamycin, 
streptomycin, gentamicin, chloramphenicol, rifampicin, ciprofloxacin, fusidic acid, 
tetracycline, trimethoprim, sulfamethoxazole, vancomycin and mupirocin) were determined 
using custom veterinary international Sensititre staphylococci plates EUST (Trek Diagnostics 
System, England) according to the manufacturer’s instructions. MIC values were qualitatively 
interpretated using CLSI susceptibility breakpoints provided for Staphylococcus spp. in the 
2008 document M31-A3 on antimicrobial susceptibility testing of bacteria isolated from 
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animals (CLSI, 2008). For clindamycin, quinupristin/dalfopristin, linezolid, ciprofloxacin, 
trimethoprim and sulfamethoxazole, the CLSI susceptibility breakpoints provided for 
Staphylococcus spp. in the 2009 document M100-S19 were used (CLSI, 2009). Isolates showing 
an ‘intermediate’ MIC were counted as resistant. No CLSI breakpoints are available for 
streptomycin, tiamulin and fusidic acid, while for rifampicin the dilution range tested did not 
contain the CLSI breakpoint (1 mg/l); therefore, no qualitative interpretation was done for the 
latter four antimicrobials. The susceptibility breakpoint used for mupirocin was ≤ 4 mg/l, 
based on the literature (Finlay et al., 1997). 
Refer to Tables 13a-b for the dilution ranges tested for erythromycin, clindamycin, 
quinupristin/dalfopristin, tiamulin, streptomycin, tetracycline, fusidic acid, trimethoprim and 
sulfamethoxazole. The dilution ranges tested for the agents not included in Tables 13a-b were: 
kanamycin 4-64 mg/l; gentamicin 1-16 mg/l; linezolid 1-8 mg/l; chloramphenicol 4-64 mg/l; 
rifampicin 0.016-0.5 mg/l; ciprofloxacin 0.25-8 mg/l; vancomycin 1-16 mg/l and mupirocin 
0.5-2 mg/l + 256 mg/l. 
S. aureus strain ATCC 29213 was used as quality control strain. 
 
6.3.8 Typing of staphylococcal cassette chromosome mec elements 
All MRNAS were included in the PCR method described by Kondo and colleagues (2007) for 
typing of the SCCmec element. The first three multiplex PCRs (M-PCRs) described in this 
method were used, respectively, for typing of the mec complex (M-PCR 1), typing of the ccr 
complex (M-PCR 2) and type IV subtyping (M-PCR 3) (Kondo et al., 2007). In M-PCR 2, an 
internal control for mecA is included. The following control strains were used: NCTC 10442 
for type I SCCmec; N315 for type II; 85/2082 for type III; 8/6-3P (JCSC 1978) for type IVb; 
MR108 for type IVc; JCSC 4469 for type IVd; and two field isolates previously characterised 
in the Belgian Reference Laboratory for Staphylococci-MRSA as being type IVa and V. 
 
6.4 Results 
6.4.1 Detection and identification of MRNAS 
Presence of mecA was set as the gold standard to consider a NAS isolate as methicillin-
resistant (a methicillin-resistant NAS, MRNAS). In total, the mecA gene was detected in 72 
isolates from 59 of the 200 samples (29.5%) and from all ten farms (100%). Among these 72 
MRNAS, seven species were identified (Table 12). In descending order of number of isolates 
these were S. epidermidis (n = 28; 38.9%), Staphylococcus pasteuri (n = 13; 18.1%), S. sciuri   
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(n = 13; 18.1%), Staphylococcus rostri (n = 9; 12.5%), Staphylococcus warneri (n = 6; 8.3%), S. haemolyticus (n = 2; 2.8%) and Staphylococcus 
hominis (n = 1; 1.4%). 
The distribution of the MRNAS species over the different farms is presented in Table 12. As shown there, MR S. sciuri was the most 
widespread species, being detected on eight farms. Four other MRNAS species were detected on multiple farms: MRSE, present in five farms, 
methicillin-resistant S. pasteuri, found in four farms, and methicillin-resistant S. haemolyticus and methicillin-resistant S. rostri, both detected in 
two farms. Methicillin-resistant S. hominis and methicillin-resistant S. warneri were detected in samples from only one farm. 
 
Table 12. Distribution of methicillin-resistant non-S. aureus (MRNAS) species (n isolates) and their SCCmec types
a
 on the ten farms (F1-10). 
MRNAS species F1  F2  F3  F4  F5  F6  F7  F8  F9  F10  
S. epidermidis 
(n = 28) 
1
 
NT 2 
6 
IVa 
1 
V 
8 
IVa, IVc 
- 
12 
IVa, IVc, V 
- - - - 
S. haemolyticus 
(n = 2) 
- - - - - 
1 
V 
- - - 
1 
V 
S. hominis 
(n = 1) 
- - - - - - 
1 
NT 4 
- - - 
S. pasteuri 
(n = 13) 
- - - 
1 
IVc 
3 
IVc 
1 
IVc 
8 
IVc 
- - - 
S. rostri 
(n = 9) 
- - - - - 
6 
III 
3 
III, IVa, NT 1 
- - - 
S. sciuri 
(n = 13) 
- 
2 
NT 3 
2 
III 
2 
III 
1 
NT 3 
2 
III 
1 
IIIvar1 
1 
III 
2 
III, NT 1 
- 
S. warneri 
(n = 6) 
- - - - - - 
6 
IVvar1 
- - - 
a
 IIIvar1, IVvar1 and NT1-4 (non-typeable): SCCmec cassettes described in Table 14. 
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Some pigs carried more than one MRNAS: 11 pigs carried two MRNAS and one pig 
carried three MRNAS. In all but one samples, the different MRNAS were also different 
MRNAS species. In the one exception, two MRSE were detected, which were, however, 
found to carry different SCCmec types. 
 
6.4.2 Cefoxitin disk diffusion testing 
A correlation of 86.1 % (95% CI: 76.1 %- 92.4 %) was observed between cefoxitin disk 
diffusion testing and presence of mecA (p < 0.05). Only the nine mecA-positive isolates of S. 
rostri appeared to be susceptible to cefoxitin, with zone diameters of 26 - 32 mm. 
 
6.4.3 E-test and penicillin binding protein 2a testing 
The nine S. rostri isolates with discordant mecA PCR - cefoxitin disk diffusion test results 
tested positive for PBP2a production, proving the presence and expression of mecA. However, 
E-test showed cefoxitin MICs to be 1 μg/ml and oxacillin MICs to be 0.125 μg/ml (7 isolates) 
or 0.25 μg/ml (2 isolates), which is susceptible according to CLSI breakpoints (CLSI, 2008). 
 
6.4.3 Antimicrobial susceptibility testing 
All isolates were susceptible to vancomycin (MICs ≤ 2 mg/l), linezolid (MICs ≤ 4 mg/l) 
and gentamicin (MICs ≤ 4 mg/l). 
One methicillin-resistant S. haemolyticus isolate was resistant to kanamycin (MIC = 32 
mg/l), one methicillin-resistant S. pasteuri isolate was resistant to chloramphenicol (MIC = 64 
mg/l), one methicillin-resistant S. sciuri isolate was resistant to mupirocin (MIC > 256 mg/l) 
and single MRSE and MR S. sciuri isolates were resistant to ciprofloxacin; all other MRNAS 
were susceptible to the respective antimicrobials. The MIC distributions for the remaining 
nine antimicrobials are shown in Tables 13a and 13b. 
The single MR S. hominis isolate was resistant to tetracycline and sulfamethoxazole and 
susceptible to all other antimicrobials. 
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Table 13a. MICs of methicillin-resistant non-S. aureus (MRNAS) species from pigs (S. epidermidis & S. 
haemolyticus [n = 30], S. pasteuri & S. warneri [n = 19], S. rostri [n = 9] and S. sciuri [n = 13]) to the macrolide-
lincosamide-streptogramin antimicrobials erythromycin, clindamycin and quinupristin/dalfopristin and to 
the pleuromutilin tiamulin. 
Test agent 
a 
Species 
b 
% of isolates with MIC (mg/l) of 
R%
c 
0.06 0.12 0.25 0.5 1 2 4 8 16 
Erythromycin S. epi/haemo   80.0 0.0 3.3 0.0 0.0 0.0 16.7 20.0 
 S. past/warn   42.1 0.0 0.0 0.0 0.0 0.0 57.9 57.9 
 S. rostri   77.8 22.2 0.0 0.0 0.0 0.0 0.0 0.0 
 S. sciuri    61.5 0.0 0.0 0.0 0.0 0.0 38.5 38.5 
Clindamycin S. epi/haemo  73.3 0.0 0.0 0.0 0.0 6.7 20.0  26.7 
 S. past/warn  26.3 15.8 0.0 0.0 0.0 0.0 57.9  57.9 
 S. rostri  0.0 0.0 77.8 22.2 0.0 0.0 0.0  22.2 
 S. sciuri   0.0 0.0 0.0 61.5 0.0 0.0 38.5  100 
Quinu/dalfo S. epi/haemo    90.0 10.0 0.0 0.0 0.0  0.0 
 S. past/warn    57.9 10.5 5.3 26.3 0.0  31.6 
 S. rostri    100 0.0 0.0 0.0 0.0  0.0 
 S. sciuri     0.0 15.4 84.6 0.0 0.0  84.6 
Tiamulin
 
S. epi/haemo    90.0 0.0 0.0 0.0 10.0
 
 NA 
 S. past/warn    63.2 0.0 0.0 0.0 36.8
d 
 NA 
 S. rostri    0.0 0.0 0.0 0.0 100  NA 
 S. sciuri     0.0 0.0 0.0 0.0 100  NA 
 
a 
The dilution ranges tested for each antimicrobial agent are those contained within the white area, including the diagonally striped 
boxes at the left. The values situated in these striped boxes indicate the % of isolates that had a MIC smaller than or equal to the 
lowest concentration tested. Values situated in the first green box at the right of the dilution range represent the % of isolates that 
had a MIC higher than the highest concentration tested. CLSI susceptibility breakpoints are indicated with vertical black lines (CLSI 
2008, 2009). 
b The results are presented together for the MR S. epidermidis and MR S. haemolyticus isolates and for the MR S. pasteuri and MR S. 
warneri isolates, because of the good agreement between the MIC distributions for the obtained isolates of these species. The 
results for the MR S. rostri and the MR S. sciuri isolates are presented separately. The results for the single MR S. hominis isolate are 
given in the text. 
c
 R%: total percentage of resistant isolates; NA: not applicable (see text for explanation) 
d All six MR S. warneri and one of thirteen MR S. pasteuri 
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Table 13b. MICs of methicillin-resistant non-S. aureus (MRNAS) species from pigs (S. epidermidis & S. haemolyticus [n = 30], S. pasteuri & S. warneri 
[n = 19], S. rostri [n = 9] and S. sciuri [n = 13]) to streptomycin, tetracycline, fusidic acid, trimethoprim and sulfamethoxazole. 
Test agent
a 
Species
b 
% of isolates with MIC (mg/l) of 
R%
c 
0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 
Streptomycin
 
S. epi/haemo     50.0 20.0 0.0 3.3 26.7     NA 
 S. past/warn     26.3 10.5 15.8 0.0 47.4     NA 
 S. rostri     22.2 66.7 11.1 0.0 0.0     NA 
 S. sciuri     53.8 15.4 7.7 7.7 15.4     NA 
Tetracycline S. epi/haemo  13.3 0.0 30.0 0.0 0.0 0.0 56.7      56.7 
 S. past/warn  5.3 0.0 0.0 0.0 0.0 0.0 94.7      94.7 
 S. rostri  0.0 0.0 0.0. 0.0 0.0 0.0 100      100 
 S. sciuri  15.4 0.0 0.0 0.0 0.0 0.0 84.6      84.6 
Fusidic acid
 
S. epi/haemo  100 0.0 0.0 0.0 0.0        NA 
 S. past/warn  100 0.0 0.0 0.0 0.0        NA 
 S. rostri  100 0.0 0.0 0.0 0.0        NA 
 S. sciuri  0.0 0.0 53.8 46.2 0.0        NA 
Trimethoprim S. epi/haemo    13.3 3.3 0.0 10.0 6.7 66.7     83.4 
 S. past/warn    0.0 0.0 0.0 0.0 0.0 100     100 
 S. rostri    100 0.0 0.0 0.0 0.0 0.0     0.0 
 S. sciuri     30.8 46.2 7.7 0.0 0.0 15.4     15.4 
Sulfamethoxazole
 
S. epi/haemo         33.3 0.0 10.0 30.0 26.7 56.7 
 S. past/warn         100 0.0 0.0 0.0 0.0 0.0 
 S. rostri         0.0 0.0 0.0 0.0 100 100 
 S. sciuri         76.9 7.7 15.4 0.0 0.0 0.0 
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a 
The dilution ranges tested for each antimicrobial agent are those contained within the white area, including the diagonally striped boxes at the left. The values situated in these striped 
boxes indicate the % of isolates that had a MIC smaller than or equal to the lowest concentration tested. Values situated in the first green box at the right of the dilution range 
represent the % of isolates that had a MIC higher than the highest concentration tested. CLSI susceptibility breakpoints are indicated with vertical black lines (CLSI 2008, 2009). 
b The results are presented together for the MR S. epidermidis and MR S. haemolyticus isolates and for the MR S. pasteuri and MR S. warneri isolates, because of the good agreement 
between the MIC distributions for the obtained isolates of these species. The results for the MR S. rostri and the MR S. sciuri isolates are presented separately. The results for the single 
MR S. hominis isolate are given in the text. 
c
 R%: total percentage of resistant isolates; NA: not applicable (see text for explanation). 
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6.4.4 Typing of staphylococcal cassette chromosome mec elements 
The SCCmec typing results of the 72 MRNAS are shown in Table 14. Nine different ccr-
mec-complex-combinations were detected, defining three recognized SCCmec types, two 
variants of SCCmec types and four non-typeable (NT) variants. 
Cassettes of type IV (2B) predominated (62.5%), with 29.2% cassettes of type IVa (2B), 
25% of type IVc (2B) and 8.3% of a type IV variant, IVvar1 (2B&5). Another 22.2% cassettes 
were type III (3A) or a variant, type IIIvar1 (3A&5). Type V (5C2) cassettes were present in 
5.6% of MRNAS. The remaining seven cassettes (9.7%) could not be assigned to any of the 
known types (NT 1 - 4), although NT4 had characteristics of being another type IV variant, 
except for the presence of an amplicon not corresponding to any of the expected band lengths. 
Cassettes NT 1, 2 and 3 had characteristics indicative of either being incomplete cassettes, 
either having modified primer attachment sequences, either possessing mec or ccr complexes 
that were not included in the primer sets used. 
The highest diversity of SCCmec cassettes was found for S. sciuri and S. epidermidis, in 
which four different cassettes were detected (Table 14). Yet, cassettes of type III (3A and 
3A&5) predominated in S. sciuri while in S. epidermidis, the most prevalent cassette was by 
far type IVa (2B). Two species harboured cassettes of only one type: all S. pasteuri harboured 
cassettes of type IVc (2B), while all S. warneri harboured the type IVvar1 (2B&5) cassettes. 
Eight of the nine isolates of S. rostri were found to carry complete cassettes of recognized 
types, III (3A) or IVa (2B); the remaining isolate carried a non-typeable variant (NT 1) with a 
ccr complex of type 2 but no amplification of mec complex sequences except mecA (Table 
14). 
As shown in Table 12, on three farms similar SCCmec types were detected in different 
MRNAS species. 
 
  
III – EXPERIMENTAL STUDIES           Chapter 6 - Characterisation of MRNAS from pigs 
101 
Table 14. Characteristics of the staphylococcal cassette chromosome mec (SCCmec) elements found in 
72 methicillin-resistant non-S. aureus staphylococci (MRNAS) isolated from pigs. 
ccr complex
a 
mec complex
a 
SCCmec type
b 
n isolates Species (n isolates) 
A3/B3 A III (3A) 15 S. rostri (7), S. sciuri (8) 
A3/B3 + C1 A IIIvar1 (3A&5) 1 S. sciuri (1) 
A2/B2 B IVa (2B) 21 
S. epidermidis (20), 
 S. rostri (1) 
A2/B2 B IVc (2B) 18 
S. epidermidis (5), 
S. pasteuri (13) 
A2/B2 + C1 B IVvar1 (2B&5) 6 S. warneri (6) 
C1 C2 V (5C2) 4 
S. epidermidis (2), 
S. haemolyticus (2) 
A2/B2 mecA NT 1 2 S. rostri (1), S. sciuri (1) 
C1 mecA 
NT 2 
1 S. epidermidis (1) 
- A NT 3 3 S. sciuri (3) 
A2/B2 + A4/B4 + C1 + UK
c 
B NT 4
c 
1 S. hominis (1) 
a 
The mecA gene is present in the mec-complex; nonetheless, the internal mecA control used in this typing method is included in 
the multiplex PCR (M-PCR) for ccr complex determination (Kondo et al., 2007). In the first (left) column, ‘-’ then means that no 
other bands than the mecA control were amplified. In the second column ‘mecA’ means that no bands were amplified in the M-
PCR for mec complex determination but that the mecA control was amplified in the M-PCR for ccr complex determination.  
b The SCCmec type was determined by the combination of the type of ccr complex and the class of mec complex. As suggested by 
the International Working Group on the Classification of Staphylococcal Cassette Chromosome elements (IWG-SCC, 2009), 
cassettes showing a combination of ccr complexes were considered as variants of recognized SCCmec types. Cassettes where 
no ccr complex or mec complex could be detected were considered as non-typeable (NT). 
c
 Although NT4 appears to be a variant of SCCmec type IV (2B) it is not represented like that, due to the presence of a band with a 
length not corresponding to any of the expected sizes (UK).  
 
6.5 Discussion 
Only a few studies have been performed on the occurrence of MRNAS in pigs. Here, we 
found 29.5% of 200 pigs to carry at least one MRNAS. Similarly, in Switzerland 36.3% of 
716 pigs from 241 farms were MRNAS carriers (Huber et al., 2011), whereas no MRNAS could 
be detected in pig samples obtained from three Danish pig farms (Bagcigil et al., 2007).  
The MRNAS species diversity we observed was quite different from the diversity recently 
described in Dutch pigs (Tulinski et al., 2012). In our study, MRSE was the predominant MRNAS 
species, mainly because of the high detection rate of MRSE on three farms (Table 12). This 
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finding was unexpected: MRSE is the most frequently detected MRNAS species in humans, 
both in hospitals (Kloos and Bannerman, 1994) and in the community (Jamaluddin et al., 2008), while 
it is infrequently found in animals (Huber et al., 2011; Tulinski et al., 2012). Moreover, our MRSE 
isolates were mostly carrying SCCmec elements of type IVa, which is also observed in human 
MRSE (Wisplinghoff et al., 2003; Barbier et al., 2010). This suggests that the MRSE isolates detected 
in our pig samples may have a human origin. A possible link between our animal MRSE 
strains and human strains will be the subject of further research. 
Another surprising result was the finding of methicillin-resistant S. rostri, a species only 
recently described as a major part of the nasal bacterial flora of pigs in Switzerland (Riesen and 
Perreten, 2010). In a subsequent Swiss study that investigated antimicrobial resistance in a 
population of S. rostri, none of the isolates phenotypically showed oxacillin resistance 
(Stegmann and Perreten, 2010). The presence of mecA was, however, not tested in that study. 
Although our S. rostri isolates carried mecA and produced PBP2a, they appeared 
phenotypically susceptible according to CLSI guidelines. To elucidate how to interpret results 
of phenotypical methicillin resistance-testing in S. rostri, a larger study including a significant 
amount of mecA-positive and mecA-negative S. rostri isolates will be necessary. 
Additional antimicrobial resistances of MRNAS from pigs showed some similarities with 
MRSA ST398, as in the latter, tetracycline resistance is typically present and also resistance 
to MLS-antimicrobials and trimethoprim is frequently reported (Vanderhaeghen et al., 2010b). 
Yet, resistance to aminoglycosides and ciprofloxacin was low or absent in our MRNAS, while 
being often present in MRSA ST398. Even though no CLSI breakpoints are defined for 
tiamulin, interpretation of the MIC distributions using the microbiological criterion (Butaye et 
al., 2003) indicated the existence of tiamulin resistance in the majority of MRNAS species. 
This was remarkable, as recent reports have documented on increasing levels of tiamulin 
resistance in MRSA strains from pigs (Overesch et al., 2011; Rubin et al., 2011). This might be 
linked with the emergence of multidrug resistance genes such as the vga genes, which confer 
resistance to streptogramin A, pleuromutilins and lincosamides, and are located on mobile 
genetic elements (Kadlec and Schwarz, 2009b; Schwendener and Perreten, 2011). Two new vga variants 
have recently been described in MRSA ST398 strains from pigs. Future research will 
investigate the genetic antimicrobial resistance determinants present in our MRNAS, to assess 
their role as reservoir for other determinants than mecA. 
The MRNAS isolates detected in our study carried a large diversity of SCCmec elements. 
Yet, similar to what was observed in MRNAS from Dutch pigs (Tulinski et al., 2012), known 
SCCmec types constituted the majority of the elements. SCCmec types IVa and V, which 
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predominate in MRSA ST398 (Van den Eede et al., 2009; Vanderhaeghen et al., 2010b; Crombé et al., 
2011), also formed a considerable part of the SCCmec types detected in our MRNAS. 
Moreover, the type IV variant we detected, IVvar1 (2B&5), has recently been reported to occur 
in MRSA ST398 isolated from Italian pigs (Battisti et al., 2010). Interestingly, simultaneously 
performed research on the presence of MRSA in our farms (Vandendriessche et al., 2011a) showed 
that similar SCCmec types were present in MRSA ST398 and MRNAS on five farms. On 
these farms, a total of thirteen pigs were found concurrently carrying MRNAS and MRSA 
with the same SCCmec type, including 11 type IVa cassettes, carried by S. epidermidis (n=10) 
and S. rostri (n=1) and two type V cassettes, carried by S. epidermidis (n=1) and S. 
haemolyticus (n=1). This strongly suggests that SCCmec elements are shared between 
MRNAS and MRSA in pigs, a conclusion that was inferred from the results of the recent 
Dutch study as well (Tulinski et al., 2012). The direction of transfer is hard to assess and could 
very well work in both directions. Yet, MRSE has previously been described as SCCmec 
donor of a type IVa cassette to S. aureus (Bloemendaal et al., 2010). To further investigate the 
similarity between the SCCmec elements in our MRNAS and those in MRSA ST398 strains, 
techniques with a higher discriminative power than the current classic PCR typing techniques 
will be necessary. 
A considerable number of the SCCmec elements were type IVc and type III. In the 
literature, type IVc has not yet been reported to occur in MRSA ST398, though it must be 
noted that several studies reporting on MRSA ST398 did not perform type IV subtyping 
(Vanderhaeghen et al., 2010b). Also in non-ST398 MRSA in pigs, type IVc is infrequently 
detected (Overesch et al., 2011). In contrast, type IVc is often found in various human 
community-acquired MRSA clones (Orendi et al., 2010; Higashiyama et al., 2011). It is not clear why 
type IVa is the main type IV cassette in MRSA ST398. Our detection of type IVc cassettes in 
different MRNAS species from the same farm (Table 9) suggests that this SCCmec element 
can indeed be shared between staphylococcal species. Recently, SCCmec type IVc was also 
found in different MRNAS species from Dutch pig farms, while it was absent in MRSA 
ST398 strains from these farms (Tulinski et al., 2012). One could speculate that these findings 
indicate that MRSA ST398 carrying type IV cassettes spreads largely clonally, instead of by 
frequent loss and uptake of type IV cassettes. Alternatively, for an as yet unidentified reason, 
uptake of type IVa cassettes by MSSA ST398 may be favoured over uptake of type IVc 
cassettes. Even so, the recent detection of a MRSA ST1 strain carrying IVc in Swiss slaughter 
pigs (Overesch et al., 2011) warns that MRNAS could also start function as SCCmec reservoir for 
non-ST398 MRSA lineages adapting to animals, as was suggested for ST1 (Battisti et al., 2010). 
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Type III cassettes are considered to be typically associated with human hospital MRSA 
clones (Robinson and Enright, 2003). The presence of type III in MRSA ST398 has been reported 
previously. However, this might have been due to a false result inherent to the typing method 
used (Jansen et al., 2009; Argudín et al., 2010). Also in non-ST398 MRSA in pigs, type III SCCmec 
cassettes appear to be absent (Neela et al., 2009; Pomba et al., 2009; Overesch et al., 2011). Yet, we 
detected type III cassettes in different MRNAS species (Tables 9 and 11) and in another study 
on SCCmec diversity in animal MRNAS, type III was found as the dominant SCCmec 
cassette (Zhang et al., 2009). To elucidate whether type III SCCmec cassettes detected in animal 
MRNAS are truly similar to type III cassettes prevailing in human hospital MRSA clones, the 
nature of these SCCmec elements will need to be further studied. 
 
6.6 Conclusions 
MRNAS were detected on all ten pig farms and were carried by almost one third of the 
sampled pigs. Among seven different MRNAS species, MRSE predominated, which is 
remarkable due to the general association of MRSE with humans. Also methicillin-resistant S. 
rostri was found, a species only recently described as an important constituent of the nasal 
flora of Swiss pigs. Our results indicate that MRNAS and particularly MRSE could act as an 
important SCCmec reservoir for MRSA ST398. Yet, the considerable presence of SCCmec 
types not associated with MRSA from pigs should be further studied, to elucidate the 
mechanisms explaining the presence and spread of SCCmec cassettes in animal staphylococci. 
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7.1 Abstract 
Objectives: This study aimed at assessing and characterising the methicillin resistance 
reservoir in non-Staphylococcus aureus staphylococci carried by bovines. 
Methods: Nasal swab samples were collected from 150 veal calves on 15 veal farms, 100 
dairy cows on 10 dairy farms and 100 beef cows on 10 beef farms. Suspected staphylococcal 
isolates were investigated by PCR for presence of classic mecA and mecALGA251. Methicillin-
resistant non-S. aureus staphylococci (MRNAS) were genotypically identified and were 
characterized by broth microdilution antimicrobial susceptibility testing and staphylococcal 
cassette chromosome mec (SCCmec) typing. 
Results: MRNAS (total n = 101) were carried by 30.7% of veal calves, 12.1% of dairy 
cows and 24% of beef cows. Logistic regression analysis showed no significant difference in 
MRNAS carriage between the populations. mecALGA251 was not detected. Most (n = 80) 
MRNAS were identified as S. sciuri, S. lentus or S. fleurettii. Resistance to aminoglycosides, 
macrolide-lincosamide-streptogramin-antimicrobials, tetracycline and ciprofloxacin was 
frequently detected. Two linezolid-resistant MRNAS from veal calves carried the multidrug-
resistance gene cfr. SCCmec cassettes of type III predominated (n = 46); another 40 SCCmec 
cassettes harboured a class A mec complex without identifiable ccr complex; type IVa, type V 
and several other non-typeable cassettes were detected in low frequencies, especially in 
methicillin-resistant S. epidermidis. 
Conclusions: The SCCmec types predominating in bovine MRNAS differ from those 
mostly detected in livestock-associated MRSA strains. Yet, the detection of cfr and the high 
level of other antimicrobial resistances suggest a potentially important role of bovine MRNAS 
as reservoir for resistance determinants other than SCCmec. 
 
7.2 Introduction 
Methicillin-resistant Staphylococcus aureus (MRSA) and other methicillin-resistant 
staphylococci are long known as important human pathogens (Chambers, 1997; von Eiff et al., 
2002). In veterinary medicine, increased attention was drawn to the manifestation of 
methicillin-resistant (MR) staphylococci after the unexpected detection of a particular type of 
MRSA, sequence type (ST) 398, in pigs (Voss et al., 2005; Huijsdens et al., 2006). Since, MRSA 
CC398 has been found to be present in pigs worldwide and to affect a variety of other animals 
too, including bovines (Graveland et al., 2009, 2010; Vanderhaeghen et al., 2010a). 
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The gene responsible for methicillin resistance, mecA, is contained in a chromosome-
located mobile genetic element, the staphylococcal cassette chromosome mec (SCCmec) 
(Katayama et al., 2000). Depending on the structural composition, SCCmec types and subtypes 
are distinguished (IWG-SCC, 2009). So far, 11 different SCCmec types (I-XI) and numerous 
subtypes have been recognized in MRSA (IWG-SCC, 2009; Li et al., 2011; García-Álvarez et al., 2011; 
Shore et al., 2011). However, the SCCmec diversity extends beyond these (sub)types, especially 
in MR non-S. aureus staphylococci (MRNAS) (Hanssen and Sollid, 2007; IWG-SCC, 2009; Urushibara 
et al., 2011; Zong et al., 2011). MRNAS have been proposed to function as a SCCmec reservoir for 
S. aureus (Hanssen and Sollid, 2006) and indirectly, the transfer of (parts of) SCCmec between 
MRNAS and S. aureus has been shown in several studies (Hanssen et al., 2004; Berglund and 
Söderquist, 2008; Bloemendaal et al., 2010).  
In food production animals, MRNAS have received little attention to date. Recently, two 
studies analyzed the MRNAS diversity in nasal samples from pigs in Belgium and the 
Netherlands, and found MR Staphylococcus epidermidis as dominant species, respectively 
together with MR Staphylococcus sciuri and, MR Staphylococcus haemolyticus and MR 
Staphylococcus cohnii (Tulinski et al., 2012; Vanderhaeghen et al., 2012). Both studies also described 
a great variety of SCCmec types, with a substantial part being type IV. Moreover, MRNAS 
and MRSA isolated from similar environments were found to carry similar SCCmec types. 
In cattle, presence of MRNAS has mostly been studied in relation to mastitis (Moon et al., 
2007; Feβler et al., 2010b; Sampimon et al., 2011). Studies on healthy carriage are limited (Haenni et al., 
2011a; Huber et al., 2011), and information on SCCmec types in bovine MRNAS is almost 
lacking (Haenni et al., 2011a). 
Recently, a new variant of the classic mecA gene, designated mecALGA251, has been 
discovered in MRSA from dairy cows in several European countries (García-Álvarez et al., 2011; 
Shore et al., 2011). The evolutionary origin of mecALGA251 remains unclear. Similar as suggested 
for the classic mecA gene (Couto et al., 1996; Tsubakashita et al., 2011), MRNAS could function as 
the evolutionary source and/or reservoir. So far, the presence of mecALGA251 has not been 
investigated in MRNAS from bovines.  
The current study aimed at investigating the carriage and species diversity of MRNAS, 
harbouring either classic mecA or mecALGA251, in different bovine populations (veal calves 
[VC], dairy cows [DC] and beef cows [BC]). Moreover, the role of bovine MRNAS as 
reservoirs for methicillin and other antimicrobial resistances was assessed through SCCmec 
typing and phenotypical determination of additional antimicrobial resistances. 
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7.3 Materials and methods 
7.3.1 Sampling  
Nasal swab samples were collected from 150 veal calves (VC), 100 dairy cows (DC) and 
100 beef cows (BC). VC originated from 15 Belgian farms exclusively breeding veal calves 
(veal farms, VF), while dairy and beef cows originated each from 10 Belgian farms 
exclusively breeding dairy (DF) and beef cows (BF), respectively. All farms were randomly 
selected from the national database of the Belgian Federal Agency for the Safety of the Food 
Chain. 
On each farm, a convenience sample of ten animals, evenly distributed over the farm, was 
selected. All animals were healthy at the moment of sampling (based on visual inspection and 
information from the farmer). VC were between 3 weeks and 30 weeks of age; apart from 
seven heifers, all DC were at least 2 years of age; all BC were at least two years of age. 
A dry cotton swab was introduced 2-6 cm into both nostrils of each animal. Swabs were 
stored in Stuart transporter medium (Meus s.r.l., Italy) and processed within six hours. 
 
7.3.2 Bacterial isolates 
Each sample was grown overnight at 37°C in 7.5% NaCl Brain Heart Infusion (BHI) broth 
(Becton Dickinson, US) and then subcultured at 37°C on four different agars: ChromID 
MRSA agar (BioMérieux, France), Columbia Agar (Oxoid, Germany) supplemented with 5% 
sheep blood (BioMérieux, France) and 3.5 mg/l cefoxitin (Sigma-Aldrich, US), ChromID S. 
aureus agar (BioMérieux, France), and Columbia colistin-aztreonam agar with 5% sheep 
blood (Oxoid, France). After 24-36h, each plate was examined for colonies showing a 
staphylococcal morphology; per plate, one representative colony of each different 
morphology was subcultured on Columbia agar with 5% sheep blood (Bio-Rad, Belgium). 
Isolates were grown for 48-72h at 37°C followed by another 24-48 h at room temperature, to 
be able to fully judge their morphotype (Kloos and Bannerman, 1994). Then, all isolates 
originating from a sample were compared and isolates showing identical morphotypes were 
judged as being the same strain (Kloos and Bannerman, 1994); only one such isolate was further 
included in the study. If identical morphotypes were found on (one of) the agar plates with 
cefoxitin (ChromID MRSA, blood agar + cefoxitin) and (one of) the plates without cefoxitin 
(ChromID S. aureus, colistin-aztreonam agar), an isolate originating from a cefoxitin-
containing agar plate was selected. 
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Hereafter, an ‘isolate’ refers to a pure culture showing a colony morphotype unique for a 
given sample. Isolates were stored at -80°C in 50% glycerol until further use. 
 
7.3.3 Detection of mecA, mecALGA251 and identification of MRNAS 
DNA was extracted from all isolates as previously described (Vanderhaeghen et al., 2010a). All 
isolates were examined with a 16S rRNA-mecA-nuc triplex PCR (Maes et al., 2002), in which 
the nuc sequence is used to distinguish S. aureus (possessing the nuc sequence) from non-S. 
aureus staphylococci (NAS, lacking the nuc sequence). MRSA strain NCTC10442, 
methicillin-susceptible S. aureus strain ACTC25923, E. coli strain ATCC25922 and a 
MRNAS field strain were used as control strains. All NAS isolates negative for mecA were 
also investigated for mecALGA251 using previously described primers: mecALGA251-MultiFP 
(GAAAAAAAGGCTTAGAACGCCTC), mecALGA251MultiRP (GAAGATCTTTTCCGTTTT 
CAGC) and mecALGA251RP (CCTGAATC[W]GCTAATAATATTTC) (Stegger et al., 2012). 
MRSA strain NCTC10442 and MRSA field isolates found positive for mecALGA251 (M. Holmes, 
personal communication) were included as negative and positive control strains, respectively. 
All NAS isolates positive for mecA or mecALGA251 were further identified to the species 
level using tRNA intergenic spacer PCR combined with capillary gel electrophoresis (Baele et 
al., 2000; Supré et al., 2009). In case tRNA intergenic spacer PCR was not conclusive, rpoB gene 
sequencing was performed (Drancourt and Raoult, 2002); if rpoB sequencing failed, 16S rRNA 
gene sequencing was performed (Johnson, 1994). 
 
7.3.4 Antimicrobial susceptibility testing 
For all NAS isolates positive for mecA or mecALGA251, MICs of 19 antimicrobials 
(penicillin, cefoxitin, kanamycin, streptomycin, gentamicin, erythromycin, clindamycin, 
quinupristin/dalfopristin, linezolid, tiamulin, chloramphenicol, rifampicin, ciprofloxacin, 
fusidic acid, tetracycline, trimethoprim, sulfamethoxazole, vancomycin and mupirocin) were 
determined using custom veterinary international Sensititre staphylococci plates EUST (Trek 
Diagnostics System, England) according to the manufacturer’s instructions. Clinical and 
Laboratory Standard Institute (CLSI) susceptibility breakpoints (CLSI, 2008, 2009) were used for 
qualitative interpretation of MIC values (with isolates showing an ‘intermediate’ MIC being 
counted as resistant). Refer to Tables 16a-e for the tested dilution ranges and for further 
explanation on the use of the susceptibility breakpoints. For vancomycin and mupirocin, 
which are not included in Tables 16a-e, the dilution ranges tested were 1-16 mg/l and 0.5-2 
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mg/l + 256 mg/l, respectively. The CLSI susceptibility breakpoint for vancomycin is ≤ 2 mg/l. 
The susceptibility breakpoint used for mupirocin was ≤ 4 mg/l, based on the literature (Finlay et 
al., 1997). 
MRNAS isolates that appeared resistant to linezolid (MIC > 4 mg/l) were tested for the 
presence of the cfr gene (Kehrenberg and Schwarz, 2006). 
 
7.3.5 Testing for PBP2a production 
All isolates showing discordant results for mecA PCR and cefoxitin MICs, i.e. mecA-
positive and MICs ≤ 4 mg/l, were tested for the production of PBP2a using the Clearview 
Exact PBP2a test assay (Alere, Belgium) according to the manufacturer’s instruction. S. 
aureus strains ATCC 25923 and ATCC 43300 were used as negative and positive controls, 
respectively. 
 
7.3.6 Typing of SCCmec elements 
The SCCmec type of all MRNAS was determined using the first two multiplex PCRs (M-
PCRs) described by Kondo et al. (2007), for typing of the mec complex and ccr complex, 
respectively. In M-PCR 2, an internal control for mecA is included. Subtyping of SCCmec 
type IV was done according to M-PCR 3 (Kondo et al., 2007). The following control strains were 
used: NCTC 10442 for type I SCCmec; N315 for type II; 85/2082 for type III; 8/6-3P (JCSC 
1978) for type IVb; MR108 for type IVc; JCSC 4469 for type IVd; and two field isolates 
previously characterized as being type IVa and V (Crombé et al., 2011). 
 
7.4 Results 
7.4.1 Detection and identification of MRNAS 
Presence of mecA or mecALGA251 was set as the gold standard to consider an isolate as a 
MRNAS. In total, the mecA gene was detected in 101 isolates, originating from 82 of the 350 
samples (23.4%) (Table 15). None of the NAS isolates were positive for mecALGA251.  
When regarding the different bovine groups, MRNAS carriage was highest in VC and 
lowest in DC (Table 15). Four VF harbored one MRNAS-positive animal, two VF harbored 
two MRNAS-positive animals and the remaining nine VF harbored between three and seven 
MRNAS-positive animals. One DF harbored one MRNAS-positive animal, a second harbored 
three MRNAS-positive animals and a third DF harbored eight MRNAS-positive animals. On 
the MRNAS-positive BF, between two and six animals were MRNAS-positive. 
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Table 15. Methicillin-resistant non-Staphylococcus aureus staphylococci (MRNAS) detection and 
species diversity in nasal swab samples from three bovine populationsa. 
 VC DC BC Total 
Positive farms 15 (100)
b 
3 (30) 7 (70) 25 (55.6) 
Positive animals 46 (30.7) 12 (12) 24 (24) 82 (23.4) 
MRNAS 58
c 
13 30 101 
Staphylococcus arlettae 0 0 1 1 
Staphylococcus epidermidis 11 2 0 13 
Staphylococcus equorum 1 0 1 2 
Staphylococcus fleurettii 0 1 22 23 
Staphylococcus haemolyticus 4 0 1 5 
Staphylococcus lentus 22 0 2 24 
Staphylococcus sciuri 20 10 3 33 
a VC: veal calves; DC: dairy cows; BC: beef cows        b n (%)          c n 
 
Overall, seven MRNAS species were found (Table 15). MRNAS belonging to the S. sciuri 
species group (consisting of S. sciuri, Staphylococcus lentus, Staphylococcus fleurettii and 
Staphylococcus vitulinus) made up 79% of all isolates. A distinction between the three bovine 
groups was observed. In VC, MR S. lentus and MR S. sciuri dominated, followed by MR S. 
epidermidis and MR S. haemolyticus (Table 15). In DC, MR S. sciuri was the predominant 
MRNAS species. Yet, it must be noted that nine out of ten detected MR S. sciuri originated 
from a single DF. In BC, MR S. fleurettii was by far the most isolated species, accounting for 
73% of all MRNAS isolated from BC and being present on six out of seven MRNAS-positive 
BF.  
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7.4.2 Antimicrobial susceptibility testing and PBP2a testing 
All MRNAS isolates were susceptible to vancomycin (86.1% of isolates with MIC 
≤ 1 mg/l; 13.9% with MIC = 2 mg/l) and mupirocin (60.4% of isolates with MIC ≤ 0.5 mg/l; 
12.9% with MIC = 1 mg/l; 26.7% with MIC = 2 mg/l). The MIC distributions for the 
remaining 17 antimicrobial agents are shown in Tables 16a-e. 
 
Table 16a. MICs of methicillin-resistant non-S. aureus staphylococci (MRNAS) species from bovines (S. 
epidermidis-S. haemolyticus [n = 18], S. lentus [n = 24], S. sciuri [n = 33] and S. fleurettii [n = 23]) to the β-
lactam antimicrobials penicillin and cefoxitin. 
Test agenta Speciesb 
% of isolates with MIC (mg/l) of 
R%c 
0.06 0.12 0.25 0.5 1 2 4 8 16 32 
Penicillin S. epi/haemo  5.6 0.0 5.6 11.1 27.8 50.0    94.4 
 S. lentus  16.7 16.7 20.8 33.3 8.3 4.2    83.3 
 S. sciuri  0.0 3.0 6.1 27.3 24.2 39.4    100 
 S. fleurettii  39.1 43.5 13.0 4.3 0.0 0.0    60.9 
Cefoxitin S. epi/haemo    5.6 0.0 0.0 5.6 50.0 27.8 11.1 88.8 
 S. lentus    4.2 4.2 25.0 20.8 29.2 16.7 0.0 45.9 
 S. sciuri    0.0 3.0 0.0 15.2 18.2 39.4 24.2 81.8 
 S. fleurettii    4.3 4.3 21.7 69.9 0.0 0.0 0.0 0.0 
 
 
 
a 
The dilution ranges tested for each antimicrobial agent are those contained within the white area, including the diagonally striped 
boxes at the left. The values situated in these striped boxes indicate the % of isolates that had a MIC smaller than or equal to the 
lowest concentration tested. Values situated in the first green box at the right of the dilution range represent the % of isolates that 
had a MIC higher than the highest concentration tested. Susceptibility breakpoints are indicated with vertical black lines and are the 
Clinical and Laboratory Standards Institute (CLSI) values provided for Staphylococcus spp. in the 2008 document M31-A3 on 
antimicrobial susceptibility testing of bacteria isolated from animals. For cefoxitin, the CLSI breakpoint provided in M100-S19 for S. 
aureus is used.  
b The results are presented separately for the species of the S. sciuri species group, and together for the MR S. epidermidis and S. 
haemolyticus, because of the good agreement between the MIC distributions for the obtained isolates of these species. The results 
for the two MR S. equorum isolates and the single MR S. arlettae isolate are given in the text. 
c R%: total percentage of resistant isolates 
 
Among all species, isolates were found that were phenotypically susceptible to the β-
lactam antimicrobials penicillin (total n = 14) and cefoxitin (total n = 46). Most notable were 
the results for MR S. lentus, from which 54.1% of the isolates had cefoxitin MICs ≤ 4 mg/l, 
and MR S. fleurettii, from which 100% of the isolates had cefoxitin MICs ≤ 4 mg/l (Table 
16a). Nonetheless, 43 of the 46 cefoxitin-susceptible isolates were found to produce PBP2a. 
The three non-PBP2a producers were two S. fleurettii and the single S. arlettae isolate; all 
three had cefoxitin MICs of 4 mg/l. 
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Single isolates of MR S. sciuri and MR S. lentus appeared resistant to linezolid (MICs = 8 
mg/l). These isolates displayed the PhLOPSA phenotype (for resistance to phenicols, 
lincosamides, oxazolidinones, pleuromutilins and streptogramin A antimicrobials) and were 
found to possess the cfr gene.  
Both MR S. equorum isolates were resistant to erythromycin and tetracycline. In addition, 
the isolate originating from VC additionally showed resistance to kanamycin, 
chloramphenicol, clindamycin and trimethoprim. The single S. arlettae isolate was resistant to 
clindamycin and quinupristin/dalfopristin. 
 
Table 16b. MICs of methicillin-resistant non-S. aureus staphylococci (MRNAS) species from bovines (S. 
epidermidis & S. haemolyticus [n = 18], S. lentus [n = 24], S. sciuri [n = 33] and S. fleurettii [n = 23]) to the 
aminoglycosides kanamycin, streptomycin and gentamicin. 
Test agent
a 
Species
b 
% of isolates with MIC (mg/l) of 
R%
c 
0.5 1 2 4 8 16 32 64 128 
Gentamicin S. epi/haemo  38.9 0.0 5.6 5.6 22.2 27.8   54.6 
 S. lentus  41.7 12.5 16.7 4.2 25.0 0.0   29.2 
 S. sciuri  78.8 6.1 12.1 3.0 0.0 0.0   3.0 
 S. fleurettii  100 0.0 0.0 0.0 0.0 0.0   0.0 
Kanamycin S. epi/haemo    16.7 5.6 0.0 0.0 16.7 61.1 77.8 
 S. lentus    20.8 4.2 0.0 8.3 8.3 58.3 74.9 
 S. sciuri    63.6 6.1 15.2 12.1 0.0 3.0 15.1 
 S. fleurettii    100 0.0 0.0 0.0 0.0 0.0 0.0 
Streptomycin
 
S. epi/haemo    11.1 5.6 0.0 0.0 83.3  NA 
 S. lentus    0.0 0.0 12.5 12.5 75.0  NA 
 S. sciuri    24.2 9.1 15.2 12.1 39.4  NA 
 S. fleurettii    47.8 21.7 4.3 21.7 4.3  NA 
 
 
 
 
 
a 
The dilution ranges tested for each antimicrobial agent are those contained within the white area, including the diagonally striped 
boxes at the left. The values situated in these striped boxes indicate the % of isolates that had a MIC smaller than or equal to the 
lowest concentration tested. Values situated in the first green box at the right of the dilution range represent the % of isolates that 
had a MIC higher than the highest concentration tested. Susceptibility breakpoints are indicated with vertical black lines and are the 
CLSI values provided for Staphylococcus spp. in the 2008 document M31-A3 on antimicrobial susceptibility testing of bacteria isolated 
from animals (CLSI, 2008). No CLSI breakpoint is available for streptomycin; therefore, no qualitative interpretation was done for 
that agent. 
d The results are presented separately for the species of the S. sciuri species group, and together for MR S. epidermidis and MR S. 
haemolyticus (because of the good agreement between the MIC distributions for the obtained isolates of these species). The results 
for the two MR S. equorum isolates and the single MR S. arlettae isolate are given in the text. 
e R%: total percentage of resistant isolates; NA: not applicable (see a for explanation)  
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Table 16c. MICs of methicillin-resistant non-S. aureus staphylococci (MRNAS) species from bovines (S. 
epidermidis & S. haemolyticus [n = 18], S. lentus [n = 24], S. sciuri [n = 33] and S. fleurettii [n = 23]) to the 
macrolide-lincosamide-streptogramin antimicrobials erythromycin, clindamycin and quinupristin/dalfopris-
tin, to the oxazolidinone linezolid and to the pleuromutilin tiamulin. 
Test agent
a 
Species
b 
% of isolates with MIC (mg/l) of 
R%
b 
0.06 0.12 0.25 0.5 1 2 4 8 16 
Erythromycin S. epi/haemo   27.8 0.0 0.0 0.0 0.0 0.0 72.2 72.2 
 S. lentus   4.2 0.0 0.0 0.0 0.0 0.0 95.8 95.8 
 S. sciuri   42.4 0.0 0.0 0.0 0.0 6.1 51.5 57.6 
 S. fleurettii   95.7 0.0 0.0 0.0 0.0 0.0 4.3 4.3 
Clindamycin S. epi/haemo  27.8 5.6 0.0 0.0 0.0 0.0 66.7  66.7 
 S. lentus  0.0 0.0 0.0 8.3 0.0 0.0 91.7  100 
 S. sciuri  0.0 0.0 3.0 42.4 3.0 0.0 51.5  97.0 
 S. fleurettii  4.3 47.8 26.1 21.7 0.0 0.0 0.0  21.7 
Quinu/dalfo S. epi/haemo    88.9 5.6 0.0 5.6 0.0  5.6 
 S. lentus    0.0 0.0 33.3 58.3 8.3  100 
 S. sciuri    0.0 9.1 60.6 27.3 3.0  90.9 
 S. fleurettii    73.9 21.7 0.0 0.0 4.3  4.3 
Linezolid S. epi/haemo     100 0.0 0.0 0.0 0.0 0.0 
 S. lentus     66.7 25.0 4.2 4.2 0.0 4.2
d 
 S. sciuri     66.7 30.3 0.0 3.0 0.0 3.0
d 
 S. fleurettii     91.3 8.7 0.0 0.0 0.0 0.0 
Tiamulin
 
S. epi/haemo    88.9 0.0 0.0 0.0 11.1  NA 
 S. lentus    0.0 0.0 0.0 0.0 100  NA 
 S. sciuri    0.0 0.0 0.0 3.0 97.0  NA 
 S. fleurettii    0.0 4.3 8.7 13.0 73.9  NA 
a 
The dilution ranges tested for each antimicrobial agent are those contained within the white area, including the diagonally striped 
boxes at the left. The values situated in these striped boxes indicate the % of isolates that had a MIC smaller than or equal to the 
lowest concentration tested. Values situated in the first green box at the right of the dilution range represent the % of isolates that 
had a MIC higher than the highest concentration tested. Susceptibility breakpoints are indicated with vertical black lines and are the 
CLSI values provided for Staphylococcus spp. in the 2008 document M31-A3 on antimicrobial susceptibility testing of bacteria isolated 
from animals (CLSI, 2008). For clindamycin, quinupristin/dalfopristin and linezolid the CLSI susceptibility breakpoints provided for 
Staphylococcus spp. in the 2009 document M100-S19 are used (CLSI, 2009). No CLSI breakpoint is available for tiamulin; therefore, no 
qualitative interpretation was done for that agent. 
b
 The results are presented separately for the species of the S. sciuri species group, and together for the MR S. epidermidis and S. 
haemolyticus (because of the good agreement between the MIC distributions for the obtained isolates of these species). The results 
for the two MR S. equorum isolates and the single MR S. arlettae isolate are given in the text. 
e
 R%: total percentage of resistant isolates; NA: not applicable (see a for explanation) 
d The presence of the multidrug resistance gene cfr was shown for the single isolates of methicillin-resistant S. sciuri and methicillin-
resistant S. lentus that were resistant to linezolid.  
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Table 16d. Minimum inhibitory concentrations (MICs) of methicillin-resistant non-S. aureus staphylococci (MRNAS) species from bovines (S. 
epidermidis & S. haemolyticus [n = 18], S. lentus [n = 24], S. sciuri [n = 33] and S. fleurettii [n = 23]) to trimethoprim and sulfamethoxazole. 
Test agent
a 
Species
b 
% of isolates with MIC (mg/l) of R%c 
1 2 4 8 16 32 64 128 256 512 1024  
Trimethoprim S. epi/haemo  27.8 0.0 0.0 0.0 0.0 72.2     72.2 
 S. lentus  12.5 20.8 12.5 0.0 4.2 50.0     54.2 
 S. sciuri  15.2 48.5 6.1 3.0 0.0 27.3     30.3 
 S. fleurettii  91.3 8.7 0.0 0.0 0.0 0.0     0.0 
Sulfamethoxazole
 
S. epi/haemo       11.1 5.6 16.7 5.6 61.1 66.7 
 S. lentus       16.7 12.5 4.2 12.5 54.2 66.7 
 S. sciuri       84.8 12.1 3.0 0.0 0.0 0.0 
 S. fleurettii       100 0.0 0.0 0.0 0.0 0.0 
 
 
 
 
 
a The dilution ranges tested for each antimicrobial agent are those contained within the white area, including the diagonally striped boxes at the left. The values situated in 
these striped boxes indicate the % of isolates that had a MIC smaller than or equal to the lowest concentration tested. Values situated in the first green box at the right of 
the dilution range represent the % of isolates that had a MIC higher than the highest concentration tested. Susceptibility breakpoints are indicated with vertical black lines 
and are the CLSI values provided for Staphylococcus spp. in the 2009 document M100-S19 (CLSI, 2009). 
d
 The results are presented separately for the species of the S. sciuri species group, and together for MR S. epidermidis and MR S. haemolyticus, because of the good 
agreement between the MIC distributions for the obtained isolates of these species. The results for the two MR S. equorum isolates and the single MR S. arlettae isolate are 
given in the text. 
e R%: total percentage of resistant isolates 
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Table 16e. MICs of methicillin-resistant non-S. aureus staphylococci (MRNAS) species from bovines (S. epidermidis & S. haemolyticus [n = 18], S. lentus 
[n = 24], S. sciuri [n = 33] and S. fleurettii [n = 23]) to chloramphenicol, rifampicin, ciprofloxacin, fusidic acid and tetracycline. 
Test agent
a 
Species
b 
% of isolates with MIC (mg/l) of 
R%
c 
0.016 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128 
Chloramphenicol S. epi/haemo         50.0 16.7 0.0 0.0 27.8 5.6 33.4 
 S. lentus         8.3 50.0 4.2 0.0 29.2 8.3 41.7 
 S. sciuri         63.6 18.2 0.0 3.0 12.1 3.0 18.1 
 S. fleurettii         87.0 4.3 0.0 8.7 0.0 0.0 8.7 
Rifampicin
 
S. epi/haemo 100 0.0 0.0 0.0 0.0 0.0 0.0        NA 
 S. lentus 95.8 0.0 0.0 0.0 0.0 0.0 4.2        NA 
 S. sciuri 94.0 3.0 0.0 0.0 0.0 0.0 3.0        NA 
 S. fleurettii 100 0.0 0.0 0.0 0.0 0.0 0.0        NA 
Ciprofloxacin S. epi/haemo     33.3 5.6 0.0 0.0 22.2 11.1 27.8    61.1 
 S. lentus     33.3 0.0 0.0 4.2 0.0 16.7 45.8    66.7 
 S. sciuri     18.2 60.6 3.0 0.0 0.0 0.0 18.2    18.2 
 S. fleurettii     26.1 73.9 0.0 0.0 0.0 0.0 0.0    0.0 
Fusidic acid
 
S. epi/haemo      83.3 0.0 0.0 5.6 11.1     NA 
 S. lentus      4.2 16.7 79.2 0.0 0.0     NA 
 S. sciuri      24.2 0.0 9.1 66.7 0.0     NA 
 S. fleurettii      0.0 8.7 21.7 69.6 0.0     NA 
Tetracycline S. epi/haemo      5.6 0.0 16.7 0.0 0.0 0.0 77.8   77.8 
 S. lentus      8.3 8.3 4.2 4.2 0.0 0.0 75.0   75.0 
 S. sciuri      24.2 0.0 0.0 0.0 0.0 0.0 75.8   75.8 
 S. fleurettii      100 0.0 0.0 0.0 0.0 0.0 0.0   0.0 
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a 
The dilution ranges tested for each antimicrobial agent are those contained within the white area, including the diagonally striped boxes at the left. The values situated in these striped boxes 
indicate the % of isolates that had a MIC smaller than or equal to the lowest concentration tested. Values situated in the first green box at the right of the dilution range represent the % of 
isolates that had a MIC higher than the highest concentration tested. Susceptibility breakpoints are indicated with vertical black lines and are the CLSI values provided for Staphylococcus spp. 
in the 2008 document M31-A3 on antimicrobial susceptibility testing of bacteria isolated from animals (CLSI, 2008). For ciprofloxacin, the CLSI susceptibility breakpoint provided for 
Staphylococcus spp. in the 2009 document M100-S19 is used (CLSI, 2009). For rifampicin, the dilution range tested did not contain the CLSI breakpoint (1 mg/l); therefore, no qualitative 
interpretation was done for that agent. 
b The results are presented separately for the species of the S. sciuri species group, and together for MR S. epidermidis and MR S. haemolyticus (because of the good agreement between the MIC 
distributions for the obtained isolates of these species). The results for the two MR S. equorum isolates and the single MR S. arlettae isolate are given in the text. 
c R%: total percentage of resistant isolates; NA: not applicable (see a for explanation) 
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7.4.3 Typing of staphylococcal cassette chromosome mec elements 
Table 17. Characteristics of staphylococcal cassette chromosome mec (SCCmec) elements present in 101 methicillin-resistant non-S. aureus 
staphylococci (MRNAS) isolated from three bovine populations a. 
ccr complex
b 
mec complex
b 
SCCmec
c
 (n) VC (n) DC (n) BC (n) 
A3/B3 A III (3A) (35) S. epidermidis (1) 
S. equorum (1) 
S. lentus (17) 
S. sciuri (12) 
S. sciuri (1) S. arlettae (1) 
S. fleurettii (1) 
S. sciuri (1) 
A3/B3 + A4/B4 A IIIvar1 (3A&4) (3) S. epidermidis (3) - - 
A3/B3 + C1 A IIIvar2 (3A&5) (8) S. lentus (1) 
S. sciuri (7) 
- - 
A2/B2 B IVa (2B) (3) S. epidermidis (3) - - 
C1 C2 V (5C2) (5) S. haemolyticus (3) S. epidermidis (1) S. haemolyticus (1) 
C1 + A2/B2 C2 Vvar1 (5C2&2) (1) S. epidermidis (1) - - 
A2/B2 mecA NT 1 (1) S. epidermidis (1) - - 
C1 mecA NT 2 (1) S. epidermidis (1) - - 
- A NT 3 (40) S. lentus (4) 
S. sciuri (1) 
S. epidermidis (1) 
S. fleurettii (1) 
S. sciuri (9) 
S. equorum (1) 
S. fleurettii (19) 
S. lentus (2) 
S. sciuri (2) 
- B NT 4 (1) S. epidermidis (1) - - 
- mecA NT 5 (3) S. haemolyticus (1) - S. fleurettii (2) 
a VC: veal calves; DC: dairy cows; BC: beef cows  
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b The mecA gene is present in the mec gene complex; yet, the internal mecA control used in the typing method is included in the multiplex PCR (M-PCR) for ccr gene complex 
determination (Kondo et al., 2007). In the first (left) column, ‘-’ means that no other bands than the mecA control were amplified. In the second column ‘mecA’ means that no 
bands were amplified in the M-PCR for mec complex determination but that the mecA-control was amplified in the M-PCR for ccr complex determination. 
c
 The type of SCCmec was determined by the combination of ccr complex type and mec complex class. As suggested by the International Working Group on the Classification of 
Staphylococcal Cassette Chromosome elements (IWG-SCC, 2009), cassettes showing a combination of ccr complexes were considered as variants of recognized SCCmec types. 
Cassettes where no ccr complex or mec complex could be detected were considered as non-typeable (NT). 
 
Eleven different ccr-mec-complex-combinations were detected in the 101 MRNAS, defining three recognized SCCmec types, three variants of 
SCCmec types and five non-typeable variants (Table 17). Most cassettes (45.5%) were type III (3A) or variants of type III, IIIvar1 (3A&4) and 
IIIvar2 (3A&5). In addition, six cassettes (5.9%) were type V (5C2) or a variant of type V, Vvar1 (5C2&2), and three cassettes (3.0%) were type IV 
(2B), all three subtyped as IVa. Hence, recognized SCCmec types and their variants made up slightly more than half (54.5%) of all SCCmec 
elements. The non-typeable variants NT 1 – 4 were either cassettes for which a known ccr complex was found but no mec complex sequences 
except mecA could be amplified (NT 1 and NT 2) or a known mec complex without amplification of ccr complex sequences (NT 3 and NT 4). 
For three isolates, neither ccr complex sequences nor mec complex sequences could be amplified, except for mecA (NT 5). Two NT 5 elements 
were detected in the two non-PBP2a-producing S. fleurettii isolates; the third was found in a MR S. haemolyticus isolate with cefoxitin MIC > 16 
mg/l. The most prevalent NT cassette was by far NT 3, representing 80% of NT cassettes and 39.6% of all SCCmec elements.The largest 
diversity of SCCmec elements was observed in MRNAS from VC, including all eleven above-mentioned SCCmec types or variants (Table 17). 
The predominant SCCmec cassettes in VC were type III (3A), being present in 53.4% of isolates. When including types IIIvar1 and IIIvar2, 72.4% 
of MRNAS from VC harbored a type III SCCmec element. In DC and BC, NT 3 SCCmec elements predominated (84.6% of DC isolates and 
80% of BC isolates). 
When regarding the different MRNAS species, MR S. sciuri and MR S. lentus carried mainly type III or IIIvar2 SCCmec elements and less 
frequently NT3 (Table 17). MR S. epidermidis harbored the largest diversity of SCCmec elements, with in total nine different SCCmec types and 
six types that were exclusively detected in MR S. epidermidis. The highly prevalent NT 3 cassettes were detected in five MRNAS species, but   
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were mainly associated with MRNAS from the S. sciuri species group and specifically MR S. 
fleurettii, being present in 20 (87%) of the MR S. fleurettii isolates. The non-PBP2a-
producing MR S. arlettae isolate possessed a type III (3A) SCCmec element. 
 
7.5 Discussion 
To our knowledge, this is the first study on MRNAS carriage and diversity in bovines that 
clearly distinguishes between the three main cattle breeding practices that are executed 
worldwide. Care was taken to perform the sampling in a comparable manner in the three 
groups. Yet, the housing of the animals is an important aspect inherently different between the 
three practices, and this could have influenced the data. DC and BC are housed all together or 
in relatively big groups, being allowed to graze on pastures during certain periods of the day 
or year; VC on the other hand remain inside all their life and are kept individually until the 
age of eight weeks and in small groups later on. Consequently, on DF and BF, strains might 
spread more easily throughout the entire stock by means of direct contact. On the other hand, 
the animal density on VF is higher than on DF and BF, increasing the chances of indirect 
transmission of strains, for example through air or dust. The extent in which these factors 
might have influenced our data is hard to assess; obviously, there are also differences in 
housing within VF, DF and BF, and multiple other factors have an effect on bacterial strain 
carriage. 
We found a total MRNAS carriage rate of almost 25%, which is much lower than the 61% 
reported for Swiss bovines (Huber et al., 2011). In France, 36.6% of VC were found to be 
MRNAS-positive (Haenni et al., 2011a), a comparable rate as observed in our VC (Table 15). 
This carriage rate in VC was higher compared to BC and DC. This has also been found in 
Switzerland, where 72% of calves and 52% of cows were MRNAS-positive (Huber et al., 2011). 
Interestingly, VC are the only bovine sector where MRSA CC398 carriage appears to be 
widespread (Graveland et al., 2009, 2010; Vandendriessche et al., 2011b). As a higher carriage of 
MRSA CC398 has previously also been observed in piglets compared to sows and finisher 
pigs (Crombé et al., 2011), these data support a role for age in determining carriage of 
methicillin-resistant staphylococci in animals, as previously suggested (Vanderhaeghen et al., 
2010b). However, also different management practices might be involved, including the use of 
antimicrobial agents (Broens et al. 2011). On VF, the calves typically have very diverse origins, 
resulting in an elevated health burden. Therefore, upon arrival of calves on a farm, 
antimicrobial therapy for several days up to weeks is applied.  
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In the literature, few data are available on the species diversity of NAS residing in the 
nares of cattle, rendering it difficult to weigh the diversity of our MRNAS collection against 
the normal staphylococcal nasal flora of bovines. Yet, compared to the results from recent 
studies in pigs (Tulinski et al., 2012; Vanderhaeghen et al., 2012), we found a rather low MRNAS 
species diversity. A predominance of the S. sciuri species group in MRNAS from bovines has 
previously been reported in other studies (Huber et al., 2011; Haenni et al., 2011a). S. sciuri species 
group members have also been reported to predominate in MRNAS from pigs (Zhang et al., 
2009; Huber et al., 2011; Vanderhaeghen et al., 2012), chickens (Kawano et al., 1992; Zhang et al., 2009; 
Huber et al., 2011), goats and sheep (Zhang et al., 2009) and horses (Bagcigil et al., 2007). This 
highlights the role of the S. sciuri species group as the most widespread MRNAS species 
among animals. 
Our MRNAS isolates were selected based on the presence of mecA. However, when using 
the CLSI breakpoints for cefoxitin for S. aureus and Staphylococcus lugdunensis (CLSI, 2009), 
several isolates appeared phenotypically susceptible. As the large majority of our cefoxitin-
susceptible isolates were shown to produce PBP2a, thus proving the functionality of mecA 
and its successful transcription and translation, our data illustrate that cefoxitin MIC is a poor 
indicator for mecA-mediated methicillin resistance in NAS (Swenson et al., 2009). 
Additional antimicrobial resistances were most frequently observed to aminoglycosides, 
macrolide-lincosamide-streptogramin antimicrobials, trimethoprim, sulfamethoxazole, tetra-
cycline and ciprofloxacin, suggesting that MRNAS from bovines potentially function as an 
important reservoir for various antimicrobial resistance determinants. Yet, resistance rates 
differed among the MRNAS species. The frequency of resistance was generally higher in MR 
S. epidermidis, MR S. haemolyticus and MR S. lentus compared to MR S. sciuri and MR S. 
fleurettii, being mostly very low or absent in the latter. Interestingly, MR S. epidermidis, MR 
S. haemolyticus and MR S. lentus were largely associated with VC while MR S. fleurettii was 
mainly found in BC. Moreover, among MR S. sciuri, additional antimicrobial resistances 
were seen more frequently in the isolates from VC than those from DC and BC (data not 
shown). This might indicate that the species-related difference is in fact animal-related and, 
hence, that age or management aspects might explain the observed differences in 
antimicrobial resistance rates. However, it is important to note that only MRNAS were 
studied, which are probably not representative for the general NAS population residing in the 
nares of these different bovine populations. 
The detection of two MRNAS from VC, a MR S. lentus and a MR S. sciuri, that were 
resistant to linezolid was very remarkable, as linezolid is not used in veterinary medicine. 
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Therefore, we speculated that this resistant phenotype would have been caused by the 
presence of a gene conferring cross-resistance, and the presence of the cfr gene mediating the 
PhLOPSA phenotype was proven (Kehrenberg and Schwarz, 2006; Long et al., 2006). The gene cfr 
was initially identified in a S. sciuri isolate obtained from the nasal swab of a bovine calf 
(Schwarz et al., 2000; Kehrenberg et al., 2004) and so, the current detection of cfr in two MRNAS 
from VC might not be surprising. Nonetheless, it is a worrisome observation, as the gene is 
usually plasmid borne (Kehrenberg et al., 2004; Dai et al., 2010; Shore et al., 2010) and its detection 
seems to be increasing, having been recently detected in porcine MRSA CC398 and bovine 
MRSA ST9 isolates (Kehrenberg et al., 2009; Wang et al., 2012b) and appearing to be capable of 
spreading among various other animal-associated bacteria (Dai et al., 2010; Wang et al., 2011; Liu et 
al., 2012; Wang et al., 2012c; Wang et al., 2012d). cfr has also been identified in linezolid-resistant 
staphylococci causing human infections (Toh et al., 2007; Mendes et al., 2008; Bongiorno et al., 2010), 
including outbreaks (Bonilla et al., 2010; Morales et al., 2010; Seral et al., 2011). This illustrates the 
mobility of cfr and warns to actively monitor its reservoir in (animal) staphylococci. 
The SCCmec diversity and frequency observed in the present study was quite different 
from that previously observed in MRNAS from Belgian pigs, where recognized SCCmec 
types constituted 80% of all SCCmec elements and type IV SCCmec elements, including type 
IVa, IVc and two type IV variants, were largely predominant (Vanderhaeghen et al., 2012). 
Currently, recognized SCCmec types accounted for only 42.6% and cassettes of type III were 
most common. This difference in the frequency of SCCmec types is to be explained by the 
apparent association between type III cassettes and MRNAS species of the S. sciuri species 
group, which has also been described in other studies (Zhang et al., 2009; Haenni et al., 2011a). It 
remains to be elucidated whether the type III cassettes present in S. sciuri species group 
members are similar to typical MRSA type III elements. 
It was remarkable to find nine different SCCmec elements in barely 11 MR S. epidermidis 
isolates. These findings are illustrative of a high plasticity of SCCmec in bovine MR S. 
epidermidis, as was previously shown for human MR S. epidermidis strains (Miragaia et al., 
2005; Miragaia et al., 2007). Not solely in humans but equally in animals MR S. epidermidis might 
act as a continuous source for new SCCmec variants that might then be transferred to S. 
aureus or other NAS (Miragaia et al., 2007). 
The predominance of NT 3 among the NT SCCmec elements must be interpreted with due 
caution. The NT 3 elements were grouped together based on the presence of a class A mec 
complex and the inability to detect ccr genes and so, is it fairly possible that the ccr 
complexes among the different NT 3 carriers vary or are even absent. Indeed, while our PCR 
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method is only able to detect ccrA/B allotypes 1 to 4 and ccrC1, various other allotypes have 
been described in recent years (Descloux et al., 2008; IWG-SCC, 2009; Pi et al., 2009; Zong and Lü, 2010; Li 
et al., 2011; Shore et al., 2011; Urushibara et al., 2011). In this regard, the predominance of NT 3 
elements in S. fleurettii requires special attention. Recently, a S. fleurettii mecA gene has been 
described (Tsubakishita et al., 2010). This gene, showing 99 to 100% sequence similarity with the 
classic mecA gene from pre-MRSA strain N315, was assumed to be native to S. fleurettii due 
to its association with genes essential for cell growth instead of with SCCmec structures. In 
addition, the upstream region of this S. fleurettii mecA was almost identical to the region 
surrounding mecA in a class A mec complex from MRSA strain N315 (Tsubakishita et al., 2010). 
Hence, it is possible that the mecA gene and the class A mec complex we found in our S. 
fleurettii isolates are in fact not (part of) an acquired SCCmec cassette but merely these native 
structures. Future research is needed to elucidate this. 
This study aimed to assess the role that bovine MRNAS play as a reservoir for SCCmec, 
particularly in relation to MRSA CC398. Our results suggest that this role is less important 
compared to the situation in pigs. Indeed, some elements of type IVa and V, which are typical 
for MRSA CC398, were found, especially in VC, but there was generally little agreement in 
the SCCmec types that dominate in bovine MRNAS and MRSA CC398. This might partially 
explain why so far, MRSA CC398 has not been more often described in DC and BC, except 
for some reports on MRSA CC398 in mastitis (Feβler et al., 2010a; Vanderhaeghen et al., 2010a; 
Huber et al., 2010; Spohr et al., 2011). Yet, in VC, carriage rates of MRSA CC398 equal or exceed 
those in pigs (Graveland et al., 2009, 2010; Vandendriessche et al., 2011b) and also there, MRNAS 
possessing SCCmec types IVa or V were present in low frequencies. This indicates that other 
factors than solely the presence of a SCCmec reservoir play a role in the emergence or 
maintenance of MRSA CC398 on a farm. 
 
7.6 Conclusions 
Almost a quarter of the sampled bovines carried an MRNAS, mostly of the animal-
associated S. sciuri species group. In younger bovines, carriage of MRNAS and MRNAS 
species diversity were higher than in adults. In addition, in MRNAS species predominantly 
found in VC, additional antimicrobial resistances were more frequently detected. Two 
MRNAS from VC were linezolid resistant and harbored the cfr gene. Several SCCmec 
variants were present in MRNAS from bovines, especially in MR S. epidermidis strains. 
Intriguing issues, such as the predominance of type III SCCmec elements in bovine MRNAS 
III – EXPERIMENTAL STUDIES                                     Chapter 7 – Characterisation of MRNAS from different bovine populations 
126 
and the remarkable difference in SCCmec constitution between bovine MRNAS and MRSA 
CC398, especially in VC, remain to be resolved. 
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For a long time after their discovery in the early 1960s, methicillin-resistant (MR) 
staphylococci appeared as an exclusive human problem. MRSA was initially restricted to 
hospitals but emerged also in the community during the 1990s, evoking new concerns on its 
epidemiology and control (Vandenesch et al., 2003; Stemper et al., 2004). In parallel, some MRNAS 
species, S. epidermidis and S. haemolyticus in the first place, were recognised as common yet 
usually less virulent hospital pathogens (von Eiff et al., 2002). MRNAS were also found to be 
widespread in the community and, due to their diversity, ubiquitous presence and suspected 
role as carriers of the native mecA – at least in some species – they were put forward as a 
reservoir for methicillin resistance in S. aureus (Hanssen and Sollid, 2006; Tsubakishita et al., 2010).  
Some occasional reports left aside, there was virtually no scientific veterinary literature on 
MR staphylococci until the 1990s. Then, cases of MRSA carriage, infections and even 
outbreaks were increasingly reported in companion animals (Scott et al., 1988; Cefai et al., 1994; 
Seguin et al., 1999). In addition, the first observations of methicillin resistance in S. 
pseudintermedius, the most important staphylococcal pathogen in dogs, were done (Gortel et al., 
1999; Vengust et al., 2006). Yet, in food producing animals, where one or more species of 
staphylococci were known as important pathogens, methicillin resistance remained irrelevant 
(Werckenthin et al., 2001).  
Things changed quite drastically halfway the 2000s. MRSA of a previously obscure 
genetic background, CC398, was unexpectedly detected in pigs and human contacts (Armand-
Lefevre et al., 2005; Voss et al., 2005). Driven by astonishment over this discovery and anxiety for 
its consequences, numerous studies were initiated all around the world, showing that MRSA 
strains of this and other genetic backgrounds were present, to differing extents, in pigs in the 
USA, Asia and many European countries, including Belgium (Crombé et al., 2011; Dewaele et al., 
2011). Moreover, humans intensely exposed to affected pigs were found to be at high risk for 
MRSA CC398 carriage (van Loo et al., 2007; Denis et al., 2009), with occasional infections being 
reported (Ekkelenkamp et al., 2006; Declercq et al., 2008; Mammina et al., 2010). MRSA was no longer 
an exclusively human problem but received the status of possible zoonosis (Morgan, 2008; 
Johnson, 2011)!  
Along with pigs, renewed attention was drawn to the presence of MRSA in other domestic 
animal species. In Belgium, the occurrence of MRSA in poultry was investigated, finding 
12% of recent S. aureus isolates from broiler chickens to be MRSA CC398 (Nemati et al., 2008), 
an MRSA (CC398) carriage rate in broiler chickens of 10.7% (Persoons et al., 2009) and 12.8%-
14.3% of investigated broiler farms to harbour MRSA CC398 positive animals (Nemati et al., 
2008; Persoons et al., 2009). Also in horses MRSA CC398 was detected. Thirteen MRSA strains 
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that were isolated from hospitalised horses over the period November 2005-December 2006 
were identified as MRSA CC398 (Hermans et al., 2008). In addition, in horses admitted to a 
Belgian veterinary clinic, a MRSA CC398 carriage rate of 10.9% was found (Van den Eede et al., 
2009). 
One of the aims of our research, as presented in the previous chapters, was studying the 
MRSA occurrence in bovine mastitis and in dogs, as for these species, recent information was 
lacking. In bovine mastitis, we found almost 10% of all S. aureus-mastitis cases to be MRSA 
and all MRSA strains were identified as CC398. Moreover, MRSA CC398 appeared able to 
establish itself in a similar fashion as regular S. aureus on affected farms, with within-herd 
prevalences ranging from 3.9% to 7.4%. 
Our study was one of the first reports on the presence of MRSA CC398 in bovine mastitis. 
Since, several other have been published (Argudín et al., 2010; Feβler et al., 2010a; Huber et al., 2010; 
Sakwinska et al., 2011; Spohr et al., 2011) but these have not brought essential new insights on the 
importance of MRSA CC398 in mastitis. Most were not of a systematic nature and had 
MRSA CC398 isolates from mastitis included in larger, diverse data sets (Argudín et al., 2010; 
Sakwinska et al., 2011) or did not provide information on the isolation rates (Feβler et al., 2010a). 
Yet, in a Swiss study, a much lower prevalence was found compared to our study, with 
MRSA (CC398) accounting for only 1.4% of S. aureus isolates from mastitis (Huber et al., 
2010). It is possible that this lower rate is to be explained by the fact that all S. aureus isolates 
originated from clinical cases of mastitis (Huber et al., 2010). Indeed, from the 11 MRSA CC398 
strains described in the first part of our mastitis study, also only two (= 1.7%) came from 
clinical mastitis. This suggests a tendency of MRSA CC398 to mainly cause subclinical 
mastitis, a hypothesis that requires further investigation in future research. If such tendency 
would indeed exist, this would be in line with the low pathogenic potential that is supposed 
for MRSA CC398 based on the low virulence contents of most strains (Feβler et al., 2010a; 
Argudín et al., 2011). Still, it should not be a reason for relief. A recent German study found 
similar MRSA CC398 within-herd prevalences as described in our study: in three farms, 
sampled on two occasions, prevalences of 1.4%-5.1%, 5.6%-7.5% and 10.0%-16.7% were 
found (Spohr et al., 2011). This supports the capacity of MRSA CC398 to establish itself in 
multiple animals on affected farms and confirms that MRSA CC398 might become a real 
problem in bovine mastitis. Consequently, these findings should stimulate to invest in active 
surveillance of MRSA in mastitis. Data on the exact burden of MRSA CC398 in bovine 
mastitis are now completely lacking, and with the given indications, this might no longer be 
justified. 
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If surveillance studies on MRSA in mastitis would be implemented, an essential aspect that 
should be covered is the presence of other animal species – most importantly pigs – on the 
farms. Such information was largely absent in our study. Yet, farms raising pigs along with 
dairy cows can be assumed to have an increased risk for MRSA CC398 to become established 
in mastitis. Indeed, on MRSA CC398 positive pig farms, frequent contact with the animals is 
a risk factor for MRSA carriage by the farmer (van Loo et al., 2007; Denis et al., 2009); and in 
mastitis, the milker’s hands are an important mode of transmission of mastitis pathogens 
among animals (Taponen and Pyörälä, 2009). Previously, farmers on mixed poultry-pig farms 
have been suggested to act as vectors transferring MRSA CC398 among the chickens (Pletinckx 
et al., 2011). Hence, data on other animals raised on dairy farms will provide important 
information for getting a better insight in the epidemiology of MRSA CC398 in mastitis. For 
a similar reason, surveillance studies on MRSA CC398 in dairy mastitis would benefit from 
including data on the carriage of MRSA CC398 on other body sites of the cows, such as the 
nose, the skin or the teat apices. Indeed, a truly profound study on the epidemiology of MRSA 
CC398 in dairy cattle requires elucidating the colonization ability of MRSA CC398 in dairy 
cows and linking the existence of different reservoirs to the presence of MRSA CC398 in 
mastitis. 
Concerning dogs, we found only 1% of animals admitted to a second- and third-line 
veterinary hospital and without previous hospitalisation to carry MRSA. In contrast to 
Belgian pigs, broiler chickens, horses and dairy cows, the MRSA strains belonged to human 
hospital clones. However, an important difference is that, except for horses, the latter animal 
species are linked to farming while this was likely not the case for most of our dogs. In almost 
all reports on MRSA CC398 presence in dogs in the literature (Witte et al., 2007; Nienhoff et al., 
2009; Floras et al., 2010; Haenni et al., 2012), a link with farming could be illustrated (Witte et al., 
2007; Nienhoff et al., 2009; Floras et al., 2010), indicating that dogs can indeed be affected by MRSA 
CC398 but it requires predisposing environmental conditions. Therefore, it can fairly be 
assumed that MRSA CC398 will be present in Belgian dogs residing on farms or having 
frequent contact with humans associated with farming, such as veterinarians. It might be very 
valuable to investigate this further, for two reasons. First, several cases of MRSA CC398 
causing infections in dogs have recently been described (Witte et al., 2007; Nienhoff et al., 2009; 
Floras et al., 2010; Haenni et al., 2012). Considering the typical multi-resistant phenotype of MRSA 
CC398, it can be important that (pig) farmers and their veterinarians are aware that an 
infection of their dog may be caused by MRSA CC398. Second, positive dogs might function 
as vector for MRSA CC398 to spread throughout a farm, including to humans working or 
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living on that farm. Indeed, regular contact with dogs has been found to be a significant risk 
factor for MRSA CC398 carriage by pig farmers (Denis et al., 2009). Hence, for a profound 
understanding of the epidemiology of MRSA CC398 in the farming environment, future 
research should elucidate to which extent dogs on Belgian (pig) farms are affected by MRSA 
CC398. 
The ability of MRSA CC398 to transfer from their animal hosts to humans is one of the 
most alerting aspects of the emergence of MRSA CC398. However, it has been shown that 
the ability to spread among humans is much higher for typical hospital MRSA clones 
compared to MRSA CC398 (Bootsma et al., 2011; Wassenberg et al., 2011). Consequently, animals 
carrying MRSA strains with a hospital background, as was observed in dogs in our study, 
might pose an important health threat for humans in their environment. Indeed, dogs and other 
companion animals carrying human MRSA strains have been illustrated to be involved in 
(recurrent) MRSA infection of humans (Scott et al., 1988; Cefai et al., 1994; Manian, 2003; Weese et al., 
2006). The entrance of MRSA-positive dogs in a veterinary hospital might therefore pose risks 
for contamination of veterinarians working at the hospital (Moodley et al., 2006), which in turn 
might provide a means for hospital spread, increasing the risk for the occurrence of MRSA 
outbreaks in veterinary hospitals (Seguin et al., 1999). It is remarkable to note that several recent 
studies have illustrated that also MRSP can spread from affected dogs to human contacts (Paul 
et al., 2011; Soedarmanto et al., 2011; van Duijkeren et al., 2011b). This might also pose health 
concerns, as (MR)SP has previously been identified as cause of human infections (Chuang et al., 
2010; Stegmann et al., 2010; Riegel et al., 2011). 
Whereas the transmission of MR staphylococci from animal reservoirs to humans is a 
relatively new phenomenon, the reverse direction of transfer has practically been known to 
occur ever since the first detection of MRSA in animals (Devriese et al., 1972), when biotyping 
revealed that the MRSA strains detected in Belgian cases of bovine mastitis resembled human 
MRSA strains (Devriese et al., 1975). In later years, transfer of MRSA from humans to animals 
was mainly observed in companion animals (Scott et al., 1988; Cefai et al., 1994) and such 
observations appear to have even increased in recent years (Manian et al., 2003; van Duijkeren et al., 
2004b; Baptiste et al., 2005; Strommenger et al., 2006a; Weese et al., 2006; Rutland et al., 2009), as also 
examplified by our detection of human MRSA strains in dogs. However, the intensified 
research into the presence of MR staphylococci in large animals has made clear that human to 
animal transfer can actually occur in almost all animal species. Indeed, among the various 
non-CC398 MRSA strains that have been detected in pigs, several genetic backgrounds, such 
as ST1, CC5, ST8, ST22 and ST45 (Table 5), are considered to be typically associated with 
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humans, indicating human-to-pig transfer (Sergio et al., 2007; Khanna et al., 2008; Pomba et al., 2009; 
Baba et al., 2010; Battisti et al. 2010; Velebit et al., 2010; Franco et al., 2011; Gordoncillo et al., 2011; Lim et al., 
2011; Overesch et al., 2011; Sunde et al., 2011; Agersø et al., 2012; Arriola et al., 2012). Similarly, MRSA 
strains with human genetic backgrounds, including ST1, ST5, ST8, ST72 and ST239 (Table 
6), have frequently been detected in bovine mastitis (Kwon et al., 2005; Juhász-Kaszanyitzky et al., 
2007; Monecke et al., 2007; Hata et al., 2010; Huber et al., 2010; Türkyilmaz et al., 2010; Haenni et al., 2011b; 
Nam et al., 2011). Moreover, in horses, one of the most frequently found MRSA strains, 
especially in North-America, is believed to be a human strain that has adapted to these 
animals, spa type t064-MRSA CC8-IV – also known as CMRSA-5 or USA500 (Weese et al., 
2005; Moodley et al., 2006; Tokateloff et al., 2009; Walther et al., 2009; Haenni et al., 2010; van Duijkeren et 
al., 2010; Weese and van Duijkeren, 2010; Monecke et al., 2011). So, transfer of human MRSA strains 
to animals might be an event that happens quite frequently under circumstances where close 
contact with animals occurs. Interestingly, we have found indications that human-to-animal 
transfer might also occur with MRNAS. In pigs and bovines, we found several MRNAS 
species that are considered to be typically human. This was most obvious for MR S. 
epidermidis, appearing to be one of the dominant MRNAS species in pigs. However, also MR 
S. hominis is a species atypical for pigs but typical for humans (Ibrahem et al., 2009; Bouchami et 
al., 2011), and S. warneri is another species normally associated with humans and other 
primates (Kloos, 1980; Schleifer and Bell, 2009). Future studies should elucidate whether these 
MRNAS strains indeed show genetic backgrounds similar to human strains. This might reveal 
whether the strains found in animals have any clinical relevance for humans, and hence, 
whether it might be useful to prevent livestock to function as temporary reservoirs for human 
MRNAS strains. 
Our studies on MRNAS in dogs, pigs and bovines provide almost unique data, as for a long 
time, the presence of MRNAS in animals had been poorly assessed. In recent years, it has 
been established that, while MRSA in dogs is mostly originating from human sources, the 
native MR coagulase-positive species in dogs is MRSP. Indeed, while S. aureus is not 
commonly found in dogs, S. pseudintermedius is, and among this dog-adapted staphylococcal 
species, some MR clones seem to have emerged (Ruscher et al., 2010; Perreten et al., 2010; van 
Duijkeren et al., 2011a). However, surprisingly, we did not find any MRSP in our dogs. While it 
was already suspected from our study that a possible reason for this absence was the use of 
cefoxitin in both our enrichment broth and the primary isolation media, we have found further 
support for this assumption in the studies on MRNAS carriage in pigs and bovines. Indeed, 
these studies revealed that mecA-positive strains that have a cefoxitin MIC ≤ 4 mg/l – the S. 
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aureus susceptibility breakpoint for cefoxitin broth micro-dilution testing recommended by 
CLSI (CLSI, 2009) – quite frequently occur among MRNAS. At present, the cefoxitin MIC 
distribution for S. pseudintermedius is not known. However, from the literature, it appears 
that the CLSI interpretive criteria as published in the 2008 document M31-A3 (CLSI, 2008) for 
oxacillin broth microdilution testing, oxacillin disk diffusion testing as well as cefoxitin disk 
diffusion testing considerably underestimated the presence of mecA-positive S. 
pseudintermedius strains (Schissler et al., 2009). As these breakpoints were in fact the S. aureus 
breakpoints, this suggests that also the S. aureus susceptibility breakpoint for cefoxitin broth 
microdilution testing may be too stringent. In other words, it makes it likely to suppose that 
mecA-positive S. pseudintermedius isolates exist that have cefoxitin MICS < 3.5 mg/l, and, 
hence, such strains will not have been detected in our study. Therefore, a new study, using a 
different isolation method, should re-assess the presence of MRSP in Belgian dogs. In such 
study, it would also be useful to enlarge the sampling area compared to our study, and a better 
categorisation of the animals as to origin and clinical condition would allow drawing stronger 
conclusions on MRSP presence than is possible with our current data. 
In light of the relatively large species diversity and carriage rate of MRNAS in pigs and 
bovines, the detection of only a single MRNAS isolate in almost 200 dog samples is 
remarkable. The use of only cefoxitin-containing isolation media might also be part of the 
explanation for this observation. One must neither forget that the obtained occurrence rates of 
MRNAS in dogs on the one hand and pigs and bovines on the other are to be interpreted 
differently. As the dogs comprised independent animals selected over a longer period, the 
data in that study represent the prevalence of MR staphylococci in dogs. In contrast, multiple 
pigs and bovines from a same farm were sampled at the same moment. In order to better 
estimate the MRNAS occurrence in pigs and bovines, the sampled animals should be 
independent. Indeed, also in dogs, indications of MR staphylococcal transmission between 
animals housed together have been found (Floras et al., 2010). 
Despite the difference in approach between dogs and pigs/ bovines, our studies suggest that 
carriage of MRNAS is lower in companion animals compared to industrially raised food 
producing animals. The reasons for this are not clear but investigating them might provide 
interesting information on how to control the emergence and spread of MR staphylococci in 
food producing animals. We have found indications that the carriage rates of MRNAS depend 
on management, with those sectors where antimicrobial usage is higher presenting more 
MRNAS-positive animals. Indeed, even among the industrially raised animal species, where 
the use of antimicrobials is more common, MRNAS carriage rates were (much) lower in those 
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animal types (dairy and beef cows) for which antimicrobial use is individually organised and 
more aimed at treatment than at prevention. Moreover, when regarding only the pigs, a 
significant lower MRNAS carriage was observed in sows compared to piglets and slaughter 
pigs (data not shown), and the use of antimicrobial agents is much lower in sows compared to 
slaughter pigs and especially piglets (Aarestrup et al., 2008). 
However, the finding of a higher MRNAS occurrence in veal calves, piglets and fattening 
pigs suggests that the observed differences in MRNAS carriage might as well be attributed to 
an age effect. Interestingly, similar observations have previously been reported for MRSA: 
Belgian piglets were found to carry significantly more MRSA CC398 than sows and fattening 
pigs (Crombé et al., 2011). In addition, among different bovine groups, MRSA is (almost) 
lacking in Belgian dairy and beef cows, while being ubiquitously present in veal calves 
(Vandendriessche et al., 2011b). Possibly, differences in immunity in younger animals are part of 
the explanation for this apparent age-related effect. This might be a subject for further 
research. 
In pigs and veal calves, there appears to be quite a difference in carriage rates of MRSA 
and MRNAS. While MRSA prevalences of 44% have been reported for Belgian pigs (Crombé 
et al., 2011) – even up to 52% and 77% specifically for fattening pigs (Alt et al., 2011; Crombé et al., 
2011) – we found only 29.5% of our animals to carry an MRNAS. In veal calves, a MRSA 
CC398 carriage rate of 64% has been found (Vandendriessche et al., 2011b), while this was only 
30.5% for MRNAS. Hence, MRNAS are much less prevalent in food producing animals than 
is MRSA. This is all the more remarkable when one considers that the ‘MRNAS’ represent in 
fact 43 different species while MRSA is a single species. It is an observation for which no 
immediate explanation is available. Possibly, MRSA (CC398) is competitively stronger than 
MRNAS species, for example enabling it to spread easier through direct contact or to better 
survive in the environment and spread indirectly. Remarkably though, a slightly different 
picture appears when the occurrence of MRNAS and MRSA is compared at the farm level. 
Indeed, in both pig and veal calf farms, the farm level prevalence of MRNAS was 100%, 
while this was 70% and 30% in beef and dairy farms, respectively. In contrast, 90% of veal 
calf farms were MRSA positive, while just three beef cow farms and a single dairy cow farm 
were positive for MRSA (S. Vandendriessche, personal communication). These findings might mean 
that some kind of basic MRNAS population is present in pigs and bovines. As the members of 
the S. sciuri species group were found as predominant species in pigs, veal calves, dairy and 
beef cows, they might constitute the backbone of such basic population. Then, the difference 
in MRNAS prevalence between pigs and veal calves compared to dairy and beef cows might 
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be due to an expansion of the basic MRNAS population following selective conditions. Yet, 
as the MRNAS species diversity was relatively higher among pigs than among veal calves, in 
pigs some additional exterior source of MRNAS species might have caused an ‘injection’ of 
MRNAS into the host population. Considering that quite some typical human MRNAS 
species were present in pigs, this injection might have come from humans in close contact 
with the pigs. Information that will allow for a better understanding of the exact facts of the 
matter is knowledge on the species composition of the methicillin-susceptible NAS (MSNAS) 
population and knowledge of the genetic background of the MSNAS and MRNAS isolates. 
This will allow linking the presence of MRNAS to the MSNAS population. A large collection 
of MSNAS isolates, that we have composed during the isolations of MRNAS in the different 
animals, would be excellent material to study this in the future. 
The question on the origin of MR staphylococci in animals is particularly relevant in light 
of the emergence of MRSA CC398. Clearly, generally two situations might have occurred: 
MRSA emerged from the MSSA population that naturally resides in animals, by uptake or de 
novo creation of SCCmec; or, MRSA was introduced from an external source and spread 
within the host population. According to recent research, the emergence of MRSA CC398 is 
to be understood as a human S. aureus strain that entered the animal reservoir, lost some 
human-adaptive traits and then acquired methicillin resistance (Price et al., 2012). Even though 
this conclusion is based on a rather limited collection of strains, and, hence, more research 
will be required to confirm these findings – especially the human origin of S. aureus CC398 – 
it indicates an important role for animal MRNAS species as a reservoir for SCCmec. This is 
confirmed by our research, as it provides proof that a dominant group of MRNAS from pigs 
indeed harbour similar SCCmec types as those that are frequently found in MRSA CC398 – 
an observation which has furthermore also been made in a Dutch study (Tulinski et al., 2012). An 
important consequence emerges from these findings: eradication or control measures for 
MRSA CC398 in pigs need to take the MRNAS population in consideration. If MRSA is 
successfully repressed but the MRNAS population is left intact, then it might only require 
susceptible S. aureus strains and suitable MRNAS strains for MRSA to re-emerge. 
However, the research of Price and colleagues (2012) leaves a major question unanswered: 
which is currently the normal (animal) host species for S. aureus CC398? Can it be assumed 
that all animal species in which MRSA CC398 thrives are natural hosts? The problem here is 
that data on the normal S. aureus types that are carried by food producing animals are rather 
scarce. For pigs, a limited number of studies have shown that CC398 is indeed a common S. 
aureus type (Armand-Lefevre et al., 2005; Guardabassi et al., 2007; Hasman et al., 2009). In poultry, some 
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studies have revealed that especially CC5 is an important type of S. aureus (Hasman et al., 2009; 
Lowder et al., 2009). In cattle, several studies have shown that a number of S. aureus lineages are 
typical for bovines, with CC398 not being among them (Smith et al., 2005; Rabello et al., 2007; Sung 
et al., 2008; Hasman et al., 2009; Hata et al., 2010; Delgado et al., 2011) – even though it must be noted 
that data on S. aureus healthy carriage types in bovines are practically lacking. These 
observations might indicate that in other animals than pigs, MRSA CC398 is predominantly 
introduced from another source. This statement is also supported by our data: the SCCmec 
types typically found in MRSA CC398 appeared to be almost absent in MRNAS from 
bovines. Hence, our data indicate that the emergence of MRSA CC398 may in some animals 
be the result of SCCmec uptake by susceptible S. aureus CC398 strains while in others MRSA 
CC398 strain transmission between animal species might be the major driving force.  
The MRNAS population might also function as SCCmec reservoir for other MRSA types 
that prevail in animals. Both in pigs and bovines, the other MRSA types that have been found 
carried very diverse SCCmec types (Tables 6 and 7), many of which, including type III 
cassettes, are also carried by MRNAS. However, as noted, most non-CC398 MRSA lineages 
present in pigs and bovines have typical human genetic backgrounds. A notable exception in 
pigs is CC9, of which MSSA strains have been identified as common residents (Armand-Lefevre 
et al., 2005; Guardabassi et al., 2007; Hasman et al., 2009). In the future, MRSA CC9 strains might 
also emerge in Belgium, as methicillin-susceptible S. aureus CC9 has been found in nasal 
samples of animals (Vandendriessche et al., 2011a).  
Besides its serving as a source for the classic mecA gene and recognised SCCmec 
elements, it is also interesting to consider the role of MRNAS as a reservoir for mecA variants 
and new SCCmec elements. Our study was the first to search for the presence of the new 
mecALGA251 in bovine MRNAS. This was particularly relevant considering that the emergence 
of this new type of MRSA possibly occurred in bovines (García-Álvarez et al., 2011; Shore et al., 
2011). Also in nasal samples from Belgian dairy and beef cows, some MRSA strains carrying 
mecALGA251 have been detected (S. Vandendriessche, personal communication). It was therefore kind 
of surprising not to find any MRNAS carrying mecALGA251. Future research will need to show 
whether mecALGA251 might be circulating in MRNAS in a very low prevalence. It will also be 
very interesting to investigate the presence of mecALGA251 gene in MRNAS from pigs, 
especially since many mixed pig-cattle farms exist in Belgium. Moreover, more variants of 
mecA may be circulating in MRSA or MRNAS from animals, as these would have been 
missed by the PCR methods detecting the classic mecA. Indeed, the discovery of mecALGA251 
has profound implications on the current genotypic testing protocols for mecA. Future studies 
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into the SCCmec reservoir in MRNAS should account for possible variation in the genetic 
locus they are looking for. 
Even though we found only the classic mecA gene, still a large diversity of SCCmec types 
was identified in our MRNAS. Many cassettes appeared to be non-typeable with the used 
techniques, especially in bovine MRNAS. It would be very interesting to perform more 
detailed studies on the structures of these cassettes. This is important for three reasons. First, 
it would allow a more accurate assessment of the transfer and sharing of SCCmec among 
different staphylococcal strains or species, most notably among MRNAS and MRSA. Second, 
in-depth study of the structure of the J-regions might identify the presence of additional 
resistance determinants, which is important in regard of SCCmec as a mobile genetic element. 
Third, the study of the SCCmec structures in different MRS species and strains might shed 
more light on the evolution, mobility and plasticity of SCCmec. Currently, the origin and 
evolution of SCCmec elements is poorly understood. The role of de novo creation or internal 
genetic rearrangement events is unclear. Possibly some MR staphylococcal species, such as 
MR S. epidermidis and MR S. haemolyticus, more readily function as places of SCCmec 
modification, due to the frequent occurrence of genomic rearrangements in these species 
(Takeuchi et al., 2005; Miragaia et al., 2007). 
The question can be posed on how frequently new SCCmec elements are formed and in 
which rate this adds to the emergence of MRSA (CC398) in animals. The original formation 
of SCCmec has been explained as a combination event of a class A-like mec structure in S. 
fleurettii with an ‘empty’ SCC element. The tremendous diversity of SCCmec elements that is 
currently observed, in both human and animals, might then have evolved through various 
genetic events occurring in the prototype SCCmec, such as inversions, deletions, 
substitutions, recombinations and the insertions or deletions of plasmids and transposons. Yet, 
it can neither be excluded that de novo formation of SCCmec elements still occurs in nature 
and it is completely unclear how frequently this happens. There have been quite some reports 
on spontaneous deletions of SCCmec and on SCC(mec) elements showing various genetic 
rearrangements (Noto et al., 2008; Chen et al., 2010; Chlebowicz et al., 2010; Wong et al., 2010; Boundy et 
al., 2012). Possibly, also some of the non-typeable elements we found in our MRNAS represent 
examples of incomplete or unsuccessful SCCmec formations. Whether S. fleurettii carrying 
the native mecA is always involved in de novo formations of SCCmec is unclear but highly 
unlikely. Nonetheless, methicillin-susceptible staphylococcal species coexistent with S. 
fleurettii may be prone for SCCmec formation. As S. fleurettii is an animal-associated species, 
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this highlights the role of animals as hosts for de novo SCCmec creation (Tsubakishita et al., 
2010). 
To conclude, it must be noted that the transfer of SCCmec among staphylococci is most 
often considered in the sense of S. aureus as the acceptor species and MRNAS as natural 
reservoir and the donor species, probably because S. aureus is the most virulent and most 
notorious staphylococcal pathogen and MRSA is granted with most attention. Yet, it is 
unclear whether this donor-acceptor relationship is also the dominant relationship in nature, 
and, thus, one must be cautious not to carelessly equal ‘reservoir’ with ‘donor’. It will be 
challenging for future research to elucidate a theoretical framework of how SCCmec transfer 
actually occurs among staphylococci. Such knowledge would greatly improve our 
understanding of the emergence of MR staphylococci, in both animals and humans. 
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SUMMARY 
Methicillin-resistant S. aureus (MRSA) has long been known as one of the most important 
multi-resistant bacteria in human medicine. Traditionally, two main types of MRSA were 
distinguished: strains associated with hospitals and strains associated with healthy community 
members. However, halfway the past decennium, a possible third reservoir of MRSA was 
discovered in pigs and other food producing animals. In Europe, this reservoir consisted 
principally of a single clone of MRSA, CC398. A particularly worrying observation was that 
humans having regular close contact with affected animals were also at risk of becoming 
contaminated, colonised or infected with MRSA CC398. 
Research performed some years ago revealed that Belgian pig farms were highly affected 
by MRSA CC398. In addition, this type of MRSA was identified in a considerable part of 
Belgian horses and broiler chickens. Yet, so far, no data were available on the situation in 
other animals, such as dairy cows and pets. One of the aims of the research presented here 
was to investigate this further. Moreover, the unexpected detection of MRSA in animals 
raised interest into the origin of animal-associated MRSA strains. In human medicine, the 
emergence of MRSA is often linked with the presence of a reservoir for the genetic 
determinant of methicillin resistance – the mecA gene carried in a mobile genetic element 
called staphylococcal cassette chromosome mec (SCCmec) – in methicillin-resistant non-S. 
aureus staphylococci (MRNAS). While it could be suspected that MRNAS play a similar role 
in animals, for a long time hardly any research was performed into the presence and 
characteristics of MRNAS in animals. Therefore, the second aim of this research was to 
assess the carriage and diversity of MRNAS in dogs, pigs and cattle and to study the SCCmec 
types in these MRNAS. 
In a first experimental study (Chapter 4), a collection of 118 subsequent isolates of S. 
aureus originating from cases of clinical or subclinical mastitis were found to harbour 11 
(9.3%) MRSA strains, which were all typed as belonging to the CC398 lineage. Then, four of 
the farms from which an MRSA-positive animal was retrieved were selected to study the 
within-herd prevalence of MRSA. While one of these farms was found no longer to harbour 
MRSA-positive animals, in the other three, MRSA within-herd prevalences of 3.9% to 7.4% 
were found. Also here, all isolates were identified as MRSA CC398. This study showed an 
important presence of MRSA CC398 in bovine mastitis, which, considering the typical multi-
resistant phenotype of MRSA CC398, could lead to substantial problems in the future. 
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Therefore, further research is needed to elucidate the exact burden and epidemiology of 
MRSA CC398 in bovine mastitis. 
In a second experimental study (Chapter 5), 177 nasal swabs, originating from dogs 
admitted to a veterinary hospital, were investigated for the presence of MRSA and MRNAS. 
Two MRSA strains and one methicillin-resistant Staphylococcus haemolyticus were isolated. 
The MRSA strains were identified as belonging to human hospital clones, which is in line 
with the international literature. This might pose risks for the occurrence of (re-)transmission 
to humans, and should warn owners and other contact persons of affected dogs, as the 
development of (recurrent) infections by such MRSA strains has previously been reported. 
Methicillin-resistant S. haemolyticus is one of the most common pathogens from blood 
infections in human hospitals but is also one of the MRNAS species that is most frequently – 
albeit in small numbers – isolated from various animal species. Even though this study 
showed a low prevalence of methicillin-resistant staphylococci in Belgian dogs, it is 
recommended that future studies investigate an enlarged study population and use different 
isolation methods. This will also allow gaining more insight on the presence of methicillin-
resistant Staphylococcus pseudintermedius, which was now surprisingly lacking from our 
samples. 
A third experimental study (Chapter 6) investigated nasal swab samples from 200 pigs (60 
sows, 60 piglets and 80 slaughter pigs) for the presence of MRNAS. The animals originated 
from 10 pig farms that had appeared positive for MRSA CC398 in a previous study. A total of 
72 MRNAS were isolated, from 59 (29.5%) animals and belonging to seven different species, 
with methicillin-resistant Staphylococcus epidermidis and methicillin-resistant 
Staphylococcus sciuri predominating. Additional antimicrobial resistances to macrolide-
lincosamide-streptogramin antimicrobials, tetracycline, trimethoprim and sulfamethoxazole 
were frequently detected. Interestingly, these are also the typical additional resistances present 
in MRSA CC398. A large variety of SCCmec types was present in the MRNAS; yet, type IV 
elements predominated and a considerable part of MRNAS strains carried SCCmec types that 
are also typically present in MRSA CC398. The results of this study suggest an important role 
of MRNAS in pigs as reservoir for methicillin- and other antimicrobial resistances for S. 
aureus. The predominance of methicillin-resistant S. epidermidis was remarkable, since this is 
considered to be a species typical for humans. Our data thus suggest the possibility of 
MRNAS exchange between humans and animals. 
Finally, a fourth experimental study (Chapter 7) investigated the MRNAS population in 
different bovine groups. Nasal samples were collected from 150 veal calves on 15 veal calf 
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farms, 100 dairy cows on 10 dairy farms and 100 beef cows on 10 beef farms. The MRNAS 
carriage was 30.7% in veal calves, 12% in dairy cows and 24% in beef cows. The new mecA 
variant mecALGA251, which appears to be associated with bovines, was not detected in our 
bovine non-S. aureus staphylococci. A total of seven MRNAS species was identified but 
almost 80% of the isolates belonged to the S. sciuri species group. Additional resistance to 
aminoglycosides, macrolide-lincosamide-streptogramin antimicrobials, tetracycline and 
ciprofloxacin was frequently detected. Remarkably, two strains from veal calves were found 
to be linezolid-resistant, mediated through the multiresistance gene cfr. The SCCmec types in 
MRNAS from bovines were quite different from those typically found in MRSA CC398. A 
relatively larger amount of non-typeable cassettes was detected compared to pigs. The results 
suggest an age- or management related difference in MRNAS carriage in bovines, and they 
show a rather different MRNAS diversity in bovines compared to pigs. While bovine 
MRNAS appear to show few resemblance to SCCmec types of MRSA CC398, our data 
suggest that they can function as potentially important reservoir for other antimicrobial 
resistance determinants. 
The four studies that were performed provide unique data on the presence of methicillin-
resistant staphylococci in (Belgian) animals. These data should be regarded as a good basis 
for future research to be performed in various aspects of the epidemiology of methicillin-
resistant staphylococci in animals, as many questions remain unanswered. A large collection 
of methicillin-suscpetible non-S. aureus staphylococci collected from the various animal 
species could be of major use for further elucidating the mechanisms explaining the 
emergence and spread of methicillin resistance in animal staphylococci. This would yield 
valuable information for controlling and preventing the presence of methicillin-resistant 
staphylococci in animals. 
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SAMENVATTING 
Methicilline-resistente Staphylococcus aureus (MRSA) is reeds lang gekend als een van de 
belangrijkste humane multiresistente bacteriën, die een waaier aan levensbedreigende 
infecties kan veroorzaken. Traditioneel werden twee types MRSA onderscheiden: diegene die 
voorkomen in associatie met ziekenhuizen en diegene die voorkomen bij gezonde individuen 
in de maatschappij. Halverwege het afgelopen decennium werd echter ontdekt dat er mogelijk 
nog een derde reservoir voor MRSA bestaat, m.n. bij dieren gekweekt voor voedselproductie. 
Studies hebben aangetoond dat dit reservoir in Europa bijna volledig bestaat uit één enkele 
kloon, MRSA CC398. Eén van de meest verontrustende aspecten van deze ontdekking was de 
observatie dat mensen die regelmatig in dicht contact kwamen met besmette dieren zelf ook 
besmet raakten met MRSA CC398. 
Uit onderzoek dat een vijftal jaar geleden werd uitgevoerd bleek dat MRSA CC398 
stammen in hoge mate voorkomen in Belgische varkensbedrijven. Daarnaast werd ook bij 
paarden en braadkippen vastgesteld dat een belangrijk percentage besmet was. Over andere 
dieren, zoals melkkoeien en kleine huisdieren, was er echter nog geen informatie beschikbaar. 
Het was één van de doelstellingen van het hier beschreven onderzoekswerk om dit verder te 
bestuderen. Daarbovenop zorgde de onverwachte opmars van MRSA bij dieren voor vragen 
naar de oorsprong van de diergebonden MRSA stammen. In de humane geneeskunde wordt 
het ontstaan van MRSA vaak in verband gebracht met een reservoir voor de genetische 
determinant van methicilline resistentie – het mecA gen dat bevat zit in een mobiel genetisch 
element dat “staphylococcal cassette chromosome mec (SCCmec)” wordt genoemd – in 
methicilline-resistente niet-S. aureus stafylokokken (MRNAS). Er werd vermoed dat 
MRNAS ook bij dieren een dergelijke rol kunnen spelen. Echter, tot hiertoe werd zeer weinig 
onderzoek uitgevoerd naar het voorkomen van MRNAS bij dieren. Daarom was een tweede 
doelstelling van deze doctoraatsstudie om het dragerschap, de diversiteit en de 
karakteristieken van MRNAS bij honden, varkens en runderen te onderzoeken. 
In een eerste experimentele studie (Hoofdstuk 4) werden in een collectie van 118 
opeenvolgende isolaten van S. aureus afkomstig van gevallen van klinische of subklinische 
mastitis 11 (9.3%) MRSA stammen gevonden, welke allemaal getypeerd werden als MRSA 
CC398. Daarna werd op vier bedrijven waar MRSA-positieve dieren werden gevonden de 
within-herd prevalentie van MRSA onderzocht. Op één van deze bedrijven kon geen MRSA 
meer worden gedetecteerd; op de andere drie werden within-herd prevalenties van 3.9% tot 
7.4% vastgesteld. Ook deze stammen bleken alle MRSA CC398 te zijn. Deze studie toonde 
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een belangrijke aanwezigheid van MRSA CC398 in runder-mastitis aan. De typische 
multiresistentie van dit type MRSA kan in de toekomst tot aanzienlijke problemen leiden voor 
behandeling van S. aureus gerelateerde mastitis. Bijgevolg is verder onderzoek nodig naar de 
precieze omvang van het probleem en naar de epidemiologie van MRSA CC398 op melkvee-
bedrijven. 
In een tweede experimentele studie (Hoofdstuk 5) werden nasale swabs van 177 honden, 
gescreend tijdens opname in de Kliniek kleine huisdieren van de Faculteit Diergeneeskunde 
aan de UGent, onderzocht op de aanwezigheid van MRSA en MRNAS. Twee MRSA 
stammen en één methicilline-resistente Staphylococcus haemolyticus werden geïsoleerd. De 
MRSA stammen behoorden tot typisch humane hospitaal klonen, wat in de lijn ligt van de 
internationale literatuur. Dit noopt tot voorzichtigheid bij eigenaars en andere contact-
personen, aangezien overdracht van humane MRSA stammen van honden naar mensen 
gevolgd door het ontstaan van infecties reeds meerdere malen gerapporteerd is geworden. 
Methicilline-resistente S. haemolyticus is één van de meest voorkomende pathogenen 
geïsoleerd uit bloedinfecties in Belgische ziekenhuizen. Tegelijk is het een soort die frequent, 
zij het in geringe mate, wordt gevonden bij uiteenlopende diersoorten. Hoewel dit onderzoek 
een lage prevalentie toont van methicilline-resistente stafylokokken bij Belgische honden, 
zouden verdere studies nuttig zijn om een grotere populatie honden te onderzoeken en om 
meer inzicht te verkrijgen in de aanwezigheid van methicilline-resistente Staphylococcus 
pseudintermedius bij Belgische honden, aangezien dit species nu verrassend afwezig was. 
Een derde experimentele studie (Hoofdstuk 6) onderzocht neusswabs van in totaal 200 
varkens (60 zeugen, 60 biggen en 80 vleesvarkens) op de aanwezigheid van MRNAS. De 
dieren waren afkomstig van 10 varkensbedrijven die in een voorgaande studie positief waren 
gebleken voor MRSA CC398. Een totaal van 72 MRNAS werden geïsoleerd, afkomstig van 
59 dieren (29.5%) en behorende tot 7 verschillende species, met als meest voorkomende 
species methicilline-resistente Staphylococcus epidermidis en methicilline-resistente 
Staphylococcus sciuri. Additionele antimicrobiële resistentie aan macrolide-lincosamide-
streptogramin antibiotica, tetracycline, trimethoprim en sulfamethoxazole werd frequent 
gedetecteerd. Dit is tevens de typische additionele resistentie die bij MRSA CC398 wordt 
gevonden. Er werd een grote variëteit aan SCCmec types gevonden in de MRNAS populatie. 
Echter, type IV elementen kwamen het meeste voor, en er werd een belangrijke overeenkomst 
vastgesteld met de SCCmec types die overwegend bij MRSA CC398 worden gevonden. De 
resultaten van deze studie suggereren een belangrijke rol van MRNAS in varkens als reservoir 
voor methicilline- en andere antimicrobiële resistenties voor S. aureus. De predominantie van 
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methicilline-resistente S. epidermidis was opmerkelijk aangezien dit de humane soort bij 
uitstek is en een van de meest voorkomende hospitaal pathogenen; aldus suggereren onze 
resultaten mogelijke overdracht van MRNAS tussen mens en varken. 
Tot slot werd in een vierde experimentele studie (Hoofdstuk 7) de MRNAS populatie 
onderzocht bij verschillende groepen runderen. Er werden neusstalen genomen van 150 
vleeskalveren op 15 vleeskalverbedrijven, 100 melkkoeien op 10 melkveebedrijven en 100 
vleeskoeien op 10 vleesveebedrijven. Het MRNAS dragerschap bedroeg 30.7% bij 
vleeskalveren, 12% bij melkkoeien en 24% bij vleeskoeien. Er werden in totaal zeven species 
gevonden maar bijna 80% van de isolaten behoorde tot de S. sciuri species groep. Additionele 
antimicrobiële resistentie aan aminoglycosides, macrolide-lincosamide-streptogramin 
antibiotica, tetracycline en ciprofloxacin werd frequent gedetecteerd. Een opmerkelijke 
vaststelling was de isolatie van twee stammen die resistent waren aan linezolid. Deze 
resistentie werd gemedieerd door het multiresistentie-gen cfr. De SCCmec types in boviene 
MRNAS verschilden grotendeels van die types die typisch in MRSA CC398 voorkomen. In 
vergelijking met varkens werd bovendien een groter aantal niet-typeerbare cassettes 
gevonden. De resultaten suggereren een leeftijds- of managementgebonden verschil in 
MRNAS dragerschap en ze tonen een grotendeels andere diversiteit aan van MRNAS species 
bij runderen in vergelijking met varkens. Waar MRNAS van runderen weinig gelijkenis 
vertonen in SCCmec types met MRSA CC398 suggereren onze data dat ze wel kunnen 
fungeren als potentieel belangrijk reservoir voor andere resistentie determinanten. 
De vier studies die in dit doctoraatsonderzoek werden uitgevoerd verschaffen een uniek 
inzicht in het voorkomen en de eigenschappen van methicilline-resistente stafylokokken in 
dieren. Echter, vele vragen in verband met hun epidemiologie blijven onbeantwoord en 
bijgevolg zouden de gegenereerde data kunnen dienen als startpunt voor verschillende 
toekomstige studies. Een ruime collectie aan methicilline-gevoelige stafylokokken die werd 
verzameld bij de verschillende dieren zou van grote waarde kunnen zijn om meer inzicht te 
verkrijgen in het ontstaan en de verspreiding van methicilline-resistente stafylokokken bij 
dieren. Dit zou waardevolle informatie opleveren voor het nemen van maatregelen ter 
bestrijding en preventie van methicilline-resistente stafylokokken bij dieren. 
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c. A. de Kruif, Prof. dr. Jaap Wagenaar, Prof. dr. Ann Martens en Prof. dr. Sylvie Daminet. Ik 
wil hen graag bedanken om in deze commissie te willen zetelen en voor hun inspanningen bij 
het nalezen en geven van opmerkingen. 
 
Ik wil speciaal mijn dank betuigen aan Prof. dr. Olivier Denis. Olivier, discussiëren met 
jou was nooit minder dan zeer leerrijk. De voorbije jaren heb ik je leren kennen als een zeer 
hartelijk en grappig persoon, met een grote kennis over bacteriologie en stafylokokken in het 
bijzonder. Je hebt me regelmatig geholpen met allerlei praktische en theoretische kwesties en 
ik ben je daar zeer dankbaar voor. Hoewel ik niet officieel aan de ULB verbonden was voelde 
het toch aan als m’n derde labo! 
 
Prof. dr. Marc Struelens en Prof. dr. Marie Hallin van het labo microbiologie van het 
Erasmus Ziekenhuis (Prof. Struelens is tegenwoordig werkzaam in het ECDC) wil ik 
bedanken voor hun initiële steun en betrokkenheid bij de planning en uitvoering van het 
onderzoeksproject. 
 
Graag wil ik een aantal mensen bedanken waarmee ik de voorbije jaren heb samengewerkt. 
dr. Jo Vicca van Katho Roeselare, voor haar rol in het uitschrijven van deel 2 van de mastitis 
studie, en Tineke Cerpentier, die daarbij het veldwerk voor haar rekening nam. dr. Geertrui 
Rasschaert en haar collega’s op het ILVO, voor de aangename samenwerking bij het begin 
van m’n doctoraatsstudie op typeringstechnieken van stafylokokken. Prof. dr. Ingeborgh Polis 
en collega’s van de kliniek kleine huisdieren op de Faculteit, voor de hulp bij het opzoeken en 
verwerken van de klinische data van de honden. 
 
De mensen die werken op het labo microbiologie van het Erasmus Ziekenhuis in 
Anderlecht, en dan in het bijzonder Claire Nonhoff, wil ik bedanken voor hun hulp bij het 
testen van de antimicrobiële resistentie van een aantal van m’n MRNAS stammen, en voor 
hun deskundige uitleg bij het interpreteren daarvan. Het was steeds aangenaam te telefoneren 
naar Stien – nooit wist ik wie zou opnemen, maar steeds was het wel een mooie vrouwenstem 
die me in het Frans begroette .  
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Prof. dr. Sarne De Vliegher, dr. Karlien Supré en  Prof. dr. Mario Vaneechoutte van het UZ 
Gent wil ik danken voor hun bereidwilligheid om CNS stammen af te staan; zonder dit was 
het aanleggen van m’n tDNA bibliotheek niet mogelijk geweest. Speciaal dank ook aan 
Karlien, voor de hulp en boeiende discussies bij het werken met CNS en tDNA. Je was in 
feite altijd zowat m’n enige contact in de stafylokokken-branche die ook eens niet met S. 
aureus bezig was, en heb me daarom altijd wat verbonden gevoeld. Ik hoop dat we elkaar 
later nog eens tegen het lijf lopen! 
 
dr. Ilse Vandecandelaere en Prof. dr. Tom Coenye wil ik bedanken voor het ter 
beschikking stellen van een collectie S. epidermidis stammen. Ik heb er zelf helaas niet veel 
meer mee kunnen doen, maar er wordt op dit moment volop aan gewerkt! 
 
Van het CODA-CERVA wil ik dr. Hein Imberechts bedanken voor zijn steun bij en 
interesse in mijn onderzoek. Bedankt ook aan u en aan directeur Pierre Kerkhofs om mij nog 
twee maanden langer aan te werven, wat me de tijd heeft gegeven om een aantal zaken mooi 
af te ronden. 
 
Natuurlijk zijn er dan nog een heel aantal collega’s waar ik vaak of minder vaak in contact 
mee ben gekomen, maar waar het steeds aangenaam mee praten of werken was. Van de 
faculteit in Merelbeke: Bregje, Ann, Annemieke, Elin, Alexander en Bram: merci om altijd 
‘thuis te geven’ voor een kleine koffieklets als ik eens binnenwaaide. Ik heb het altijd spijtig 
gevonden dat ik nooit echt jullie collega ben geweest. Bregje en Alex, succes nog met jullie 
doctoraat. Ik wil zeker ook Annelies bedanken. In bepaalde periodes werkten we nogal nauw 
samen, met mooi resultaat! Daarnaast was het ook steeds plezant om eens een stevig boompje 
op te zetten over doctoreren en dat het toch allemaal niet gemakkelijk is . Ik wens je alvast 
veel succes met het afwerken van je eigen doctoraat! Ook een woordje van dank aan Urszula 
en Sandrine, voor hun steun en de helaas weinige maar altijd zeer aangename babbels/mails. 
Van het Erasmus Ziekenhuis wil ik Cristina Garcia bedanken. Cristina, I wish you all the best 
in your future activities. I had so much fun going on trips with you! Thank you for your 
support. 
 
De collega’s van het IWT-MRSA project, Larissa en Marijke, wil ik ook graag bedanken. 
We waren de voorbije jaren ergens toch een klein beetje een team, en, wel, ik vind dat we dat 
goed gedaan hebben! Ik ben zeker dat jullie beide een prachtig doctoraat zullen produceren, 
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en ik wens er jullie alvast alle succes mee. En als we elkaar ooit nog eens tegenkomen op een 
terras in Washington (of elders)… bring on the beer!  
 
Er zijn vanzelfsprekend een heel aantal collega’s van op het CODA-CERVA die het 
verdienen vermeld te worden. Eerst en vooral Mieke: wat zouden de voorbije vier jaren 
geweest zijn zonder jou Mie? Altijd bereid te helpen, altijd (of toch bijna altijd ;-) een lach en 
een vriendelijk woord, regelmatig wat gezwans of een sappige roddel. Je bent meer een 
vriendin geworden dan een collega.. Ik hoop dan ook dat we elkaar zeker later nog eens zullen 
terugzien! Succes alvast verder op het CODA. En als het ooit eens saai of doods lijkt in het 
gebouw, denk dan aan mij en je zult alweer door de gang horen schallen “MIIEEEE…?”  
 
Daarnaast verdienen zeker ook Danielle, Heidi, Andy, Pierre en Vicky een stevig woord 
van dank, voor alle hulp of goeie raadgevingen die ze mij ooit geboden hebben. En dan 
natuurlijk de collega’s van ‘boven’ – jullie zijn met te veel om op te noemen, maar allen 
bedankt voor de leuke samenwerking de voorbije jaren. Eén iemand wil ik nog in het 
bijzonder bedanken: Déborah (Bonjour Débo!). Je was in den beginne mijn student maar zie, 
amper een jaar later ben je al incontournable in het labo! Ik wens je al het goede, zowel op het 
werk als daarbuiten, en wil je nog eens extra bedanken voor het vele werk dat je tijdens uw 
stage verzet hebt. 
 
Nu dat het toch over stage/studenten gaat, wil ik ook Eveline bedanken voor de korte maar 
krachtige en zeer leuke samenwerking tijdens haar masterthesis. Moge het je goed gaan in het 
leven! En ook Clément hoort hier thuis. Ik weet niet of je dit ooit zult lezen maar ik vond je 
een coole kerel, en een goeie laborant. Merci voor al uw werk! Katrien Geurts was dan wel 
geen stagair noch student maar toch hoort ze ook in dit rijtje, voor de ontzettend grote 
hoeveelheid werk die ze gedaan heeft tijdens haar zes maanden als laborant hier! Merci, 
Katrien. Je zit daar nu in het verre Australië, zelf aan het doctoreren, maar spoedig kom je 
terug, en als ik dan met enige trots mijn thesis aan u kan tonen, weet dat het voor een groot 
stuk ook uw verdienste is. Je hebt me lucht gegeven toen ik even moeite had om te ademen. 
En misschien moet ik je ook nog in bedekte termen bedanken voor uw werk als relatie-
therapeute – you know what I mean… ;-) 
 
Voorts een groot woord van dank aan Michelle: bedankt om altijd, steeds en overal klaar te 
staan om mij te helpen met vanalles en nog wat van administratief werk! Echt, als ik het 
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belang van personen voor mijn doctoraat zou moeten meten aan het aantal mails dat ik naar 
hen gestuurd heb, je zou wellicht dicht tegen de top vijf staan . Een hele dikke merci! Ook 
Nadine en Linda wil ik bedanken voor hun hulp. Linda, met jou (en Sandra!) aan de eettafel 
was het nooit vervelend. Denken aan uw hartelijke lach tovert hier een brede glimlach op m’n 
lippen. Veel succes nog met de Turkse les, en als ik binnen 50 jaar nog steeds gelukkig samen 
ben met m’n lieve Kristien, ik zal eens aan u denken . 
 
Een speciaal woord van dank moet zeker ook gaan naar de mensen van het magazijn: 
Ronny, Kim, Pascale, Jean-Marie en vooral Bettina. Ik kan de keren niet meer tellen dat ik de 
telefoon greep om u met een of andere vraag lastig te vallen, Bettina, en steeds was je daar 
met een vriendelijk antwoord en een helpende hand! Echt een hele dikke merci! Daarnaast 
verdienen ook Marleen, Katalin, Anabelle, Dominique, Christel en Katrien Vanhecke een 
grote ‘dank u’ om altijd klaar te staan als ik weer eens een vraag had of iets nodig had. 
 
Flavien bedank ik voor zijn hulp bij het opstellen van de bellijsten met landbouwbedrijven, 
en Yves, Ilse, Sofie en Marc voor hun hulp bij de statistiek en de aangename gesprekken 
tussendoor. Daarnaast wil ik ook Isabelle, Toon, Orkun, Koen, Tom, Mohammed, Hugo, PJ, 
Bart, Matthias, Eveline en Elke (zwangere Elke ) bedanken voor de leuke babbels (of het 
leuke pinten-gedrink) op de momenten dat onze wegen kruisten. Elke (niet-zwangere Elke) 
wordt bedankt om steeds het zonnetje te zijn als het weer eens slecht weer was. 
 
En dan nu, de dichtste collega’s… Stéphanie, ik wens je al het beste toe in de jaren die je 
nog resten (op het CODA bedoel ik ). Ik ben zeker dat je een mooi doctoraat zult schijven. 
We zegden nooit veel tegen elkaar maar je charmante aanwezigheid was als een constante 
factor die me rust bracht. Bedankt! Marian, you only arrived a few months ago but I have the 
feeling that we are colleagues for already some years. Your enthousiasm and working spirit 
are sure to be an inspiration for everyone at the lab, and I hope you will get funding soon, so 
that you can continue the good work! And if you ever come to Ghent, I’ll be happy to show 
you around… John, maybe you will ever come to read this in the future. I owe you a big 
‘thanks’ too. You were always very supportive, friendly and eager for a good listening or 
conversation. I hope you have big successes in your scientific career in the future! If you ever 
come back to Belgium, we should go take a beer. Leon, ‘t was kort en krachtig dat we 
collega’s waren maar ik heb me in die tijd toch goed geamuseerd. Je had het niet gemakkelijk, 
halverwege een doctoraat overnemen, maar je nam het vastberaden en met een flinke dosis lef 
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over, wat ik zeer bewonderenswaardig vind. Succes in de toekomst! Lotte, bij jou was het iets 
langer maar toch zijn we al een tijd geen collega’s meer. Ik heb je al gemist in tussentijd; je 
vinnige aanwezigheid maakte het een plezier om samen met jou in den bureau te zitten. Je 
hebt het zwaar gehad de voorbije maanden, zowel in je werk als daarbuiten, maar zie, je moet 
niet groot zijn om grootse dingen te doen . ‘k Zou zeggen, niet versagen, meid, je komt er 
zeker wel! 
 
En dan zijn er natuurlijk nog twee personen waar ik zeer speciaal eens stil bij wil staan: 
mijn twee dichtste collega’s, Stien en Florence. Meisjes, wat kan ik zeggen? Wat zouden de 
voorbije jaren geweest zijn zonder jullie? Ik kan jullie niet genoeg bedanken voor jullie steun, 
voor alles wat we al die tijd samen beleefd hebben. Jullie lagen beide in de weegschaal voor 
de twee vacature’s die toentertijd openstonden maar wie ook wat had gekregen, we waren 
voorbestemd om collega’s te worden . Maar kijk, je begint als collega’s, en eindigt als 
vrienden voor het leven. 
 
Florence, mijn lieve Flo, welke tijden hebben wij niet doorstaan, zeg? We’ve come a long 
way, zeggen de Engelsen, en verdraaid, ze hebben gelijk. Op den duur werd je toch vaak de 
reden dat ik ’s morgens met plezier opstond om naar het CODA te komen, maar dan werd je 
ook even vaak de reden dat ik dacht, verdorie, op het CODA kan ik mij toch niet zo goed 
concentreren ;-). Ik ben heel heel zeker dat je bezig bent een prachtig doctoraat uit je mouw te 
schudden, en ik ben heel heel zeker dat om het even wie u later in dienst zal nemen er een 
werknemer van goudwaarde zal bij krijgen. Zeer spijtig dat onze professionele wegen straks 
scheiden en dat er een flinke afstand tussen ons zal komen te bestaan. Maar geen nood, als ik 
ooit trouw, zal je zeker eregaste zijn ;-) Ik wens je het aller-, allerbeste! 
 
Stien, Stiena, ook we have come a long way, maar dan iets letterlijker . ’t Moet nog maar 
sinds enkele weken zijn dat ik, als ik in de auto aan het rijden ben, niet meer in paniek naast 
mij kijk om vast te stellen dat jij daar niet meer zit . Je bent echt een supermeid, en je was 
echt een supercollega! ‘k Ben me al enkele weken het hoofd aan het breken wat ik nu met al 
die gratis belminuten zal moeten doen als ik niet meer honderd keer per week met u aan de 
telefoon moet hangen . Heel veel succes met de afwerking van je doctoraat, en ja, tot straks 
aan de telefoon zeker ;-) 
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Ik wil ook graag al mijn vrienden en familie bedanken die niets met stafylokokken te 
maken hebben maar die me toch steeds gesteund hebben, in goede en slechte dagen. Heel veel 
dank!! 
 
Tot slot wil ik ook zeer zeker nog alle landbouwers bedanken die hebben meegewerkt aan 
het onderzoek dat tot deze thesis heeft geleid. De boerenstiel heeft het tegenwoordig verre van 
gemakkelijk, en nieuwe slechte tijdingen over alweer een gevaarlijke bacterie bij hun dieren 
kunnen ze missen als kiespijn. Hoewel ik hoop dat ik in de voorgaande teksten veel nuance 
heb kunnen leggen wat betreft de problamtiek van methicilline-resistente stafylokokken vergt 
het toch moed om aan dergelijke onderzoeken deel te nemen (al zijn ze dan anoniem). Ik wil 
hen dan ook van harte bedanken. Zonder hun medewerking is er simpelweg geen dergelijk 
wetenschappelijk onderzoek mogelijk, en daar verdienen ze alle respect voor. 
 
Mijn allerlaatste woord is voor zij die zich goed een halfjaar geleden aan mij heeft 
geopenbaard als een bloem die op een mooie morgen in mei ontluikt onder de lentezon. Mijn 
liefste Kristien, we zijn nog niet lang samen, en de maanden waarin we samen waren hebben 
we achtereenvolgens het schrijven van mijn doctoraat, het schrijven van uw eindwerk en de 
blok voor uw examens moeten overwinnen. Maar zelfs al volgen er nog 100 van dergelijke 
periodes, ik weet dat dat niet veel zal uitmaken, want jij bent hét voor mij…  
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Dierkunde, met grote onderscheiding. Het jaar daarop volgde hij de academische initiële 
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